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Abstract	  	  
The identification of Corynebacterium glutamicum as a glutamate producer in the 
1950’s was the start of its career as an amino acid producer. C. glutamicum has now been employed 
as cell factory for industrial amino acid production for over five decades and has a market size to 
reach $20 billion by 2020. As C. glutamicum was isolated for its natural ability to produce 
glutamate it makes it an excellent chassis for engineering it to produce its derivatives ornithine, 
proline, putrescine, citrulline, and arginine. These products are becoming increasingly important as 
they have a wide range of applications and the demand for these products is rising. The construction 
of a platform strain can reduce the time and resources required for strain development. Another 
approach to reduce the time and resources required for strain development is by developing new 
tools for metabolic engineering. These strategies were both explored to ease the process of strain 
construction. 
 
Proline, citrulline, and putrescine can be synthesized directly from ornithine, and three more 
reactions are required to synthesize arginine. Hence a strain engineered to produce ornithine can 
serve as a platform to produce the other four compounds. The first step was to establish proline and 
citrulline production by C. glutamicum as the rational engineering of C. glutamicum for production 
of these two amino acids had not previously been described.  
 
Proline is synthesized from glutamate via the proline biosynthetic pathway in most microorganisms, 
but with the help of the enzyme ornithine cyclodeaminase (Ocd) it can be synthesized from 
ornithine. Overexpression of putative ocd from C. glutamicum in an ornithine overproducing strain 
did not result in detectable proline production. Plasmid-based expression of ocd from Pseudomonas 
putida (ocdPp) on the other hand allowed accumulation of proline with a yield of 0.06 g proline / g 
glucose (g pro/g glc). Interestingly replacing the stop codon TGA of ocdPp with TAA resulted in a 
remarkable decrease in glutamate accumulation while the yield of proline increased to 0.25 g pro/g 
glc. The byproduct accumulation was further reduced by medium optimization, which also entailed 
a 25% higher proline yield. Lastly, the yield was boosted by overexpression of argBfbr encoding 
feedback-alleviated N-acetylglutamate kinase to 0.36 ± 0.01 g pro/g glc.  
 
A base strain suitable for the production of ornithine, proline, putrescine, citrulline, and arginine 
was constructed by deleting the repressor of the arginine pathway ArgR. Additionally the genes 
encoding enzymes of the arginine biosynthetic pathway were deleted, the deletion of argF allows 
ornithine to accumulate, and the deletion of argG allows citrulline to accumulate when argF is 
overexpressed. To add citrulline to the product spectrum of the platform strain we found it 
necessary to overexpress argBfbr along with argF. The strain accumulated citrulline with a yield of 
0.38  ±  0.01 g citrulline / g glucose. The potential and versatility of the strain was demonstrated by 
producing citrulline from the alternative carbon sources starch, xylose, and glucosamine. 
 
After the product range of the base strain had been extended to include citrulline, metabolic 
engineering was performed to increase the ornithine yield of the strain. The initial assumption was 
that an increased ornithine yield could be translated into increased yields of the other four 
	  	  VII	  
bioproducts. The ornithine yield was improved by 71% with a yield of 0.52 g ornithine / g glucose 
(g orn/g glc) compared to 0.31 g orn/g glc of the parent strain. This was achieved by feedback 
alleviation of N-acetylglutamate kinase, tuning of the promoter of gdh encoding glutamate 
dehydrogenase, lowering expression of pgi encoding phosphoglucoisomerase, along with the 
introduction of a second copy of the arginine biosynthetic operon argCJBfbrD into the chromosome. 
Strains capable of efficiently producing citrulline, proline, arginine or putrescine were derived from 
ornithine producing strains by plasmid-based overexpression of appropriate pathway modules with 
one to three genes. It was found that optimizing the base strain for ornithine production did not 
increase citrulline and arginine yields any further, indicating that the reaction converting ornithine 
into to citrulline is a bottleneck in citrulline and arginine production. 
 
Finally the popular CRISPR/dCas9 technology was adapted for the use of metabolic engineering in 
C. glutamicum. The system could be used to reversibly perturb gene expression. As proof of 
concept we targeted pgi in the lysine overproducing strain DM1729, where an almost complete 
repression of the transcription of the gene resulted in a 2-fold increase in the lysine titer. We also 
targeted the genes pck and pyk to increase glutamate production in wild-type C. glutamicum where 
we also observed nearly complete repression and increased glutamate titers. 
 
With this work it was shown how valuable the concept of using a platform strain for production of 
several industrially relevant bioproducts is. Moreover an efficient way to screen for new targets for 
metabolic engineering in C. glutamicum was demonstrated. From the initial cloning in Escherichia 
coli the C. glutamicum clones could be obtained in as little as four days by adapting the 
CRISPR/dCas9 system. 
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Chapter	  1.	  Introduction	  	  
	  
1.1	  Motivation	  
	  
Amino acids have been produced by microbial fermentation for over five decades. 
The central carbon metabolism and the amino acid pathways of several microorganisms including 
Escherichia coli, Corynebacterium glutamicum, and Saccharomyces cerevisiae are well known. 
Moreover a large number of publications on metabolism, characterization of pathways, and strain 
improvement for amino acid production are available.  
Microbial amino acid production has been extensively explored in academia as well as in industry. 
From a scientific point of view this does not make amino acid overproduction any less interesting, 
in fact, this along with new technologies available makes it more interesting than ever. The vast 
information available on the microbes commonly used for microbial fermentation can now be used 
to predict phenotypes useful for production of a given compound [1], [2]. 
However, it remains a challenge to engineer strains that are genetically stable, robust, fit, and 
accumulating high product concentrations. There are still many unknowns, such as regulation of 
pathways and how the pathways are intertwined. Furthermore it is difficult to predict the effect of 
multiple deletions, insertions, and mutations performed for improved production.  
 
Also from an industrial point of view amino acid production remains to be of major interest, not 
only because the compounds also can serve as precursors to high-value products, but mainly due to 
the growing amino acid market that is expected to reach an impressive size of US $20 billion in 
2020 [3], keeping in mind that amino acids are bulk products.  
Microbial amino acid production is a highlight of biotechnology; it is one of the few examples of 
production of bulk products that chemical synthesis cannot compete with. With only a few 
exceptions amino acids are nowadays produced by microbial fermentation, yielding the biologically 
active L-enantiomer [4]. Today over four million tons of amino acids are produced annually, many 
of them by coryneform bacteria [2], [4]. 
 
The industrial workhorse C. glutamicum, commonly used for amino acid production, has a strong 
flux towards glutamate synthesis and therefore can advantageously be employed as host for the 
production of glutamate derived bioproducts [2], [4]. These bioproducts include ornithine, 
citrulline, proline, putrescine, and arginine. They are industrial compounds with an increasing 
demand and importance due to their wide use in the chemical, bioplastic, cosmetic, food, feed, and 
pharmaceutical industries [5]–[8]. In this thesis the production of these compounds by C. 
glutamicum was explored. 	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1.2	  Objectives	  of	  this	  study	  
 
Under the concept of reducing the time and resources spent on the construction of new strains for 
biotechnological production the aims of this study was to optimize the production of ornithine by C. 
glutamicum that can serve as precursor of several other valuable compounds, and to develop the 
CRISPR/Cas9 system for metabolic engineering of C. glutamicum. To meet these aims the 
following objectives were framed: 
 
 
• Construct an ornithine producing base strain suitable for the production of proline, 
putrescine, citrulline, and arginine. 
 
• Construct a citrulline producing C. glutamicum strain. 
 
• During my master I found that proline could be produced by C. glutamicum ∆argFR with 
ornithine cyclodeaminase from Pseudomonas putida. In extension to this discovery, it was 
the aim to further explore proline production by C. glutamicum. 
 
• Increase the ornithine yield of the base strain. 
 
• Determine if an increase in ornithine production can be translated into increased production 
of citrulline, proline, putrescine, and arginine. 
 
• Explore the use of the CRISPR/dCas9 system for metabolic engineering of C. glutamicum  	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Chapter	  2.	  Background	  
	  	  
Wendisch, V.F., Eberhardt D., Herbst M., Jensen, J.V.K. Chapter 3. Amino Acids and Nucleotides. 
Biotechnological production of natural ingredients for food industry. Edited by Bicas, J.L., 
Maróstica Jr., M.R., Pastore G.M. Bentham eBooks. 	  	  
2.1	  Corynebacterium	  glutamicum	  and	  its	  versatility	  	  	  
 Corynebacterium glutamicum is an industrial workhorse, employed for the 
production of amino acids, nucleotides, and vitamins. Prior to the discovery of C. glutamicum and 
the production of glutamate by fermentation, amino acids were exclusively produced by chemical 
synthesis or extraction methods [4].  
In the 1950s C. glutamicum was isolated from a soil sample in a zoo in Japan as part of a screening 
project to identify microorganisms capable of accumulating glutamate [9].  
The screening project was initiated due to the increased demand for the seasoning glutamate 
responsible for the taste umami, the costly chemical decomposition of wheat and soybean to obtain 
glutamate, and the knowledge of the successful production of citric acid by fermentation [9].  
 
An advantageous feature of C. glutamicum is its ability to co-utilize several different carbon 
sources. For instance acetate, fructose, lactate, or pyruvate can be co-utilized with glucose [7–9]. 
Moreover it can grow aerobically on a variety of compounds as sole carbon and energy sources 
such as ribose [13], ethanol [14], glutamate, [15] and propionate [16]. Glucose is widely used for 
industrial production of amino acids; however other cheap and renewable carbon sources for 
production are wanted. This could lower production costs and not compete with the use of carbon 
sources for the food industry. C. glutamicum has been engineered to grow on succinate [17], 
fumarate [17], malate [17], starch [18], lactose [19], galactose [20], cellobiose [21], xylose [22], 
arabinose [23], glucosamine [24], and glycerol [25].  
  
Not only is C. glutamicum able to utilize a vast number of carbon sources, over recent years it has 
been engineered to produce a wide range of bioproducts including poly-3-hydroxybutyrate [26], 
ethanol [27], lactate [28], succinate [29], isobutanol [30], 1,2-propanediol [31], cadaverine [32], 
putrescine [33], xylitol [34], and proteins [35]. The whole genome sequencing of C. glutamicum in 
2003 [36], [37], the development of genetic tools [38], and the development of molecular 
technologies helped this development along the way. 	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2.2	  The	  arginine	  pathway	  	  
The arginine pathway is fascinating both from a biochemical and evolutionary point 
of view. There is a great range of information available on arginine biosynthesis and regulation for 
prokaryotes and eukaryotes. Covering only a part of this information would extend this thesis 
beyond reason. Therefore I here mainly present information specific for C. glutamicum. 	  
2.2.1	  Arginine	  biosynthesis	  in	  Corynebacterium	  glutamicum	  	  
2-oxoglutarate of the tricarboxylic acid (TCA) cycle is a branch point from where the 
metabolic flux can continue through the TCA cycle for energy production or glutamate can be 
synthesized. Once glutamate has been synthesized it is the acetylation of the amino group of 
glutamate that initiates de novo arginine biosynthesis. It is this acetylation that distinguishes the 
arginine pathway from the proline pathway, as it prevents the spontaneous cyclization of the semi 
aldehyde into the direct precursor of proline, pyrroline carboxylate (Figure 1). 	  
	  	  
Figure 1. The arginine pathway of Corynebacterium glutamicum extended to include heterologous synthesis of 
putrescine and proline. ocd from Pseudomonas putida and speC from Escherichia coli. See text for enzyme names. 
Shaded pink boxes denote that the only difference between the compounds of the proline and arginine pathway is the 
acetyl group.  
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The acetylation reaction is catalyzed by N-acetylglutamate synthase (NAGS, EC 2.3.1.1). Not until 
recently was an enzyme with NAGS activity in C. glutamicum identified [39]. The gene cg3035 
was shown to encode an enzyme that catalyzes the acetylation with acetyl-CoA as the acetyl donor 
[39]. This enzyme belongs to a novel class of NAGS genes, which thus far only have been found in 
bacteria of the suborder Corynebacterineae [39]. The function of the enzyme is anaplerotic i.e. it 
serves to drive the flux into the arginine pathway. It is ornithine acetyltransferase (OAT, EC 
2.3.1.35, argJ gene product) that is responsible for the main supply of NAG as it recycles it via the 
transfer of the acetyl group of acetylornithine to glutamate, leaving ornithine as the product.  
Three more reactions are required to synthesize ornithine from N-acetylornithine; the second step of 
the pathway is catalyzed by N-acetylglutamate kinase (NAGK, EC 2.7.2.8, argB gene product) 
where N-acetylglutamate is converted into N-acetylglutamyl phosphate. This intermediate is then 
converted into N-acetylglutamate semialdehyde by N-acetyl-γ-glutamyl phosphate reductase (EC 
1.2.1.38, argC gene product) and lastly into N-acetylornithine by acetylornithine aminotransferase 
(EC 2.6.1.11, argD gene product). Biosynthesis of arginine from ornithine further requires three 
more reactions: Ornithine carbamoyltransferase (OTC, EC 2.1.3.3, argF gene product) catalyzes the 
carbamoylation of ornithine into citrulline. Argininosuccinate synthase (EC 6.3.4.5, argG gene 
product) is responsible for the conversion of citrulline into argininosuccinate, which is following 
split into arginine and fumarate catalyzed by argininosuccinase (EC 4.3.2.1, argH gene product).  
 
Interestingly some microorganisms including Bacillus subtilis have bifunctional OATs that catalyze 
both the first and fifth reactions of the pathway [40]. Microorganisms with bifunctional OAT that 
have no NAGS have been reported [40]. Some groups of Proteobacteria including E. coli, and 
possibly Archaea possess acetylornithinase (AO, EC 3.5.1.16, ArgE) instead of OAT, which 
catalyzes the conversion of acetylornithine to ornithine with the release of acetate [41]. This is 
referred to as the linear pathway whereas C. glutamicum has the cyclic pathway. The cyclic 
pathway is so named because the acetyl group of N-acetylornithine is reused by transferring it to 
glutamate. The cyclic pathway is more economical since the acetyl group is recycled and not 
released as acetate [40].  
A variety of enzymes can carry out the synthesis of acetylglutamate, for instance ArgO of 
Campylobacter jejuni that is a short NAGS homologous to the C-terminal domain of NAGS. A 
fusion of short NAGS and ArgH are found in some marine Bacteria [40]. 	  
2.2.2	  Regulation	  of	  the	  arginine	  pathway	  in	  Corynebacterium	  glutamicum	  	  
In microorganisms like E. coli with the linear pathway NAGS catalyzes the committed 
step and is feedback inhibited by arginine. In microorganisms with the cyclic pathway NAGK 
catalyzes the committed step and is feedback inhibited by arginine [40]. In C. glutamicum the 
acetyl-group is recycled in the OAT reaction and therefore NAGK is feedback regulated to maintain 
the regulation of arginine synthesis [42]. In C. glutamicum crude cell-free extracts, arginine was 
shown to inhibit NAGK activity with a half-inhibitory concentration of 2 mM and NAGS activity 
with 40 mM, but the enzymes were not inhibited by ornithine [42]. 
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In some organisms OAT is also a target of feedback inhibition. In Geobacillus stearothermophilus 
the activities of the bifunctional OAT are both inhibited by ornithine, wheras NAGK is not 
regulated by inhibition [40]. OAT of C. glutamicum is feedback inhibited by ornithine where the 
half-inhibitory concentration was determined to be 5 mM [42] and very recently it was also shown 
to be inhibited by citrulline with a half-inhibitory concentration of 30 mM [43]. 
 	  	  
	  	  	  	  	  	  	  
The arginine repressor ArgR exerts regulation at the transcriptional level in C. glutamicum. ArgR 
binds to ARG boxes that overlap promoter elements, and thereby the binding of RNA polymerase is 
repressed by steric exclusion [44]. The genes encoding the enzymes of the arginine pathway are 
arranged in two operons; argCJBDFR and argGH (Figure 2). In C. glutamicum ArgR represses the 
transcription of the arginine operon argCJBDFR, gdh (encoding glutamate dehydrogenase), and 
gltB (encoding the large subunit of glutamine 2-oxoglutarate aminotransferase) [44], [45]. Besides 
binding to the ARG boxes, located in the promoter region of the arginine operon, ArgR also binds 
within the operon upstream argB [45]. In a study it was shown that the addition of FeSO4 decreases 
the binding affinity of ArgR to upstream regions of gdh and gltB, which was beneficial for the 
biotransformation of phenol to glutamate and proline [45]. Later it was shown that when arginine 
was added to the growth medium the binding affinity of ArgR upstream argB was increased, 
resulting in reduced ornithine production, whereas the addition of proline or ornithine had the 
opposite effect, and ornithine production increased [46]. 
 
Another transcriptional regulator FarR was found to bind upstream argC and argG [47]. 
Transcriptomics performed on C. glutamicum ∆farR showed an up-regulation of the arg genes 
compared to the wildtype [47]. Hence the function of the regulator was assumed to be repression. 
The authors also showed that FarR bound upstream gdh, but were not conclusive on the type of 
regulation exerted [47].  
The transcriptional control of gdh is still not fully comprehended. It has been shown that FarR, 
AmtR, GlxR, WhiH, and OxyR bind upstream gdh. Moreover gdh transcription is dependent on 
growth conditions, and it was reported to have two transcriptional start sites [48].  
argR argD argC! argJ! argB!
PargC PargG 
argH argF argG 
Figure 2. The arginine operons of Corynebacterium glutamicum. Arrows denote promoters, and pink 
boxes genes. The figure was not drawn to scale. 
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2.3	  Production	  of	  glutamate	  derivatives	  	  
The arginine pathway encompasses reactions responsible for ornithine and citrulline 
production (Figure 1). Moreover the pathway can be extended from ornithine to include putrescine 
and proline (Figure 1). Hence several engineering targets for production of ornithine, proline, 
putrescine, citrulline, and arginine are similar. Here the use and specific modifications for the 
production of each of these products is described. In the next section strain construction strategies 
that might be beneficial for all products are covered. Focus was put on the metabolic engineering 
strategies rather than the obtained yields as comparing published yields can be difficult; not only are 
different strains used, but also the components of the media, the production conditions, and the 
presentation of the results vary greatly. 
 
2.3.1	  Ornithine	  
 
Ornithine has a use in the pharmaceutical industry where for instance the stable salt L-
ornithine-L-aspartate is used for the treatment of hepatic encephalopathy [49] or for wound healing 
as ornithine 2-oxoglutarate [50].  
Shortly after the isolation of C. glutamicum the overproduction of ornithine by an arginine or 
citrulline requiring C. glutamicum mutant capable of accumulating 26.2 g/L ornithine from 10% 
(w/v) glucose was reported [51]. Since then several approaches have been taken to increase the 
yield of ornithine, which will be explored in the following section. 
 
2.3.2	  Proline	  	  
Proline, the only proteinogenic amino acid with a secondary amine, is commonly used 
by the chemical industry as an organocatalyst [5]. Additionally it serves as a feed additive and as a 
precursor in the pharmaceutical and cosmetic industry [52], [53]. Initially, proline was extracted 
from protein hydrolysates, but has now been produced by fermentation for more than five decades 
[54], [55]. The natural functions of proline, besides in protein synthesis, have been shown to be as 
carbon, nitrogen, and energy source, as a virulence factor of some pathogenic bacteria [56]–[58], 
and as a protectant against osmotic stress [59], [60].  
In C. glutamicum proline is synthesized from glutamate by phosphorylation by γ-glutamyl kinase 
encoded by proB. Then a reduction to glutamate-γ-semialdehyde occurs, consuming NADPH by the 
proA gene product γ-glutamyl phosphate reductase. A spontaneous reaction occurs whereby 
glutamate-γ-semialdehyde cyclizes into Δ1-pyrroline-5-carboxylate and lastly the proC gene 
product catalyzes the formation of proline [61]. Some plants and bacteria are able to convert 
ornithine of the arginine pathway to proline with the enzyme ornithine cyclodeaminase as shown in 
Figure 1 [62]. 
 Published or patented proline producers have mainly been obtained by mutagenesis and selection, 
where the most common traits of these strains are a disrupted proline degradation system and a 
feedback resistant γ-glutamyl kinase [63]. C. glutamicum does however not appear to posses an 
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active proline degradation system as proline cannot be used as carbon source and is a poor source of 
nitrogen [64]. 
B. flavum was the first L-proline producing strain reported, with a yield of 0.12 g proline / g glucose 
[54]. Another example of a proline producing strain is a Thermus thermophiles mutant resistant to 
3,4-dehydroproline that was constructed by site-directed mutagenesis of proB. To disrupt proline 
degradation the strain was mutated by UV irradiation and one of the isolated mutants unable to 
utilize proline for growth produced 2 mg/L in 12h [65].  
 
2.3.3	  Citrulline	  	  
Citrulline is a precursor of arginine (Figure 1) and a key intermediate for urea 
formation in humans [66]. Most ingested free arginine does not reach the bloodstream because it is 
cleared by the liver. Citrulline is however not cleared from portal circulation and is converted to 
arginine in the liver where it is distributed to other organs in the body. Hence citrulline can be used 
as an alternative way to supplement arginine and has potential to be applied for short bowel 
syndrome, immunostimulation, and blood pressure control [8]. The non-proteinogenic amino acid 
citrulline has been produced by extraction from watermelon juice, by chemical and biochemical 
methods, and by microbial fermentation [67], [68]. In an early report on microbial citrulline 
production, a B. subtilis, strain obtained by irradiation, auxotrophic for arginine produced 19 g/L 
citrulline [69]. Until recently, rationally engineered citrulline producing microbes had not been 
described. For the production of citrulline by metabolically engineered C. glutamicum ATCC 13032 
argR and argG were deleted and with plasmid-based overexpression of argJ the strain accumulated 
8.51 g/L [43]. In another study it was shown that the overexpression of argB encoding a feedback 
resistant NAGK was required for citrulline accumulation [68]. 
 
2.3.4	  Arginine	  	  
Arginine has applications in the food, pharmaceutical, and cosmetic industries [70], 
[71]. It is regarded a nutraceutical as it is a conditionally essential amino acid for humans. Arginine 
has several functions in the body, while humans produce arginine, a supplement can be required for 
growth or tissue repair [72]. Moreover arginine is a precursor of the neurotransmitter nitric oxide 
that is an important component of the endothelium-derived relaxing factor [6]. 
Biosynthesis of arginine is energetically demanding; from glutamate it requires the donation of 
three nitrogen atoms. The nitrogen donors in these reactions, glutamate, glutamine, and aspartate 
need to be regenerated at the expense of ATP and NADPH. Furthermore there is a high demand for 
bicarbonate, which is assimilated during the formation of carbamoyl phosphate [73]. Therefore, 
sparging with carbon dioxide during the fermentation is important and might be advantageous for 
the arginine yield [74]. In arginine production by C. glutamicum citrulline is a by-product [75]. By 
replacing the promoter of the argGH operon with the constitutive promoter of the elongation factor 
Tu the accumulation of citrulline could be prevented [76]. Plasmid-borne heterologous 
overexpression of carAB in C. glutamicum led only to a small increase of the arginine titer in the 
fermentation supernatant [77]. In C. glutamicum the lysine exporter LysE exports excess arginine, 
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as it cannot catabolize it [79–81]. Heterologous as well as homologous overexpression of lysE and 
argO in C. crenatum had a positive impact on arginine accumulation in the medium [81]. Arginine 
import in C. glutamicum seems to be absent [82]. The gene cg3045, however, was proposed to 
function as a permease of an uptake system for glutamine or arginine [82]. 
 
2.3.5	  Putrescine	  	  
Putrescine is a diamine belonging to the group of biogenic amines and can be used as 
monomer in polyamide-4,6 production, including nylon-4,6 (bioplastic) [7]. Putrescine is primarily 
produced chemically by hydrogenation of acrylonitrile. The process requires high temperature and 
pressure, highly toxic and flammable petrochemical products as raw materials, and expensive 
catalyst systems. Therefore effort has been put into the development of microbial strains for 
production of putrescine by fermentation as a sustainable and more environmental friendly 
alternative [7]. 
Putrescine can be synthesized via ornithine decarboxylation or arginine decarboxylation. Although 
the metabolism of polyamines remains unknown in C. glutamicum, a putrescine producing strain 
was constructed by overexpression of ornithine decarboxylase encoded by speC from E. coli. 
Efforts made to increase putrescine production include deleting cg1722 that encodes an enzyme 
with acetyltransferase activity. Upon the deletion cells no longer accumulated the byproduct N-
acetylputrescine and the putrescine concentration was increased [83]. A C. glutamicum ATCC 
13032 strain with deletions of genes argF and yggB (encoding a protein involved in glutamate 
export), substitution of the promoter of the argCJBD operon with a synthetic promoter, thereby also 
disrupting repression by ArgR, and speC from E. coli was inserted on the chromosome. On 2% 
(w/v) glucose 8.1 g/L putrescine was accumulated [84]. Moreover a protein possibly involved in 
putrescine export encoded by cgmA was identified. The gene of the cgmAR operon is repressed by 
the CgmR regulator [85]. Interestingly it was shown that putrescine and other diamines perturb the 
binding of CgmR to its operator upstream cgmAR. The deletion of cgmR or overexpression of cgmA 
could increase putrescine accumulation by 19 and 24%, respectively [85]. 
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2.4	  Metabolic	  engineering	  of	  the	  ornithine/arginine	  pathway	  	  
A quick search on Pubmed reveals that publications on the topic ornithine or arginine 
production by C. glutamicum has been increasing over the past ten years. In this section some of the 
findings of these publications are presented and have been ordered into the subsections regulation, 
tricarboxylic acid cycle, increasing glutamate supply, directing the flux into the arginine pathway, 
energetics, and other strategies. 	  
2.4.1	  Regulation	  	  
To create either an ornithine or arginine producing strain it is crucial to prevent the 
negative regulator ArgR from binding the promoter region of the argCJBDFR operon (Figure 3, 1). 
Once the arginine concentration within the cell passes a certain threshold, ArgR binds to the 
promoter region and physically prevents the RNA polymerase from binding the promoter; as a 
result transcription cannot be initiated [44]. In one study the deletion of argR in wild type C. 
glutamicum did not result in any apparent L-arginine accumulation, however the simultaneous 
overexpression of argB gene variants encoding feedback resistant NAGKs increased the arginine 
titer to between 15 and 46 mM (Figure 3, 2) [41]. As the regulator FarR also binds upstream 
argCJBDFR, argGH, and gdh the effect of the deletion of farR for the production of arginine was 
tested. In C. glutamicum RES167 the deletion did not result in a difference in the intracellular 
arginine concentration [47]. It cannot be excluded that the knock out of farR does not have an effect 
on arginine production as the strain tested only excreted very low concentrations of arginine. The 
deletion of farR had also been implemented in another study for increased arginine production, the 
effect of the deletion appeared to be beneficial although it was not completely clear due to the 
experimental setup [76]. Hence the quantitative benefit the deletion of farR poses on arginine 
production requires further research. 	  
2.4.2	  Tricarboxylic	  acid	  cycle	  	  
2-oxoglutarate is a branch point where the flux can continue trough the TCA cycle to 
be converted to succinyl coenzyme A by the 2-oxoglutarate dehydrogenase complex (ODHC) or it 
can be converted to glutamate by glutamate dehydrogenase (GDH) (Figure 3). Three subunits 
encoded by odhA (2-oxoglutarate dehydrogenase E1 component), aceF (dihydrolipoamide 
acetyltransferase), and lpd (dihydrolipoamide dehydrogenase) make up ODHC, and deleting one of 
these subunits has been a target for increasing the flux towards glutamate production [86]. 
As an example odhA was knocked out in the C. glutamicum ∆argF∆proB double deletion mutant 
resulting in an ornithine titer of 4.78 g/L compared to 2.68 g/L of the parent strain (Figure 3, 3) 
[87]. This strategy was based on the observation that ODHC activity is decreased during 
overproduction of glutamate by C. glutamicum with biotin limitation, addition of penicillin, or 
addition of surfactants [88]. 	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Figure 1. Selected metabolic engineering targets potentially beneficial for the production of glutamate 
derivatives. Genes in green boxes are part of glycolysis/gluconeogenesis, genes in orange boxes are part of the pentose 
phosphate pathway, genes in blue boxes are part of the tricarboxylic acid cycle, genes in pink are part of the glutamate, 
proline, or arginine biosynthetic pathways. 1.  Deletion of ∆argR. 2. Feedback resistant NAGK 3. Deletion of odhA 4. 
Deletion of proB 5. Exhange of pgi start codon, exchange of zwf start codon, exchange of native promoter with Psod 6. 
Overexpression of gapA 7. Overexpression of gdh and rocG from Bacillus subtilis 8. Deletion of speE.  
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A different strategy employed to reduce the level of ODHC for increased putrescine production was 
to exchange the start codon of the subunit encoded by odhA. An exchange of the start codon from 
GTG to TTG resulted in an increased putrescine yield. OdhI, the inhibitor of OdhA, inhibits ODHC 
activity in its unphosphorylated state. Introduction of a mutation in odhI results in partial or 
complete loss of phosphorylation of OdhI. This means that the inhibition of ODHC will be 
maintained and the complex therefore will have a lower activity. This modification also resulted in 
increased putrescine production. When the two modifications were combined, an even further 
increase in production was observed, namely 28% more than the parent strain [89].  	  
2.4.3	  Increasing	  the	  glutamate	  supply	  	  
Increasing the availability of the precursor glutamate for ornithine production was 
tested by deleting pck encoding phosphoenolpyruvate carboxykinase (catalyzing the first step of 
gluconeogenesis) and overexpressing pyruvate carboxylase. This strategy was previously shown to 
be beneficial for glutamate production by C. glutamicum [92, 93] however when tested in the 
∆argFR∆proB background no increase in ornithine production was observed [92]. Moreover 
supplementing glutamate to the growth medium also had no effect on ornithine production [92]. 
Glutamate does not readily diffuse through the cell membrane and relies on transport proteins. 
However with the addition of up to 50 mM glutamate the authors did expect some glutamate to be 
taken up by the cells [92]. On this account it has to be noted that glutamate uptake is repressed by 
glucose that was the carbon source used in the study [15]. 	  
2.4.4	  Directing	  the	  flux	  into	  the	  arginine	  pathway	  	  
Disrupting the first gene of a competing pathway is a common way to direct the flux 
into the desired pathway. As glutamate is a precursor of both the proline and arginine pathways the 
flux can be directed into the arginine pathway by disrupting proB, encoding the enzyme catalyzing 
the first step of the proline pathway (Figure 3, 4).  This strategy has been applied for both arginine 
and ornithine production [76], [93]. In the ∆argFR background a disruption of proB resulted in an 
increase in ornithine production from 9.65 mg ornithine / g dry cell weight (mg/g) to 12.65 mg/g 
[92]. Depending on the production process a disruption of proB may not be desired as it results in a 
proline auxotrophic strain that requires proline supplementation. Tuning the level of 
transcription/translation of proB could be used as strategy to avoid auxotrophy, while still 
benefitting from the increased flux into the arginine pathway. A lowered translation of proB mRNA 
was achieved by exchanging the start codon with the less commonly used TTG codon, this was 
shown to be beneficial for putrescine production as the exchange not only abolished formation of 
the byproduct acetylputrescine but also increased the putrescine titer [89]. It remains to be 
determined if the exchange of the start codon also is beneficial for the production of the other 
compounds of the glutamate family.  	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2.4.5	  Energetics	  	  
Both ornithine and arginine biosynthesis are NADPH requiring processes with a 
demand of three or four NADPH molecules, respectively. This high demand for NADPH could 
pose a limiting factor for overproduction of the amino acids. Hence increasing the intracellular 
NADPH level of the cell has been addressed by several approaches.  
One strategy relies on redirecting the carbon flux into the pentose phosphate pathway (PPP). For 
lysine production this was successfully implemented by a knock out of pgi encoding 
phosphoglucoisomerase resulting in a significantly higher yield. While the disruption of pgi results 
in a higher NADPH availability it is however associated with poor growth on glucose as sole 
carbon source [94]. Although the NADPH availability in C. glutamicum ∆argFR∆pgi doubled 
compared to the ∆argFR parent strain, ornithine production had decreased from 8.78 to 1.37 g/L 
[95]. Redirecting the carbon flux into the PPP was also applied in other studies with arginine and 
ornithine producing strains. Instead of disrupting pgi the start codon of pgi ATG was exchanged 
with GTG thereby lowering the translation of the mRNA. Moreover the start codon of zwf encoding 
glucose-6-phosphate dehydrogenase was changed from GTG to ATG, and the promoter of the tkt 
operon, that zwf is part of, was exchanged with the strong constitutive sod promoter (Figure 3, 5). 
For both the arginine and ornithine producing strains this resulted in significantly higher yields [77, 
96].  
 
Jiang et al. took a different approach. They compared plasmid-based overexpression of the genes 
gapA from C. glutamicum (Figure 3, 6) and gapC from Clostridium acetobutylicum both encoding 
the NADPH generating enzyme glyceraldehyde-3-phosphate dehydrogenase of glycolysis [97]. In 
both cases a significant increase in ornithine production was observed. In the same paper they 
furthermore showed that reducing the NADPH requirement of the ornithine biosynthetic pathway 
by overexpressing rocG from B. subtilis encoding a NAD-dependent GDH resulted in a higher 
ornithine titer (Figure 3, 7) [97]. It should be noted that they also showed that plasmid-based 
overexpression of endogenous gdh, encoding NADPH requiring GDH, resulted in a similar titer 
(Figure 3, 7).  Integration of both gapC and rocG on the chromosome did however not increase the 
ornithine production any further [97]. 
 
Based on the assumption that 6-phosphogluconate can be synthesized through the gluconate bypass 
in C. glutamicum, genes NCgl2399 and NCgl2905 assumed to encode gluconate kinases were 
disrupted in C. glutamicum ∆argFR. The double deletion strain exhibited increased 6-
phosphogluconate dehydrogenase (6PGD, encoded by gnd) and glucose dehydrogenase activities, 
an increased NADPH level and an increase in ornithine production from 0.71 g ornithine/ g dry cell 
weight (g/g) to 13.16 g/g [95]. 
The genes NCgl0281, NCgl2582, and NCgl2053 were speculated to encode NADP+-dependent 
isoenzymes of glucose dehydrogenase catalyzing the oxidation of glucose to gluconate. So far it has 
however not been demonstrated that C. glutamicum should posses such an activity [98]. The 
deletions entailed an increased production of the C. glutamicum strain with the genetic background 
∆argFR∆NCgl0281∆NCgl2582∆NCgl2053 from 14 g/L compared to 8 g/L of the parent strain with 
the genetic background ∆argFR.  
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Glucose dehydrogenase and gluconate kinase appear to provide an alternative path for glucose to 
enter the PPP. Both the inactivation of three putative oxidoreductases and two gluconate kinases 
were shown to induce activity of glucose-6-phosphate dehydrogenase (encoded by zwf and opcA) 
and 6PGD of the oxidative PPP and increased NADPH levels, by what appears to be a loss of 
operation of the gluconate bypass system, although the mechanism of activation appears to be 
different for the gluconate kinase and the glucose dehydrogenase deficiencies [98].	  	  
2.4.6	  Other	  strategies	  	  
speE encodes putative spermidine synthase catalyzing the conversion of putrescine to 
spermidine (Figure 3, 8). The specific function of the enzyme in C. glutamicum has not been 
proven, nor have the other polyamine synthetic enzymes, however C. glutamicum does contain 
putrescine and polyamines [101, 102]. It was proposed that the deletion might prevent ornithine 
degradation, although no biochemical/biological evidence for this exists. The deletion of speE 
resulted in an increased ornithine titer from 10.2 ± 0.2 g/L to 11.3 ± 0.3 g/L in the ∆argF∆proB 
background [100]. 
 
Plasmid based overexpression of argCJBD to increase the enzymatic activity of the enzymes of the 
ornithine pathway has also been explored. Such overexpression led to a 30% increase in ornithine 
production in the ∆argFR ∆proB background, from 12.73 mg ornithine/g dry cell weight to 16.49 
mg/g [92].  
Similarly, overexpression of the argCJBDFRGH operon in the arginine producing 
Corynebacterium crenatum strain SYPA 5-5, insensitive to ArgR regulation, resulted in increased 
arginine production by about 25% [101]. 
 
A combination of adaptive evolution and metabolic engineering was used to obtain the strain C. 
glutamicum ΔAPE6937R42 producing 24.1 g/L ornithine in a 5L fermenter [100].  The strain was 
constructed by deleting the genes speE, argF, and proB. Then the strain was subjected to 70 
passages of adaptive evolution. First by adding glucose and ornithine to the medium, after 30 
passages ornithine addition was omitted and an increased glucose concentration was added to the 
medium and after 20 more passages the glucose concentration was increased further. One clone that 
produced 20% more ornithine (from 11.3 g/L to 13.6 g/L) than the parent strain was selected and 
argR was disrupted to result in the strain ΔAPE6937R42 with a titer of 17.3 g/L [100]. 
 
Although the strategies above have all had an impact on increasing yields of ornithine and arginine 
there is still much room for improvement. Taking the step to the next level requires a combination 
of several engineering strategies to obtain superior producers. Engineering strains for industrial 
production of a compound is no trivial task; building a new strain can cost from millions to 
hundreds of millions of US dollars [102]. 	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2.5	  Metabolic	  engineering	  and	  the	  CRISPR/dCas9	  system	  	  
Traditionally, strains for production of amino acids were improved by chemical or 
UV-mutagenesis and selection based on resistance to antimetabolites or other analogues. Amino 
acid biosynthesis is commonly regulated by end-product inhibition, and by this approach mutants 
with feedback alleviated enzymes could be isolated. Moreover mutants with a higher tolerance to 
the desired product could be isolated [93]. 
Although mutagenesis and selection is a powerful approach for obtaining high producing strains, 
they often have growth defects, are genetically unstable, have low tolerance to stress, or have a 
demand for specific nutrients [103]. A further disadvantage is that it can be difficult to identify the 
individual effects of the mutations introduced.  
Targeted changes to cells could be performed already back in the 1970s with the introduction of 
recombinant DNA technology, and in 1991 Bailey defined the term metabolic engineering as “The 
improvement of cellular activities by manipulations of enzymatic, transport, and regulatory 
functions of the cell with the use of recombinant DNA technology” [103]. The constantly 
expanding information available on enzyme kinetics, genetics, and regulation along with genome 
sequencing projects, advances in the fields of DNA synthesis, sequencing, fluxomics, 
metabolomics, transcriptomics, and proteomics all facilitate the construction of rationally 
engineered high producing strains [104], [105]. Moreover computational methods for metabolic 
engineering have been successfully employed [106][107].	   	  
A time-limiting factor in strain construction can be the modifications performed on the genome. 
The widely used two-step homologous recombination approach with a suicide plasmid can at times 
be difficult, and therefore time consuming [108].  
Here the widely used Clusters of Regularly Interspaced Short Palindromic Repeats 
(CRISPR)/dCas9 system could potentially be applied for fast strain construction. The system has 
already been successfully employed in a variety of organisms including bacteria [109][110], yeast 
[111], plants [112], and mammals [113]. 	  
2.5.1	  Using	  the	  CRISPR/dCas9	  system	  as	  a	  tool	  for	  metabolic	  engineering	  	  
The CRISPR/Cas system is found in a wide range of bacteria and archaea and 
functions as an adaptive immune system [114]. In short the system works by cleaving foreign DNA 
in a sequence specific manner using small base-pairing RNA to target the sequence with [115].  
Several different CRISPR systems exist, one of the simplest, a type II CRISPR system, was recently 
used for targeted genome editing [110]. This system from Streptococcus pyogenes employs the 
double-stranded DNA endonuclease Cas9, mature CRISPR RNA (crRNA), and trans-acting RNA 
(tracrRNA) to silence foreign DNA [116]. 
 
CRISPR loci consist of short multiple repeats separated by spacers as the name CRISPR implies 
[117]. These spacer sequences are short stretches of DNA that match mobile genetic elements and 
genomes of bacteriophages [117]. The stretch of repeats and spacers are transcribed as one 
precursor mRNA. This precursor mRNA is then processed within the repeats to generate the 
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crRNA. The target sequence that is cleaved by the CRISPR systems is specified by the crRNA 
[118]. The tracrRNA along with RNase III are required to mature the crRNA [119], these elements 
are not needed if instead engineered small guide RNA (sgRNA) with a hairpin mimicking the 
tracrRNA-crRNA complex is used [116]. The sgRNA should have a 20 bp region complementary to 
the target sequence. Cas9 can then introduce double-strand breaks once the sgRNA and the target 
DNA base pair. For the binding to occur the promoter adjacent sequence NGG juxtaposed the 
complementary region is required [120]. 
 
The CRISPR/Cas9 system was recently modified to enable its use for regulation of transcriptional 
expression. With this system binding of the RNA polymerase to a promoter, binding of 
transcription factors, and transcriptional elongation can be prevented [110]. To achieve this, a 
catalytically inactive Cas9 (dCas9) was constructed by introducing two mutations in the RuvC1 and 
HNH nuclease domains of Cas9. The gene expression could thereby be reversibly repressed in E. 
coli with no off-target effects [110]. 
 
What makes this technology particularly useful for metabolic engineering is that it can be used to 
target several targets at once. This allows the researcher to assess the combined effect of multiple 
deletions, without going through the taunting, slow, and laborious process the deletion of one gene 
after another can be.  
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Chapter	   3.	   Ornithine	   cyclodeaminase-­‐based	   proline	   production	   by	  
Corynebacterium	  glutamicum	  
 
 
Jensen, J.V.K., & V.F. Wendisch (2013). Ornithine cyclodeaminase-based proline production by 
Corynebacterium glutamicum. Microb Cell Fact, 12, 63. 
 	  
3.1	  Abstract	  	  
 
The soil bacterium Corynebacterium glutamicum, best known for its glutamate 
producing ability, is suitable as a producer of a variety of bioproducts. Glutamate is the precursor of 
the amino acid proline. Proline biosynthesis typically involves three enzymes and a spontaneous 
cyclization reaction. Alternatively, proline can be synthesized from ornithine, an intermediate of 
arginine biosynthesis. The direct conversion of ornithine to proline is catalysed by ornithine 
cyclodeaminase. An ornithine overproducing platform strain with deletions of argR and argF 
(ORN1) has been employed for production of derived compounds such as putrescine. By 
heterologous expression of ocd this platform strain can be engineered further for proline production.  
 
Plasmid-based expression of ocd encoding the putative ornithine cyclodeaminase of C. glutamicum 
did not result in detectable proline accumulation in the culture medium. However, plasmid-based 
expression of ocd from Pseudomonas putida resulted in proline production with yields up to 0.31 ± 
0.01 g proline/g glucose. Overexpression of the gene encoding a feedback-alleviated N-
acetylglutamate kinase further increased proline production to 0.36 ± 0.01 g/g. In addition, 
feedback-alleviation of N-acetylglutamate kinase entailed growth-coupled production of proline and 
reduced the accumulation of by-products in the culture medium. 
 
The product spectrum of the platform strain C. glutamicum ORN1 was expanded to include the 
amino acid L-proline. Upon further development of the ornithine overproducing platform strain, 
industrial production of amino acids of the glutamate family and derived bioproducts such as 
diamines might become within reach.  
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3.2	  Background	  
  
The workhorse Corynebacterium glutamicum has for decades been used as an amino 
acid producer. Although, in terms of quantity, the main contributors to the amino acid market are L-
lysine and L-glutamate, minor amino acids such as L-proline are also of importance. Proline is 
predominantly used as an organocatalyst by the chemical industry, as a precursor for compounds 
with pharmaceutical and cosmetic applications, and as a feed additive [1-3]. The natural functions 
of proline in prokaryotic and eukaryotic cells have been reported to be as an osmolyte, a potential 
virulence factor for some pathogenic bacteria, and a source of carbon, nitrogen, and energy [4]. The 
amino acid functions as a compatible solute of C. glutamicum and in this respect the organism has 
been shown to grow at intracellular concentrations of up to 94 g/L proline with no determined upper 
limit [5]. In Escherichia coli the bifunctional enzyme PutA catalyses the two-step oxidation of 
proline to glutamate with proline dehydrogenase and Δ1-pyrroline-5-carboxylate dehydrogenase 
activities: reactions that occur at high proline concentrations [6]. C. glutamicum contains a putative 
putA gene, but the activity of the encoded enzyme has thus far not been confirmed. It is not clear 
whether C. glutamicum can utilise proline as a carbon or nitrogen as contradictory statements about 
proline utilisation by this bacterium have been published [7,8].  
 
Proline is synthesized from glutamate via three enzymatic and one spontaneous reaction, in most 
investigated microorganisms [4,9,10]. The enzymes of the proline pathway encoded by proB, proA, 
and proC catalyse the phosphorylation of glutamate followed by reduction to glutamate-γ-
semialdehyde, a spontaneous cyclisation, and finally the reduction to proline. An alternative route to 
proline biosynthesis involves ornithine cyclodeaminase (OCD) which catalyses the conversion of 
ornithine to proline and ammonia with deamination of the α-amino group prior to cyclization 
(Figure 1). However, only a few organisms such as Clostridium sporogenes, Treponema denticola, 
Agrobacterium tumefaciens, and Pseudomonas putida have been reported to contain OCD [11-15]. 
The genome of C. glutamicum contains a putative ocd gene, however, evidence for its function as 
ornithine cyclodeaminase has not been reported [16].  
In C. glutamicum ornithine is an intermediate of arginine biosynthesis and is synthesized from 
glutamate through five enzymatic steps where the second enzyme, N-acetylglutamate kinase 
(NAGK), is feedback-inhibited by arginine [17]. It is known that the arginine biosynthetic pathway 
of C. glutamicum is regulated at the transcriptional level by the repressor ArgR that has been shown 
to bind upstream regions of argC, argB, argF, and argG [18]. Further genetic regulation, although 
not fully comprehended, is concerted by the acyl-responsive transcriptional regulator FarR and by 
the potential allosteric inhibition of ornithine acetyltransferase by ornithine [18,19].  
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An ornithine overproducing C. glutamicum strain [20] [21] with deletions of the genes argR and of 
argF, the gene encoding ornithine carbamoyl-transferase, which converts ornithine to citrulline in 
the arginine biosynthetic pathway, has been constructed. This strain, called ORN1 has the potential 
of serving as a platform for the production of several industrially relevant bioproducts of the 
glutamate family; namely ornithine, citrulline, arginine, putrescine, and spermidine. Based on C. 
glutamicum ORN1, strains PUT1 [22] and PUT21 [23] have been developed for production of 1,4-
diaminobutane (putrescine), and ARG1 [20] is an arginine-producing ORN1 derivative. Here, the 
production of proline based on ORN1 is reported. Heterologously produced ornithine 
cyclodeaminase from P. putida led to a conversion of ornithine to proline and thereby constitutes an 
expansion of the product palette of the platform strain ORN1. 
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3.3	  Results	  	  
 
3.3.1	  Proline	  utilisation	  	  
 
To establish if the putative proline degradation system of C. glutamicum had an effect 
on extracellular accumulation of proline, we first investigated the utilisation of proline as carbon 
and nitrogen source. Wild-type C. glutamicum was inoculated to an optical density (OD) of 1 in 
CGXII minimal medium with 20 g/L glucose or a C-equimolar concentration of proline as carbon 
source and 20 g/L ammonium sulfate and 5 g/L urea or a N-equimolar concentration of proline as 
nitrogen source. For cells cultured in medium with proline as carbon source no biomass formation 
was observed during 48 h of incubation. An OD of ~30 could be reached within 10 h by cultivation 
in CGXII medium with glucose, ammonium sulfate, and urea. When an N-equimolar proline 
concentration was used as the sole nitrogen source, the cells were able to duplicate twice in 24 h 
within the 48 h of incubation resulting in a maximum OD of ~3.5. For comparison an OD of ~1.5 
could be reached when no nitrogen source was added to the medium.  
 
3.3.2	  Plasmid-­‐based	  overexpression	  of	  ocd 
 
The gene encoding the biochemically characterized OCD from P. putida [24] and the 
putative ocd from C. glutamicum were cloned into the IPTG-inducible expression plasmid pVWEx1 
[25]. The resulting plasmids pVWEx1-ocdCg and pVWEx1-ocdPp were transformed into the 
ornithine producer ORN1 to yield strains JJ002 (ORN1 carrying pVWEx1-ocdCg) and JJ003 (ORN1 
carrying pVWEx1-ocdPp1). For a presumed more efficient translational termination, the original 
stop codon TGA of ocdPp was replaced by the more frequently used TAA (JJ004).  
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The specific cyclodeaminase activities in crude extracts of these strains and the control strain JJ001 
(ORN1 carrying pVWEx1) were determined and the presence of the overproduced proteins 
visualized by SDS-PAGE (Figure 2, Table 1). No activity could be observed for crude extracts of 
JJ001 and JJ002, although the crude extract of JJ002 exhibited a band on an SDS-gel corresponding 
to the weight of the putative C. glutamicum OCD of 40.96 kDa, calculated based on the amino acid 
sequence (Figure 2). Substitution of the translational stop codon caused an almost 12-fold increased 
specific activity of OCDPp. 
 
Shake flask fermentations in glucose minimal medium with IPTG were performed                                                                                                                                  
with the aforementioned strains. Samples were withdrawn for product quantification by HPLC. 
Upon glucose depletion, proline could not be detected in the supernatants of strains JJ001 and 
JJ002, whereas ornithine was produced by both strains (Table 2). By contrast, JJ003 and JJ004 
accumulated proline in the supernatant (Figure 3, Table 2). Owing to the feedback inhibition of 
NAGK by arginine, production of proline was growth decoupled. Strain JJ004 accumulated about 
three folds more proline than JJ003 indicating that the improved translational termination of ocdPp 
entailed not only increased OCD activity, but also increased proline production. All strains 
accumulated ornithine and the by-products threonine, alanine, and valine. Furthermore trace 
amounts of glutamate (up to 5 µM) could be detected, except for strain JJ003 where 0.24 ± 0.1 g/L 
was accumulated.  
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3.3.3	  Identification	  of	  key	  medium	  components	  for	  proline	  production	  
 
As deamination of ornithine by OCD yields ammonia besides proline, and as CGXII 
contains a high nitrogen concentration, it was tested if the nitrogen content of the medium had an 
effect on proline formation and if other medium components influenced production. First the effect 
of the nature of the nitrogen source was tested; here urea, and/or ammonium sulphate or ammonium 
chloride were selected (Table 3). Urea as sole nitrogen source at the concentration tested appeared 
to be superior for proline overproduction.  
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After the initial screen a Plackett-Burman design was used to identify key components in the 
medium affecting proline production and to verify that the nitrogen source significantly affects 
proline production. The design made it possible to determine the relevant factors with a small 
number of trials. Twelve factors were screened; all components of CGXII medium and in addition 
IPTG and arginine. The experimental design and responses are shown in Table 4. Significant effects 
on proline production were observed when concentrations of glucose, urea, and monopotassium 
phosphate were varied (Figure 4). A positive effect on proline production was observed for high 
concentrations of glucose, while low concentrations of urea and monopotassium phosphate 
improved proline production. As the t-values of the effects of glucose, urea, and monopotassium 
phosphate lie above not only the t-value threshold, but also the conservative Bonferroni threshold, 
the components are more likely to be key medium components and their effect not stochastic. 
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Thus, three different concentrations of urea (2.5, 5, and 7.5 g/L), glucose (20, 35, and 50 g/L) and 
monopotassium phosphate (0.5, 1.25, and 2 g/L) were tested (data not shown) and an improved 
medium was derived (5 g/L urea as nitrogen source, 35 g/L glucose as carbon source and 2 g/L 
potassium phosphate) and was used for further proline production experiments. Fermentations of 
JJ004 in the modified medium increased proline production by 25% compared to production in 
CGXII medium (0.31 ± 0.01 as compared to 0.25 ± 0.003 g proline/ g glucose, Table 2) and 
ornithine accumulation was reduced. 
 
 
 
 
 
 
 
3.3.4	  Coupling	  growth	  to	  proline	  production	  
 
In C. glutamicum the second enzyme of the ornithine pathway NAGK is feedback 
inhibited by arginine. The feedback inhibition therefore constitutes a rate-limiting step at high 
arginine concentrations. Hence, both the feedback alleviation of NAGK and leaky expression of 
argF have been employed as means to increase/ couple growth to production [20,23]. Here we 
show that the overexpression and feedback alleviation of argB (strain JJ006) resulted not only in 
increased and growth-coupled proline production, but also in a reduction of by-products when 
cultured in the modified CGXII medium (Figure 5, Table 5).  
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3.4	  Discussion	  
 
C. glutamicum is, especially with regards to carbon and amino acid metabolism, a 
well-studied bacterium. Nevertheless, details on the proline degradation pathway and regulation of 
the proline and arginine biosynthetic pathways remain to be elucidated. C. glutamicum can utilise 
several amino acids as sole carbon and/or nitrogen source [7] e.g. glutamine has been demonstrated 
to be an excellent nitrogen source and also allows growth when used as sole carbon and nitrogen 
source [26]. In the case of proline contradictory observations of its utilisation as nitrogen source 
have been made [7]. Bott & Niebisch reported that C. glutamicum could utilize proline as carbon 
and nitrogen source, however very slowly. In this study, it was shown that proline did not serve as 
sole source of carbon for growth of C. glutamicum, and that it is a very poor source of nitrogen. 
 
When comparing proline synthesis starting from 2-oxoglutarate via the proline pathway to the 
conversion via the ornithine pathway, there is a difference in the requirement for ammonia. In the 
proline biosynthetic pathway one molecule of ammonium is assimilated in the reductive amination 
of 2-oxoglutarate to glutamate by glutamate dehydrogenase (GDH) per molecule of proline 
produced (Figure 1). In the OCD-based pathway, a second ammonium molecule is required to be 
assimilated by GDH, however, it is released during the final ornithine cyclodeaminase reaction. 
Therefore the conversion of 2-oxoglutarate to glutamate via GDH must be twice as high in the 
OCD-based pathway as compared to the proline pathway. By medium optimization employing the 
Plackett-Burman design it could be shown that a low urea concentration had a positive effect on 
proline accumulation. While urea utilization needs to be induced, ammonium assimilation via GDH 
only shows a weak dependency on nitrogen availability [27]. Besides the low affinity assimilation 
to ammonium via GDH, C. glutamicum also possesses the high affinity GS-GOGAT system for 
ammonium assimilation, which is induced upon nitrogen starvation [27]. The in vivo fluxes of 
ammonia assimilation via GDH and GS-GOGAT could be determined in C. glutamicum ATCC 
13032 and a direct dependency of flux via the GS-GOGAT system on ammonium availability was 
observed [27]. Under C-limited conditions in a continuous culture GS and GOGAT activities in 
crude extracts were significantly reduced [27]. Proline production was performed with sufficient 
ammonium, therefore it is assumed that GDH primarily contributes to ammonium assimilation 
under these conditions. 
 
The genome of C. glutamicum contains a gene annotated to encode ornithine cyclodeaminase [16] 
within the nitrogen-regulated putative amt-ocd-sox operon [28]. Overexpression of this operon was 
beneficial for lysine production, but the molecular mechanism remained unknown [29]. The 
deletion of ocd in an argF-, argR- strain of C. glutamicum increased ornithine production by this 
strain. Supplementing 5 mM proline improved ornithine production further, which was 
hypothesized to indicate a possible role of OCD in the conversion of proline to ornithine [30]. As 
shown here, overexpression of ocd from C. glutamicum neither entailed proline production nor 
detectable OCD activity, although a SDS-PAGE of crude extracts revealed overproduction of the 
protein. Thus, the protein encoded by ocdCg either does not possess OCD activity or its activity was 
too low to be detected. It is interesting to note that multiple protein sequence alignments of 
biochemically characterized OCDs with putative OCDs [32, 24] revealed that some conserved 
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active site residues of OCDs are not conserved in OCDCg. Instead of Arg45 (numbering according 
to OCD from P. putida), one of three residues whose side chains interact with the ornithine 
carboxyl group, OCDCg contains a glutamate residue and Asp228, whose side chain forms a 
hydrogen bond with the leaving ammonia group, is a glycine residue in OCDCg. The lack of 
conservation of these and further amino acids might explain why no OCD activity could be detected 
in C. glutamicum. Physiologically, C. glutamicum differs from pseudomonads that typically are able 
to catabolize arginine and ornithine as sole carbon and nitrogen source. In most Pseudomonas 
species utilization of ornithine as carbon source involves succinylation of ornithine, however P. 
putida, which is devoid of such activity, catabolizes ornithine via OCD and subsequently via proline 
degradation [32]. OCD is also involved in opine degradation by Agrobacterium tumefaciens with 
e.g. the nopaline catabolism region of Ti plasmid C58 encoding OCD for degradation of nopaline 
via arginine and ornithine to proline [33]. The observation that C. glutamicum does not appear to be 
able to utilise proline, as shown in this study, or ornithine (unpublished observation) as sole 
nitrogen or carbon source is commensurate with the lack of OCD activity. It remains to be shown if 
the protein annotated as putative OCD is active as ornithine cyclodeaminase, or whether it catalyses 
another reaction. 
 
Heterologous expression of ocdPp by the ORN1 strain resulted in proline accumulation, and a 
significant increase in production could be achieved by changing the stop codon from TGA to TAA. 
While examples of modulating translation initiation by changing the start codon or by changing the 
sequence or spacing of the ribosome binding site exists for C. glutamicum [23], modulating 
translation termination by altering the stop codon has to the best of our knowledge not yet been 
reported. Increased OCD levels and activities as consequence of changing the stop codon from 
TGA to TAA is in line with a bioinformatic study on codon usage of C. glutamicum. Putative 
highly expressed genes exhibited a strong bias for the UAA stop codon, while such a preference 
was not observed in lowly expressed genes [34]. It is likely that optimization of sense codons of 
ocdPp to fit the sense codon preference of C. glutamicum better, could contribute to a further 
increase in proline production. 
 
As previously demonstrated, glutamate is not limiting the flux through the ornithine pathway, rather 
it is the feedback inhibition of NAGK by arginine and potentially the feedback inhibition of OAT 
by ornithine [18, 21]. Accordingly, overproduction of feedback-alleviated NAGK not only led to 
growth-coupled production of proline, but improved proline production. In addition, growth was 
affected as less biomass formed and as the growth rate was reduced. It is noteworthy that proline 
production already started early during growth which may be beneficial for the overall space-time 
yield of the process. Moreover, formation of the by-products valine and threonine that are not 
amino acids of the glutamate family was reduced. As trace amounts of glutamate could be detected 
in the samples taken for all strains constructed (JJ001-JJ006), this is an indication of that the 
bottleneck in proline production is located between glutamate and proline. A further improvement 
of the conversion of glutamate to ornithine can be envisioned by alleviating a potential feedback 
inhibition of OAT and/or employing a bifunctional enzyme with OAT and NAGS activities. 	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3.5	  Conclusions	  	  
 
 Heterologous overexpression of ocd in C. glutamicum ORN1 resulted in the 
overproduction of proline through the ornithine pathway. C. glutamicum JJ004 had a yield of 0.31 ± 
0.01 g proline / g glucose. Alleviating feedback inhibition of N-acetylglutamate kinase entailed 
growth-coupled and improved proline production with a yield of 0.36 ± 0.01 g/g. The addition of 
proline to the product palette of the ornithine producing strain ORN1 emphasises that this strain 
might be exploited as platform strain for industrially relevant bioproducts such as ornithine, proline, 
putrescine, spermidine, citrulline, and arginine. Moreover, engineering strategies of the platform 
strain can easily be transferred and applied to improve derived producer strains. 
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3.6	  Methods	  
 
3.6.1	  Strains,	  plasmids,	  and	  media	  
 
C. glutamicum strain ATCC 13032 [35], ORN1 [21], and its derivatives have been 
used in this study. As ornithine is a precursor to several interesting products, such as amino acids, 
di- and polyamines of the glutamate family, ORN1 has the potential to serve as a platform strain.  E. 
coli DH5α [36] was used for the cloning procedures and cultured at 37°C in Lysogeny Broth (LB) 
[37] or on LB-agar. Competent E. coli cells and molecular techniques were performed according to 
standard procedures [37]. Chromosomal DNA from C. glutamicum and Pseudomonas putida 
KT2440 was isolated by resuspending overnight cultures in 360 µL 50 mM Tris-HCl (pH 8) 
followed by the addition of a spatula tip of lysozyme, and incubation at 37°C for two hours. 
Thereafter the procedure “DNA purification from tissues” with the QiaAmp DNA mini kit (Qiagen, 
Hilden, Germany) was followed. Preparation and transformation of C. glutamicum competent cells 
was performed according to published methods [38]. Plasmids pVWEx1-ocdPp2 and pVWEx1-
ocdPp1 were constructed by amplifying ocd from P. putida [NCBI-GeneID: 1046312] with primers 
ocd2-FW (CTTctgcagAAGGAGATATAGATATGACGTATTTCATTGATGTTCCA) and ocd3-
RV (CCTggtaccTTAGGCAACCCGTCGGATAC, the stop codon was modified from TGA to 
TAA) or ocd2-RV (CCTggtaccTCAGGCAACCCGTCGGATAC). The amplified fragments were 
treated with KpnI and PstI and ligated with similarly treated pVWEx1. Plasmid pVWEx1-ocdCg was 
constructed similarly, however primers ocd1-FW 
(CTTctgcagAAGGAGATATAGATATGACCGCAACCTACACCACTG) and ocd1-RV 
(CCTggtaccTCAAGCCAGTGCGGGTG) were used for the amplification of ocd from C. 
glutamicum [NCBI-GeneID: 3343467]. The construction of pEKEx3-argBA49VM54V has been 
described elsewhere [20]. Plasmids pVWEx1, pVWEx1-ocdCg, pVWEx1-ocdPp2, pVWEx1-ocdPp1, 
pEKEx3, and pEKEx3-argBA49VM54V were transformed into ORN1 resulting in strains JJ001, JJ002, 
JJ003, JJ004, JJ005, and JJ006, respectively. Brain heart infusion broth (BHI, Roth Chemie GmbH, 
Karlsruhe, Germany) was used for inoculation of precultures, while CGXII minimal medium 40 g/L 
glucose or CGXIIm (CGXII but without ammonium sulfate) 35 g/L glucose was used for growth 
and proline production.  
 
3.6.2	  Culture	  conditions	  
 
C. glutamicum was inoculated to an OD of 1 in 50 mL minimal medium, 0.75 mM 
arginine, 1 mM Isopropyl-β-D-thiogalactopyranosid (IPTG), 25 µg/mL kanamycin, and when 
required 50 µg/mL spectinomycin on a rotary shaker (120 rpm) in baffled shake flasks at 30°C. 
Cultivations were always performed in triplicates. Growth was monitored measuring the OD at 600 
nm using a spectrophotometer (V-1200, VWR, Radnor, PA, USA). 5 g/L urea and N-equimolar 
concentrations of ammonium sulfate and ammonium chloride were used for screening of nitrogen 
sources. For the screening of nitrogen sources and the Plackett-Burman design, cells were grown in 
48-well flower plates using the Biolector microfermentation system (m2p-labs GmbH, Aachen, 
Germany). 1 mL medium was used per well with a shaking frequency of 1100 rpm. Biomass 
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formation was measured as backscattered light intensity sent at 620 nm with a signal gain factor of 
20. 
 
3.6.3	  Utilization	  of	  proline	  as	  carbon	  and	  nitrogen	  source	  
 
C. glutamicum was inoculated to an OD of 1 in variants of CGXII medium. For the 
utilization of proline as carbon source CGXII with 20 g/L glucose or with a C-equimolar 
concentration of proline was used. For the utilization of proline as nitrogen source CGXII with 5 
g/L urea and 20 g/L ammonium sulfate, with a N-equimolar concentration of proline, or with no 
nitrogen source added, was used. 
 
3.6.4	  Screening	  of	  medium	  components	  using	  the	  Plackett-­‐Burman	  design	  
 
A Plackett-Burman design [39] for 19 factors (including seven dummies) with 20 runs 
was employed to screen for factors that significantly affect proline production through the ornithine 
biosynthetic pathway. The dummies serve as a measure for the error in estimating the main effects. 
The medium components were screened at a low (-) and a high (+) level, where the concentrations 
can be found in Table 6 and the design in Table 4. The concentrations of the two levels were 
selected based on a literature search and preliminary results. The effect of each factor on proline 
production was determined by the equation: 
 
E(Xi) = 2 (ΣY+i – ΣY-i) / N 
 
where E(Xi) is the factor main effect, Y+i and Y-i are the proline concentrations in which the factors 
being tested are at their high and low levels respectively, N is the number of runs. The  t-values of 
the factor main effects were plotted in a Pareto chart, and evaluated based on a t-value and a 
Bonferroni limit [40].  The t-test assesses the risk of declaring an effect significant, when it actually 
was caused by chance. The Bonferroni correction is a conservative adjustment that takes the 
number of estimated effects into account by dividing it into the desired probability for the risk 
value. Effects above the Bonferroni limit are likely not stacastic [40]. 
 
The experiment was designed, and obtained data analysed, using the software Design-Expert 8.0.7.1 
(Stat-Ease Inc., Minneapolis, USA). The experiment was carried out in duplicates, where the mean 
was considered the response (Table 6). 
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3.6.5	  Ornithine	  cyclodeaminase	  assay	  
 
BHI broth supplemented 25 µg/mL kanamycin and 1 mM IPTG was inoculated to an 
OD of 1 and grown for 4 h at 30 °C. Cells were harvested and washed in 20 mM KH2PO4 (pH 8.2). 
Then, cells were lysed by means of sonication (Ultraschalldesintegrator Sonoplus GM 200, 
Sonotrode M72, Bandelin electronic GmbH & Co KG, Berlin, Germany) for 6 min (cycle 0.5, 
amplitude 55) and centrifuged for 60 min at 4°C and 14600 rpm.  
Crude extracts were purified using PD10 desalting columns (GE Healthcare, Chalfont St Giles, 
United Kingdom) with 20 mM KH2PO4 (pH 8.2). The reaction solution consisted of 20 mM 
KH2PO4 (pH 8.2) and 0.5 mM NAD+. Tubes with reaction solution and between 0.08 and 0.4 mg 
protein pr. 250 µL reaction were equilibrated to 30°C for 3 min in a water bath. The reaction was 
initiated upon the addition of 25 mM L-ornithine. The reaction was stopped upon addition of 50% 
formic acid. The samples were then neutralized with 10 N KOH and precipitate was pelleted by 
centrifugation. Reactions were performed in triplicates with two enzyme concentrations. The 
conversion of ornithine to proline was measured by HPLC. Unpurified extracts were analysed by 
SDS-PAGE, and protein quantification was performed by the procedure of Bradford with bovine 
serum albumin as the standard [41].  
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3.6.6	  N-­‐Acetylglutamate	  kinase	  assay	  
 
Crude extracts were prepared as stated for the ornithine cyclodeaminase assay. The 
NAGK activity assay was performed as described by Haas and Leisinger [42]. The assay was 
performed in triplicates and carried out at 30°C at pH 7.2. One enzyme unit is the amount of 
enzyme that catalyses the formation of 1 µmol of product in 1 min. 
 
3.6.7	  Amino	  acid	  and	  glucose	  determination	  
 
Extracellular amino acids and carbohydrates were quantified by means of high-
pressure liquid chromatography (1200 series, Agilent Technologies Deutschland GmbH, Böblingen, 
Germany). Samples were withdrawn from cultures, centrifuged (13,000 × g, 10 min), and the 
supernatant was used for analysis. For the detection of amino acids, samples were derivatised with 
9-fluorenylmethyl chloroformate (FMOC) or ortho-phthaldialdehyde, separated on a system 
consisting of a pre-column (LiChrospher 100 RP18 EC-5µ (40 x 4 mm), CS-Chromatographie 
Service GmbH, Langerwehe, Germany) and a main column (LiChrospher 100 RP18 EC-5µ (125 x 
4 mm), CS-Chromatographie), and detected with a fluorescence detector (FLD G1321A, 1200 
series, Agilent Technologies). L-Asparagine was used as internal standard. For the detection of 
carbohydrates the separation of the analyte was achieved with a column for organic acids (300 x 8 
mm, 10 µm particle size, 25 Å pore diameter, CS-Chromatographie) and a refractive index detector 
(RID G1362A, 1200 series, Agilent Technologies) was used. Derivatisation and quantification was 
carried out according to published methods [22] with the following modifications of the 
quantification of FMOC derivatised samples: The mobile phases used were A: 50 mM sodium 
acetate (pH 4.2) and B: acetonitrile. The gradient used was: 0 min 38% B, 5 min 38% B, 12 min 
57% B, 14 min 76% B, 15 min 76% B, and 18 min 38% B.  
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Chapter	   4.	   L-­‐citrulline	   production	   by	   metabolically	   engineered	  
Corynebacterium	   glutamicum	   from	   glucose	   and	   alternative	   carbon	  
sources.	  
 	  
Eberhardt, D., Jensen, J.V.K., & Wendisch, V.F. (2014). L-citrulline production by metabolically 
engineered Corynebacterium glutamicum from glucose and alternative carbon sources. AMB 
Express, 4, 85. 
 
 
4.1	  Abstract	  
 
L-citrulline plays an important role in human health and nutrition and is an 
intermediate of the L-arginine biosynthetic pathway. L-citrulline is a by-product of L-arginine 
production by Corynebacterium glutamicum. In this study, C. glutamicum was engineered for 
overproduction of L-citrulline as major product without L-arginine being produced as by-product. 
To this end, L-arginine biosynthesis was derepressed by deletion of the arginine repressor gene 
argR and conversion of L-citrulline towards L-arginine was avoided by deletion of the 
argininosuccinate synthetase gene argG. Moreover, to facilitate L-citrulline production the gene 
encoding a feedback resistant N-acetyl L-glutamate kinase argBfbr as well as the gene encoding L-
ornithine carbamoylphosphate transferase argF were overexpressed. The resulting strain 
accumulated 44.1  ±  0.5 mM L-citrulline from glucose minimal medium with a yield of 
0.38  ±  0.01 g⋅g−1 and a volumetric productivity of 0.32  ±  0.01 g⋅l−1⋅h−1. In addition, production of 
L-citrulline from the alternative carbon sources starch, xylose, and glucosamine could be 
demonstrated. 
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4.2	  Introduction	  	  
 
L-citrulline is a natural non-proteinogenic amino acid whose name is derived from 
watermelon Citrullus lanatus (Wada 1930). In mammalians it serves as a precursor for L-arginine. 
In contrast to the proteinogenic L-arginine, which is not transferred to the blood stream, when 
ingested, L-citrulline can be converted to L-arginine, which is then released by the kidney into the 
blood stream. It is applied in several medical approaches e.g. as a pharmaconutrient (Rimando and 
Perkins-Veazie 2005; Curis et al. 2005).  
Currently, biocatalytic and fermentative methods to produce L-citrulline using Pseudomonas putida 
(Kakimoto et al. 1971; Yamamoto et al. 1974) or Bacillus subtilis strains exist (Okumura et al. 
1966). Additionally, extraction processes from watermelon have been established (Fish 2012). L-
citrulline is an intermediate of L-arginine biosynthesis and accumulates as a by-product of 
engineered L-arginine producing Corynebacterium glutamicum strains (Ikeda et al. 2009; Schneider 
et al. 2011).  
 
C. glutamicum is a workhorse for amino acid production and is employed for the annual production 
of several million tons of L-glutamate and L-lysine (Wendisch 2014). C. glutamicum has been 
engineered to produce a wide range of bioproducts, such as diamines, carotenoids, terpenes, 
proteins (Schneider and Wendisch 2010; Schneider et al. 2012; Heider et al. 2014a, b; Frohwitter et 
al. 2014; Kikuchi et al. 2009; Teramoto et al. 2011; An et al. 2013) and the L-glutamate family 
amino acids L-arginine, L-ornithine, and L-proline (Schneider et al. 2011; Ikeda et al. 2009; Georgi 
et al. 2005; Blombach et al. 2009; Jensen and Wendisch 2013). However, the production of L-
citrulline as the only or major product has not been published yet.  
 
Due to its natural ability to produce L-glutamate under several eliciting conditions, C. glutamicum 
is a suitable producer of L-glutamate-derived products (Sato et al. 2008; Radmacher et al. 2005; 
Kim et al. 2009, 2010; Delaunay et al. 1999; Wendisch et al. 2014). L-ornithine is a non-
proteinogenic glutamate-family amino acid and an intermediate of L-arginine biosynthesis (Figure 
1). An ornithine producer was obtained by deletion of argR, the gene encoding the genetic repressor 
of the arginine biosynthetic operon, and argF to prevent further processing of ornithine (Schneider 
et al. 2011). The production of L-proline from L-ornithine is possible by the heterologous 
overexpression of ocd from Pseudomonas putida, encoding ornithine cyclodeaminase (Jensen and 
Wendisch 2013). The diamine putrescine can be produced by overexpression of the Escherichia 
coli gene speC, which encodes ornithine decarboxylase (Schneider et al. 2012; Schneider and 
Wendisch 2010). As the arginine biosynthetic pathway is naturally regulated by feedback inhib- 
ition of N-acetylglutamate kinase (encoded by argB) by arginine, the use of feedback resistant 
enzyme variants in combination with deletion of argR has been described to overproduce L-
arginine (Sakanyan et al. 1996; Ikeda et al. 2009; Schneider et al. 2011).  
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C. glutamicum can utilize a variety of carbon sources. In contrast to many other microorganisms 
used in biotechnology, simultaneous utilization of carbon sources e.g. present in mixtures such as 
lignocellulosic hydrolysates is a hallmark of C. glutamicum (Blombach and Seibold 2010; 
Meiswinkel et al. 2013a, b). The natural substrate spectrum of C. glutamicum includes mono- 
saccharides, disaccharides, and organic acids as well as alcohols (Blombach and Seibold 2010; 
Arndt and Eikmanns 2008; Peters-Wendisch et al. 1998; Jolkver et al. 2009; Sasaki et al. 2011). To 
allow access to alternative carbon sources, C. glutamicum has also been engineered for utilization 
of glycerol, pentoses, and amino sugars as well as polysaccharides (Schneider et al. 2011; Rittmann 
et al. 2008; Seibold et al. 2006; Uhde et al. 2013; Gopinath et al. 2011; Matano et al. 2014).  
One aim to reduce production cost is the use of complex sugar substrates for the production of 
biotechnological products. As an example of using a polymeric raw material without decomposition 
to its monomeric compounds e.g. by enzyme treatment, soluble starch could be used as a carbon 
source for the production of L-lysine and organic acids by engineered C. glutamicum (Seibold et al. 
2006; Tateno et al. 2007; Tsuge et al. 2013). However, due to the growing world population and a 
correlating higher demand for food, biotechnological processes based on non-food derived carbon 
sources are sought. Xylose is a pentose sugar compound present in the hemicellulosic fraction of 
agricultural wastes as for example rice straw. Glucosamine, on the other hand, is a constituent of 
chitin, the second most abundant biopolymer in nature, which is accessible e.g. from shrimp shell 
waste accumulating in the food industry. C. glutamicum has been engineered to efficiently utilize 
both xylose and glucosamine as alternative carbon sources for growth and amino acid production 
(Gopinath et al. 2011; Meiswinkel et al. 2013a; Uhde et al. 2013; Matano et al. 2014).  
In this study, the rational engineering of L-citrulline production by C. glutamicum is reported and 
the concept was extended to production of L-citrulline from the alternative carbon sources 
glucosamine, xylose, and starch.  
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4.3	  Materials	  and	  methods	  	  
 
4.3.1	  Microorganisms	  and	  growth	  conditions	  	  
Microorganisms and plasmids used in this study are listed in Table 1. E. coli DH5α 
was used for gene cloning. C. glutamicum and E. coli strains were routinely grown in lysogeny 
broth (LB) (10 g L−1 tryptone, 5 g L−1 yeast extract, 10 g L−1 sodium chloride) in 500-mL baffled 
flasks on a rotary shaker (120 rpm) at 30°C or 37°C. For growth experiments, CGXII minimal 
medium (Eggeling and Reyes 2005) was used for C. glutamicum. Growth was followed by 
measuring the optical density at 600 nm using a V-1200 Spectrophotometer (VWR, Radnor, PA, 
USA). An OD600 of 1 corresponds approximately to an estimated cell dry weight of 0.25 g/L.  
When necessary, the growth medium was supplemented kanamycin (25 µg mL−1), spectinomycin 
(100 µg mL−1), tetracycline (10 µg mL−1), isopropyl β-D-1-thiogalactopyranoside (IPTG) (1 mM) 
and L-arginine (750 µM). The growth behavior and L-citrulline production of recombinant C. 
glutamicum strains were analyzed in 500 ml baffled flasks. Briefly, a 50 mL BHI (37 g L−1) seed 
culture was inoculated from an agar plate and grown overnight. The cells were harvested by 
centrifugation (4,000  ×  g, 10 min) and washed twice with CGXII minimal medium lacking the 
carbon source. Subsequently, 50 mL CGXII medium, containing a given concentration of carbon 
source and necessary supplements, was inoculated to an optical density of 1.0. Detailed information 
on the carbon source concentrations employed is given in the Results chapter. 
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4.3.2	  Molecular	  genetic	  techniques	  	  
 
Standard methods such as restriction digestions, and ligation were carried out as 
described elsewhere (Sambrook and Russell 2012). Digested DNA was purified by using the 
QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany). E. coli cells were transformed by heat 
shock (Sambrook and Russell 2012) and C. glutamicum cells were transformed by electroporation 
(Eggeling and Reyes 2005). Isolation of genomic DNA was performed as previously described 
(Jensen and Wendisch 2013). Chromosomal changes in C. glutamicum were performed as described 
elsewhere (Eggeling and Reyes 2005).  
 
4.3.3	  Construction	  of	  strains	  and	  plasmids	  	  
 
The deletion of ΔargFR in MB001 was performed by using pK19mobsacBΔargFR. 
Afterwards argG was deleted by using pK19mobsacBΔargG to obtain CIT0. pK19mobsacBΔargG 
contains the up- and downstream regions of argG in the ΔargFR strain. The plasmid was 
constructed by amplifying the upstream region with argG_up_f 
(CTTgaattcAGAAGCTGCGCCGCATG) and argG_up_r 
(agagacgacctaagccagtctAACGATGCGGTTAGTCATGAGG) and the downstream region with 
argG_down_f (agactggcttaggtcgtctctGCTAACAAGCGCGATCGC) and argG_down_r 
(CCTctgcagAACGACCAGCGCGCAGA). The two fragments were combined by crossover PCR 
using argG_up_f and argG_down_r and finally cloned into pK19mobsacB with PstI and EcoRI. 
pVWEx1-argF was constructed by amplifying argF with primers argF_f 
(CTTgtcgacAAGGAGATATAGATATGACTTCACAACCACAGGTTCG) and argF_r 
(CCTggatccTTACCTCGGCTGGTTGGC). The PCR product was treated with SalI and BamHI and 
ligated with similarly treated pVWEx1. pVWEx1-argFG was constructed by amplifying argG with 
primers argG_f (GGGgtcgacGAAAGGAGGCCCTTCAGATGACTAACCGCATCGTTCTTG) 
and argG_r (GGGgtcgacTTAGTTGTTGCCAGCTTCGCGA). The PCR product was treated with 
SalI and ligated with similarly treated pVWEx1-argF.  
The plasmid vector pEKEx3-argBfbr (argBA49VM54V (Schneider et al. 2011)) was digested with 
BamHI and KpnI and the DNA fragment with a size of 0.9 kb harboring the argBfbr gene was 
cloned into the BamHI/KpnI digested vector pVWEx1-argF.  
 
4.3.4	  Determination	  of	  amino	  acid	  and	  carbohydrate	  concentrations	  	  
For the quantification of extracellular amino acids and carbohydrates, a high-
performance liquid chromatography system was used (1200 series, Agilent Technologies 
Deutschland GmbH, Böblingen, Germany). Samples were withdrawn from the cultures, centrifuged 
(13,000 × g, 10 min), and the supernatant used for analysis.  
Glucose and xylose were analyzed on a normal phase column (organic acid resin 300 × 8 mm, 10 
µm particle size, 25 Å pore diameter; Chromatographie Service GmbH, Langerwehe, Germany) 
using 5 mM sulfuric acid as the mobile phase at a flow rate of 1 mL min−1 and were detected with 
a refractive index detector (RID G1362A, 1200 series, Agilent Technologies). Amino acids were 
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automatically modified by pre-column derivatisation with ortho-phthalaldehyde and separated as 
described previously (Georgi et al. 2005). L-ornithine was quantified using a pre-column 
(LiChrospher 100 RP18 EC-5 µ (40 × 4 mm), CS-Chromatographie Service GmbH, Langerwehe, 
Germany) and a reversed phase column (LiChrospher 100 RP18 EC-5 µ (125×4 mm), CS 
Chromatographie) as a main column and detected with a fluorescence detector at excitation at 230 
nm and 450 nm emission (FLD G1321A, 1200 series, Agilent Technologies). For the determination 
of L-citrulline, a reverse-phase (RP) LiChrospher 100 RP8 EC-5 µ precolumn (40 × 4.6 mm) and a 
RP8 EC-5 µ (125 × 4.6 mm) main column (CS Chromatographie, Langerwehe, Germany) were 
used. 100 µM L-asparagine was used as an internal standard. The mobile phases used were in case 
of RP8 A: 0.25% Na-acetate pH 6, B: methanol. The gradient used was: 0 min 30% B, 1 min 30% 
B, 6min, 70% B, 11min 90% B, 14min 70% B, 16 min 30% B. In case of RP18, the mobile phases 
used were A: 0.1 M Na-acetate pH 7.2, B: methanol. The gradient used was: 0 min 20% B, 0.5 min 
38% B, 2.5 min 46% B, 3.7 min 65% B, 5.5 min 70% B, 6 min 75% B, 6.2 min 85% B, 6.7 min 
20% B.  
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4.4	  Results	  	  
 
4.4.1	  Engineering	  a	  prophage-­‐free	  C.	  glutamicum	  strain	  for	  L-­‐citrulline	  production	  
 
C. glutamicum has recently been cured of prophage sequences to yield MB001 
(Baumgart et al. 2013). This strain was used as the parental strain because it can be transformed 
easily and plasmid-based gene overexpression is more efficient (Baumgart et al. 2013). As C. 
glutamicum ATCC 13032, this strain does not accumulate L-citrulline, an intermediate of L-
arginine biosynthesis (Figure 1). The deletion of three genes of the L-arginine operon (L-ornithine 
carbamoyltransferase (EC 2.1.3.3) argF, argininosuccinate synthetase (EC 6.3.4.5) argG, and L-
arginine biosynthesis operon repressor gene argR) in C. glutamicum MB001 yielded the L-arginine 
auxotrophic strain CIT0. When supplemented with 0.75 mM L-arginine, C. glutamicum CIT0 
accumulated 25.2 ± 2.6 mM L-ornithine from 2% glucose. The deletion of argF and argG could be 
complemented by plasmid-borne expression of these genes since the complemented strain 
CIT0(pVWEx1-argFG) grew without L-arginine supplement while the empty vector carrying 
control CIT0(pVWEx1) did not (data not shown). Comparable growth rates and biomass 
concentrations were observed.  
 
To enable L-citrulline accumulation, two plasmids were constructed and used to transform C. 
glutamicum CIT0. While pVWEx1-argF only carries argF encoding L-ornithine 
carbamoyltransferase, pVWEx1-argFBfbr in addition carries argBfbr encoding feedback-resistant N-
acetyl L-glutamate kinase (NAGK, EC 2.7.2.8). When grown in minimal medium with 2% glucose 
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and 0.75 mM L-arginine C. glutamicum CIT0(pVWEx1-argF) grew to a higher OD than 
CIT0(pVWEx1) (Figure 2) and did not accumulate notable concentrations of L-citrulline. As 
opposed to CIT0(pVWEx1), CIT0(pVWEx1-argF) did not produce L-ornithine (Figure 3). By 
contrast, the combined overexpression of argF and argBfbr entailed L-citrulline production and the 
respective strain was named CIT1. C. glutamicum CIT1 accumulated 44.1 ± 0.5 mM L-citrulline in 
minimal medium with 2% glucose (Figure 4).  
When comparing the growth of C. glutamicum CIT0 (pVWEx1) to that of CIT0(pVWEx1-argF), 
similar growth rates (0.37 ± 0.01 h−1 and 0.35 ± 0.04 h−1, respectively) were obtained, whereas L-
citrulline formation by CIT0 (pVWEx1-argFBfbr) was accompanied by a reduced growth rate (0.15 
± 0.01 h−1) (Figure 2). Moreover, the final OD600 of CIT0(pVWEx1-argFBfbr) was 20 ± 1 as 
compared to an OD600 of 26 ± 1 of CIT0(pVWEx1). By contrast, C. glutamicum CIT0(pVWEx1-
argF) grew to a higher biomass concentration with a final OD600 of 35 ± 1. As shown in Figure 3, 
the lower growth rates of CIT0(pVWEx1) and CIT0(pVWEx1-argFBfbr) correlated inversely with 
the formation of the respective amino acids L-ornithine and L-citrulline, whereas C. glutamicum 
CIT0(pVWEx1-argF) reaches a higher final biomass and neither produces L-ornithine nor L-
citrulline.  
 
         
 
 
	  
4.4.2	  Production	  of	  L-­‐citrulline	  from	  alternative	  carbon	  sources	  	  
 
Due to the high demand of biotechnological processes of using complex sugar 
substrates derived from raw materials and industrial wastes, the L-citrulline producer strain CIT1 
was enabled to utilize the alternative carbon sources starch (as an example of a high molecular 
weight carbohydrate), xylose, and glucosamine (as an example of carbohydrates derived from 
forestry and food industrial wastes).  
To enable C. glutamicum CIT1 to consume starch, the gene amyA from Streptomyces griseus was 
overexpressed. The combined overexpression of xylA from Xanthomonas campestris and 
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endogenous xylB allowed the utilization of xylose by C. glutamicum CIT1. The endogenous nagB 
was overexpressed ectopically to facilitate the consumption of glucosamine. The resulting strains 
were tested for growth and L-citrulline production.  
When cultured in CGXII medium supplemented 0.75 mM L-arginine all strains engineered for 
alternative carbon source consumption grew with their respective substrate (Table 2). The empty 
vector carrying strain CIT1(pEKEx3) neither grew in xylose or glucosamine minimal medium nor 
consumed these substrates. By contrast, the recombinant strain CIT1(pEKEx3-xylAB) grew in 
xylose minimal medium with a growth rate of 0.03 ± 0.01 h−1 and reached a final OD600 of 6 ± 1 
(Table 2). In glucosamine minimal medium, C. glutamicum CIT1(pEKEx3-nagB) grew to a final 
OD600 of 3±1 with a growth rate of 0.02 ± 0.01 h−1. In minimal medium containing 1% starch and 
0.25% glucose as carbon sources, the empty vector harboring strain CIT1(pEC-XT99A) formed 
roughly one third of the biomass as compared to C. glutamicum CIT1(pAmy) (Table 2). Growth of 
CIT1(pEC-XT99A) was slower (growth rate of 0.10 ± 0.01 h−1) than that of CIT1(pAmy) (growth 
rate of 0.21 ± 0.01 h−1). While strain CIT1(pEC- XT99A) only utilized glucose, but not starch, 
CIT1(pAmy) was able to consume both, glucose and starch.  
 
 
 
 
 
The strains engineered for utilization of xylose and glucosamine, respectively, also produced L-
citrulline from these carbon sources (Figure 5). C. glutamicum CIT1(pEKEx3-nagB) accumulated 
2.6 ± 0.3 mM L-citrulline which corresponds to a yield of 0.045 ± 0.002 g/g since glucosamine was 
utilized completely. Similarly, after complete utilization of xylose by C. glutamicum 
CIT1(pEKEx3-xylAB) 6.4± 0.1 mM L-citrulline accumulated corresponding to a yield of 0.075 ± 
0.001 g / g xylose.  
 
As the determination of the starch concentration by HPLC was not possible, residual starch content 
was assayed by the use of Lugols solution. However, as it is known that overexpression of amyA in 
C. glutamicum results in high molecular mass degradation products of starch, which remain in the 
medium and are not detectable by Lugols solution (Seibold et al. 2006), the L-citrulline 
concentration was measured until no change in OD600, starch content and L-citrulline 
concentration was observed. The starch utilizing strain CIT1(pAmy) was able to produce 11.9 ± 0.5 
mM L-citrulline which corresponds to a yield of 0.167 g/g.  
 
 
	  	  53	  
 
 
 
 
  
	  	  54	  
4.5	  Discussion	  	  
 
C. glutamicum was engineered to accumulate L-citrulline as major product, both from 
glucose as well as from the alternative carbon sources starch, glucosamine and xylose.  
Feedback insensitive N-acetyl L-glutamate kinase (encoded by argBfbr; (A49VM54V)) was required 
for production of L-citrulline since CIT0(pVWEx1-argF) did not produce L-citrulline, while 
CIT0(pVWEx1-argFBfbr) produced L-citrulline. It is unlikely that addition of L-arginine to 
CIT0(pVWEx1-argF) inhibited generation of L-ornithine, a precursor of L-citrulline, because strain 
CIT0(pVWEx1) produced L-ornithine when supplemented with L-arginine. However, it is possible 
that intracellular L-citrulline affects arginine biosynthesis. As overexpression of argBfbr entailed L-
citrulline formation, we assume that L-citrulline inhibits the NAGK of C. glutamicum, but this has 
not yet been described. As expected due to its structural similarity to L-arginine, L-citrulline 
inhibits NAGK of other microorganisms (Farago and Denes 1967; Haas and Leisinger 1975). In 
Chlamydomonas reinhardtii, NAGK is inhibited by several L-arginine structure analogs, including 
L-citrulline, however, inhibition was less pronounced than L-arginine inhibition (Farago and Denes 
1967). NAGK from Pseudomonas aeruginosa lost two thirds of its activity in the presence of 2.5 
mM L-citrulline, which was claimed to be too weak under physiological conditions (Haas and 
Leisinger 1975). However, it is conceivable that inhibition of NAGK by L-citrulline may play a role 
in recombinant C. glutamicum strains engineered for L-citrulline production, thus, possibly 
explaining the finding that L-citrulline production required overexpression of argBfbr encoding 
NAGK feedback resistant to L-arginine. Commensurate with this notion, simultaneous production 
of L-arginine and L-citrulline resulted from argBfbr overexpression in a ΔargR background (Ikeda et 
al. 2009). In this argBfbr overexpressing strain, the ratio of L-citrulline to L-arginine was higher 
than by classically obtained strains, which solely contain native argB (Ikeda et al. 2009). Currently, 
it remains to be studied if L-citrulline inhibits NAGK from C. glutamicum and if (some) variants 
feedback resistant to L-arginine are also desensitized to L-citrulline.  
Notably, about two fold more L-citrulline (about 7.7 g/L) was produced by strain CIT1 than L-
ornithine was produced (about 3.3 g/L) by the isogenic strain CIT0 (pVWEx1). Both, 
overexpression of argF and argBfbr may have contributed to this effect. It is more likely that argBfbr 
is responsible as L-arginine supplementation may have limited flux in the arginine biosynthesis 
pathway of strain CIT0(pVWEx1) especially in the beginning of the cultivation. In C. glutamicum 
CIT1, only feedback resistant NAGK is present and additionally a gene dosage effect due ectopic 
overexpression of argBfbr might have contributed to increase L-citrulline production.  
 
Glucose, glucosamine, xylose, and starch were shown to be suitable substrates for the production of 
L-citrulline. Strain construction was based on previously established engineering strategies (Seibold 
et al. 2006; Uhde et al. 2013; Meiswinkel et al. 2013a; Gopinath et al. 2011). The achieved L-
citrulline concentrations on these substrates were lower than with glucose as carbon source. 
However, L-citrulline production from xylose (6.44 ± 0.12 mM) by CIT1(pEKEx3-xylAB) was 
lower, but in a similar range as production of L-ornithine (19.6 ± 1.9 mM) and putrescine (15.1 ± 
1.2 mM), respectively, from the same xylose concentration by the respective recombinant C. 
glutamicum strains (Meiswinkel et al. 2013a). Similarly, product yields with glucosamine as carbon 
source were lower for L-citrulline (0.067 g/g) than for putrescine (0.112 g/g) (Uhde et al. 2013). 
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Unexpectedly and hitherto not understood, the growth rate (0.02 ± 0.01 h−1) and, thus, product- 
ivity by CIT1(pEKEx3-nagB) were very low. By contrast, a putrescine producing strain carrying 
pEKEx3-nagB showed only a slightly decreased growth rate (Uhde et al. 2013).  
C. glutamicum strains carrying pAmy co-utilized starch with glucose (Seibold et al. 2006). 
Substrate co-utilization is observed with C. glutamicum WT as well as recombinant strains for 
almost all mixtures of carbon sources (Blombach and Seibold 2010). A L-lysine producing strain 
carrying pAmy showed increased biomass formation by addition of 10 g/L starch to 10 g/L glucose, 
whereas L-lysine production increased only upon addition of higher starch concentrations (Seibold 
et al. 2006).  
 
In this study, the additional presence of starch increased the growth rate of CIT1 (from 0.15 to 0.21 
h−1) as well as L-citrulline production. Production of L-citrulline by CIT1(pAmy) from a starch 
glucose mixture was higher (11.95 ± 0.48 mM) than that by the empty vector carrying control strain 
(4.83 ± 0.4 mM) demonstrating that starch contributed to production of L-citrulline. It has to be 
noted that starch cannot be utilized completely by C. glutamicum strains overexpressing the α-
amylase gene amyA because high-molecular-weight carbohydrates are generated from starch and 
remain unutilized in the medium (Seibold et al. 2006).  
Taken together, production of L-citrulline as major product from glucose, starch, glucosamine, and 
xylose by recombinant C. glutamicum strains was achieved.  
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   compounds	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  proline,	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  citrulline,	  and	  arginine	  	  	  	  
Jensen, J.V.K., Eberhardt, D., Wendisch, V.F. (2015) Modular pathway engineering of 
Corynebacterium glutamicum for production of the glutamate-derived compounds ornithine, 
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5.1	  Abstract	  
 
The glutamate-derived bioproducts ornithine, citrulline, proline, putrescine, and 
arginine have applications in food and feed, the cosmetic, pharmaceutical, and chemical industries. 
Engineering an ornithine overproducing Corynebacterium glutamicum strain to accumulate a high 
ornithine yield could be useful not only for the production of ornithine, but also for production of 
the amino acids citrulline, proline, and arginine, and the diamine putrescine. We here demonstrate 
how the feedback alleviation of N-acetylglutamate kinase, tuning of the promoter of the glutamate 
dehydrogenase gene gdh, lowering expression of the phosphoglucoisomerase gene pgi, along with 
the introduction of a second copy of the arginine biosynthesic operon argCJBA49V,M54VD into the 
genome resulted in a C. glutamicum strain with a yield of 0.52 g ornithine / g glucose, an increase 
of 71% as compared to the parental ΔargFRG strain.  
Strains capable of efficiently producing citrulline, proline, arginine or putrescine were derived from 
ornithine producing strains by plasmid-based overexpression of appropriate pathway modules with 
one to three genes.  
C. glutamicum is not only an excellent producer of glutamate but also of glutamate-derived 
products. Engineering targets beneficial for ornithine production were identified and the advantage 
of rationally constructing a platform strain for the production of bioproducts of the glutamate family 
was demonstrated. 
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5.2	  Background	  	  
Corynebacterium glutamicum has for several decades been employed as workhorse 
for industrial production of amino acids and is especially known for its ability to secrete glutamate 
(Ikeda, 2003; Zahoor et al., 2012). The production of several other industrially relevant products of 
the glutamate family, namely ornithine, proline, citrulline, putrescine, and arginine, by C. 
glutamicum has been reported (Eberhardt et al., 2014; Hwang and Cho, 2014; Hwang et al., 2008; 
Ikeda et al., 2009; Jensen and Wendisch, 2013; Jiang et al., 2013a; Jiang et al., 2013b; Sakanyan et 
al., 1996; Schneider et al., 2012; Schneider et al., 2011; Schneider and Wendisch, 2010). These five 
compounds are of industrial interest due to their uses in for instance feed and food, cosmetics, 
pharmaceuticals, and in the case of putrescine as a monomer in the production of nylon-4,6 or 
nylon-4,10 (Jensen and Wendisch, 2013; Kaore et al., 2013; Scott et al., 2007; Shi et al., 2002; 
Zajac et al., 2010).  
 
In C. glutamicum, glutamate is synthesized from the tricarboxylic acid cycle intermediate 2-
oxoglutarate and five enzymatic steps are required for further conversion of glutamate to ornithine 
(Figure 1). The ornithine biosynthetic pathway in C. glutamicum is cyclic due to ornithine 
acetyltransferase (OAT), which catalyzes conversion of N-acetylornithine and glutamate to 
ornithine and N-acetylglutamate (NAG). NAG kinase (NAGK) then phosphorylates NAG in the 
second step of the pathway. Recently, cg3035 was found to encode a new type of NAG synthase 
catalyzing acetyl-CoA-dependent acetylation of glutamate to NAG (Petri et al., 2013). It is assumed 
that most NAG is produced by OAT, while the role of the cg3035 encoded NAG synthase is 
anaplerotic (Petri et al., 2013).  Besides OAT and NAGK, argC-encoded N-acetylglutamate 5-
semialdehyde dehydrogenase and argD-encoded N-acetylornithine aminotransferase are necessary 
for conversion of glutamate to ornithine (Figure 1). Once ornithine has been formed, citrulline can 
be produced by argF-encoded ornithine carbamoyltransferase (Eberhardt et al., 2014), proline by 
heterologous ornithine cyclodeaminase Ocd from Pseudomonas putida (Jensen and Wendisch, 
2013), putrescine by heterologous ornithine decarboxylase SpeC from Escherichia coli (Schneider 
and Wendisch, 2010), and arginine by endogenous ornithine carbamoyltransferase and argGH-
encoded argininosuccinate synthetase and argininosuccinate lyase (Ikeda et al., 2009; Park et al., 
2014; Schneider and Wendisch, 2010) (Figure 1). 
 
The regulation of the pathway is complex and involves allosteric regulation and transcriptional 
regulation. The transcriptional repressor ArgR represses transcription of the arginine operon 
argCJBDFR and is involved in regulation of gltB and gdh (Lee et al., 2010; Yim et al., 2011). 
Furthermore, the acyl-responsive transcriptional regulator FarR exerts control at the transcriptional 
level, although the mechanism is not fully comprehended (Lee et al., 2011). Lastly, NAGK is 
subject to allosteric inhibition as it is feedback inhibited by arginine. In addition, OAT is feedback 
inhibited by ornithine and citrulline (Hao et al., 2015; Sakanyan et al., 1996; Udaka, 1966). 
Alleviation of feedback inhibition is an important part of increasing product yield, evident by the 
number of publications dealing with this subject for the arginine pathway of C. glutamicum (Huang 
et al., 2015; Ikeda et al., 2009; Kim et al., 2015; Park et al., 2014; Schendzielorz et al., 2013; 
Schneider et al., 2011; Xu et al., 2012).  
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Feedback resistant NAGK from E. coli (EcNAGK) is a homodimer, whereas the so far investigated 
arginine sensitive NAGKs appear to be hexamers consisting of a trimer of dimers, where the dimers 
resemble EcNAGK (Ramon-Maiques et al., 2006). Arginine sensitive NAGKs like CgNAGK have 
an N-terminal extension. The extension was found to form a helix that interlaces with the helix of 
the adjacent dimer in Pseudomonas aeruginosa NAGK (PaNAGK) and Thermotoga maritima 
NAGK (TmNAGK). It was proposed that the N-helix plays an important modulatory role. Based on 
the crystal structure of TmNAGK, arginine was found to bind NAGK in a crevice near the 
interdimeric junction that flanks the N-helix and interacts with the C-terminal portion of it. The 
binding of arginine to the NAGK subunits results in an increased separation between the ATP and 
NAG sites, which appears to cause the inhibition. The inhibition by arginine is cooperative and 
NAGK has a high affinity for arginine (Fernandez-Murga and Rubio, 2008; Llacer et al., 2007; 
Ramon-Maiques et al., 2006). 
Here we describe the construction and improvement of ornithine producing C. glutamicum strains 
by metabolic engineering. Furthermore, we show that ornithine producing strains can serve as 
platform for the overproduction of proline, putrescine, citrulline, and arginine. The study 
emphasizes the importance of improving ornithine yield, as it can be beneficial for at least four 
industrially relevant products. 
 
Figure 1:  Pathways for the production of ornithine, proline, citrulline, putrescine, and arginine by C. 
glutamicum adapted from (Wendisch et al., 2014). Starting with ornithine the amino acids citrulline and 
proline as well as the diamine putrescine are synthesized in a single enzymatic step catalyzed by ornithine 
carbamoyltransferase (encoded by argF), ornithine cyclodeaminase (encoded by ocd from Pseudomonas 
putida) and ornithine decarboxylase (encoded by speC from Escherichia coli). From citrulline arginine is 
formed by the reactions catalyzed by argininosuccinate synthase and argininosuccinate lyase encoded by 
argG and argH, respectively. The gene written in grey denotes its anaplerotic function, genes written in grey 
boxes originate from a different microorganism. 
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5.3	  Materials	  and	  methods	  
	  
5.3.1	  Strains,	  plasmids,	  and	  primers	  
	  
C. glutamicum MB001 and its derivatives have been used in this study (Table 1). E. 
coli DH5α or Stellar competent cells were used for the cloning procedures. All primers used were 
purchased from Metabion (Planegg/Steinkirchen, Germany) and can be found in the Appendix 
(supplementary material – chapter 5) along with the plasmids used.  
	  
Table 1: Strains used in this study 
Strains Relevant characteristics Reference or source 
Escherichia coli   
DH5α F-, endA1, supE44, thi-1, recA1, relA1, 
gyrA96, phoA, Φ80d lacZ∆ M15, ∆ (lacZYA 
– argF) U169, hsdR17 (rK-, mK+) λ- 
(Hanahan, 1983) 
Stellar F-, endA1, supE44, thi-1, recA1, relA1, 
gyrA96, phoA, Φ80d lacZ∆ M15, ∆ (lacZYA 
– argF) U169, ∆(mrr – hsdRMS – mcrBC), 
∆mcrA, λ- 
Clontech 
Laboratories, 
Mountain View, 
CA, USA 
Corynebacterium glutamicum   
MB001 ATCC 13032 with in-frame deletion of 
prophages CGP1 (cg1507-cg1524), CGP2 
(cg1746-cg1752), and CGP3 (cg1890-
cg2071) 
(Baumgart et al., 
2013) 
MB001∆argFR  This study 
ORN1-pEKEx3-argB ATCC 13032 ∆argFR, SpecR This study 
ORN1-pEKEx3-argBE19R,H26E,H268N ATCC 13032 ∆argFR, SpecR This study 
ORN2 MB001∆argFRG This study 
ORN2-Pgdh1 Pgdh1: -35: TGGTCA -10: TATAAT  This study 
ORN2-Pgdh2 Pgdh2: -35: TGGTCA -10: 
TGCTATAATGG  
This study 
ORN2-Pgdh3 Pgdh3: -35: TTGACA -10: TATAAT This study 
ORN2-Pgdh4 Pgdh4: -35: TTGCCA -10: TATAAT This study 
ORN3 ORN2-Pgdh4-argBA49V,M54V This study 
ORN4 ORN3-pgiGTG This study 
ORN5  ORN3-Ptuf-argCJBA49V,M54VD This study 
ORN6 ORN4-Ptuf-argCJBA49V,M54VD This study 
ORN2B ORN2∆argB This study 
ORN2B-pEKEx3 SpecR This study 
ORN2B-pEKEx3-argB SpecR This study 
ORN2B-pEKEx3-argB∆1-23 SpecR This study 
ORN2B-pEKEx3-argBE19R SpecR This study 
ORN2B-pEKEx3-argBH26E SpecR This study 
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ORN2B-pEKEx3-argBH268N SpecR This study 
ORN2B-pEKEx3-argBG287D SpecR This study 
ORN2B-pEKEx3-argBA49V,M54V SpecR This study 
ORN2B-pEKEx3-
argBE19R,H26E,A49V,M54V 
SpecR This study 
ORN2B-pEKEx3-
argBA49V,M54V,H268N 
SpecR This study 
ORN2B-pEKEx3-
argBA49V,M54V,G287D 
SpecR This study 
ORN2B-pEKEx3-
argBE19R,H26E,H268N 
SpecR This study 
ORN2B-pEKEx3-
argBE19R,H26E,A49V,M54V,H268N 
SpecR This study 
ORN2B-pEKEx3-
argBE19R,H26E,A49V,M54V,H268N,G287D 
SpecR This study 
ORN2B-pEKEx3argBE.coli SpecR This study 
ORN2J ORN2∆argJ This study 
ORN2J-pEKEx3 SpecR This study 
ORN2J-pEKEx3-argJCg SpecR This study 
ORN2J-pEKEx3-argJCc SpecR This study 
ORN2-pEKEx3 SpecR This study 
ORN2-pEKEx3-argJCg SpecR This study 
ORN2-pEKEx3-argJCc SpecR This study 
ORN2D ORN2∆argD This study 
ORN2DD2 ORN2D∆argD2 This study 
ORN2DD2∆gabT  This study 
ORN2DD2∆bioA  This study 
ORN2DD2∆gapT∆bioA  This study 
ORN2DD2-pEKEx3 SpecR This study 
ORN2DD2-pEKEx3-argD SpecR This study 
ORN2DD2-pEKEx3-argD2LA SpecR This study 
ORN2DD2-pEKEx3-argD2LT SpecR This study 
ORN2DD2-pEKEx3-argD2MA SpecR This study 
ORN2DD2-pEKEx3-argD2MT SpecR This study 
ORN2-pEPR1 KanR This study 
ORN2-pEPR1-Ptuf KanR This study 
ORN2-pEPR1-Psod KanR This study 
ORN2-pEPR1-PargC KanR This study 
ORN2∆argCJBD  This study 
ORN2∆argCJBD-
argCJBA49V,M54VD 
Insertion of Ptuf-argCJBA49V,M54VD-
rrnBT1T2 at site where prophage CGP1 
was deleted 
This study 
ORN2∆argCJBD-
argBA49V,M54VJCD 
Insertion of Ptuf-argBA49V,M54VJCD-
rrnBT1T2 at site where prophage CGP1 
This study 
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was deleted 
CIT1 ORN2-pVWEx1-argFBA49V,M54V, kanR This study 
CIT2 ORN2-Pgdh4-pVWEx1-argFBA49V,M54V, kanR This study 
CIT3 ORN4-pVWEx1-argFBA49V,M54V, kanR This study 
PRO1 ORN2-pVWEx1-ocdPp, kanR This study 
PRO2 ORN2-Pgdh4-pVWEx1-ocdPp, kanR This study 
PRO3 ORN4-pVWEx1-ocdPp, kanR This study 
PUT2 ORN2-pVWEx1-speCEc, kanR This study 
PUT3 ORN2-Pgdh4-pVWEx1-speCEc, kanR This study 
PUT4 ORN4-pVWEx1-speCEc, kanR This study 
ARG5 ORN2-pVWEx1-argGFBA49V,M54V, kanR This study 
ARG6 ORN2-Pgdh4-pVWEx1-argGFBA49V,M54V, 
kanR 
This study 
ARG7 ORN4-pVWEx1-argGFBA49V,M54V, kanR This study 
	  
	  
5.3.2	  Molecular	  Biology	  Techniques	  	  
Competent E. coli cells, transformation thereof and general molecular techniques were 
performed according to standard procedures (Sambrook and Russell, 2001). Chromosomal DNA 
from C. glutamicum was isolated as previously described (Jensen and Wendisch, 2013). The 
preparation of competent C. glutamicum cells and their transformation were performed according to 
published methods (Eggeling and Reyes, 2005). Modifications introduced into the genome of C. 
glutamicum were performed with non-replicative vectors via two-step homologous recombination 
as described previously (Niebisch and Bott, 2001). Plasmids were verified by sequencing 
(Sequencing Core Facility, Bielefeld University). The modifications introduced into the genome 
were verified by amplification of the modified region by PCR and sequencing of the PCR product. 
PCR amplification was performed with KOD Hot Start DNA Polymerase according to the 
manufacturer (Toyobo, Osaka, Japan). PCR purification and gel extraction were performed with the 
PCR purification kit and Minelute kit from Qiagen (Hilden, Germany). Plasmids were isolated 
using the Qiagen miniprep kit. Restriction enzymes were purchased from Thermo Fisher Scientific 
(Waltham, MA, USA). Dephosphorylation of plasmid DNA and ligation was performed with the 
Rapid DNA Dephos and Ligation Kit (Roche Diagnostics, Basel, Switzerland). Insert DNA was 
phosphorylated with polynucleotide kinase from Thermo Fisher Scientific. Colony PCR was 
performed with GoTaq polymerase (Promega, Madison, WI, USA). Site-directed mutagenesis was 
performed as previously described (Liu and Naismith, 2008) with PfuTurbo DNA polymerase 
(Agilent, Waldbronn, Germany). 
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5.3.3	  Media	  and	  cultivation	  conditions	  
	  
E. coli strains were cultured at 37°C in Lysogeny Broth (LB) or on LB-agar. C. 
glutamicum strains were cultured at 30°C in brain heart infusion broth (BHI, Roth Chemie, 
Karlsruhe, Germany) or CgXII minimal medium with 4% (w/v) glucose. Where appropriate 
kanamycin 25 µg/mL, spectinomycin 100µg/mL, 0.75 mM arginine, and 1 mM isopropyl ß-D-
thiogalactopyranosid (IPTG) were added. For growth experiments the Biolector microfermentation 
system (m2p-labs, Aachen, Germany) was used. For growth experiments C. glutamicum strains 
were inoculated in BHI and grown 8-12 h on a rotary shaker, the culture was washed with 0.9% 
NaCl and inoculated in CgXII medium to an optical density (OD) of 1. OD was measured at 600 
nm using a spectrophotometer (V-1200, VWR, Radnor, PA, USA). For cultivation in 48-well 
flower plates wells were filled with 1 mL medium and a shaking frequency of 1100 rpm was 
applied. Biomass formation was measured as backscattered light intensity sent at 620 nm with a 
signal gain factor of 20. The GFP fluorescence intensity was measured in the biolector with an 
excitation filter of 405 nm and an emission filter of 508 nm with a signal gain factor of 20. 
Cultivations were performed in triplicates with a minimum of three independent experiments unless 
otherwise mentioned.  	  
5.3.4	  Enzyme	  activity	  assays	  	  
For the determination of GDH, NAGS, and OAT activities crude extracts were used. 
Overnight cultures of all analyzed strains were inoculated in 50 mL BHI medium containing IPTG 
and antibiotics if appropriate. The cells were washed with 0.9% NaCl and inoculated to OD 1 in 50 
mL BHI with or without 100 µg/mL spectinomycin and grown for 4h in 500 mL baffled shake 
flasks. Plasmid-based expression of target genes was induced by the addition of IPTG to a final 
concentration of 1 mM. For the NAGK assay cells were inoculated to OD 1 in CgXII medium with 
4% (w/v) glucose, supplemented with 100 µg/mL spectinomycin, 1 mM IPTG, and 0.25 mM 
arginine. Crude extracts were obtained by sonication (Ultraschalldesintegrator Sonoplus GM 200, 
Sonotrode M72, Bandelin electronic GmbH & Co KG, Berlin, Germany) for 6 min (cycle 0.5, 
amplitude 55) and centrifugation at 4°C and 14600 rpm for 60 min. The GDH assay was performed 
as described by Hänßler et al. with an UV-1800 CE-230V UV-Spectrophotometer (Shimadzu, 
Kyoto, Japan) (Hanssler et al., 2009). The NAGK activity assay was performed as described by 
Haas and Leisinger (Haas and Leisinger, 1975). The assay was performed in duplicates and carried 
out at 30°C at pH 7.2. The reaction solution for the OAT assay consisted of 100 mM Tris-HCl (pH 
7) and 6 mM glutamate. The reactions were initiated upon addition of 6 mM N-acetylornithine and 
stopped by boiling for 10 min. The conversion of N-acetylornithine to ornithine was quantified by 
HPLC. Protein concentrations were quantified by the method of Bradford using bovine serum 
albumin as the standard (Bradford, 1976). One enzyme unit is the amount of enzyme that catalyzes 
the formation of 1 µmol product in 1 min. 	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5.3.5	  Amino	  acid,	  putrescine	  and	  glucose	  quantification	  	  
Amino acids, putrescine, and glucose were quantified by means of high-pressure 
liquid chromatography (1200 series, Agilent). Quantifications of proline (Jensen and Wendisch, 
2013), putrescine, citrulline, arginine (Klatte and Wendisch, 2014), and glucose (Jensen and 
Wendisch, 2013) were performed as previously described. Samples containing amino acids were 
derivatized with ortho-phthaldialdehyde, separated on a system consisting of a pre-column 
(LiChrospher 100 RP18 EC-5µ, 40 x 4 mm, CS-Chromatographie, Langerwehe, Germany) and a 
main column (LiChrospher 100 RP18 EC-5µ, 125 x 4 mm, CS-Chromatographie), and detected 
with a fluorescence detector (FLD G1321A, 1200 series, Agilent).  For the detection of glutamate 
and ornithine the flow rate was 1.2 mL/min and the mobile phases used were A: 0.1 M sodium 
acetate (pH 7.2), B: methanol. The gradient used was: 0 min 20 % B, 0.5 min 38 % B, 2.5 min 46 % 
B, 3.7 min 65 % B, 5.5 min 70 % B, 6 min 75 % B, 6.2 min 85 % B, 6.7 min 20 % B, 8.9 min 20%. 
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5.4	  Results	  and	  discussion 
 
5.4.1	  Construction	  of	  the	  platform	  strain	  MB001∆argFRG	  
 
Recently, the genome-reduced C. glutamicum strain MB001 was constructed that 
lacks the prophages CGP1, CGP2, and CGP3 (Baumgart et al., 2013). One of the advantages of 
using this strain is its lack of the restriction-modification system (cg1996-cg1998) located within 
the large prophage CGP3 that entails a significantly increased transformation efficiency (Baumgart 
et al., 2013). Previously, we have described the production of ornithine by C. glutamicum ATCC 
13032 ∆argFR named ORN1 (Schneider et al., 2011). Based on the prophage-free strain MB001, 
we describe here the construction of a platform strain for producing the five compounds ornithine, 
citrulline, proline, putrescine, and arginine. The absence of the regulator ArgR is necessary to 
enable efficient transcription of the argCJBDFR operon for the overproduction of ornithine and 
ornithine-derived products (Schneider et al., 2011). Here, we have deleted argR and genes argF and 
argG from the genome of MB001 by homologous recombination, resulting in an arginine 
auxotrophic strain that accumulates ornithine extracellularly. The resulting strain MB001∆argFRG 
was named ORN2.  When C. glutamicum ORN2 was grown in CgXII minimal medium with 4% 
(w/v) glucose and supplemented with 0.75 mM arginine, it produced 0.307 ± 0.003 g ornithine/g 
glucose. ORN2 served as the basis for further metabolic engineering to increase the ornithine yield. 
 
5.4.2	  Metabolic	  pull	  to	  increase	  the	  flux	  towards	  glutamate	  biosynthesis	  	  
The intermediate of the TCA cycle 2-oxoglutarate constitutes a branch point with 
either succinyl-CoA being formed by the 2-oxoglutarate dehydrogenase complex or glutamate 
being formed by glutamate dehydrogenase (GDH). Previously, Asakura et al. showed that tuning 
the gdh promoter had a positive effect on glutamate production (Asakura et al., 2007). This strategy 
was applied here to pull the flux towards glutamate biosynthesis and thereby towards ornithine 
biosynthesis. As the gdh transcript is monocistronic (Börmann et al., 1992), the change of the 
promoter sequence was assumed not to have any transcriptional effects on other genes. Four 
different constructs were tested for an increased transcription of gdh where the -10 and/or the -35 
sequences were changed according to Table 2. A GDH activity assay with crude extracts of strains 
with each of the four mutated promoters revealed that all modified promoter regions resulted in an 
increased GDH activity. The highest activity was observed for ORN2-Pgdh4 with “TATAAT” as -10 
consensus sequence and “TTGCCA” as -35 sequence, i.e. 4.5-fold more than the activity of ORN2 
crude extracts. When the strains with the altered gdh promoters were tested for ornithine 
production, a distinct difference between ORN2 and the mutants could be observed. A twofold 
increase in GDH activity in strain ORN2-Pgdh1 resulted in a 20% increase in the ornithine yield. 
Further elevation of the GDH activity of strain ORN2-Pgdh4 only led to a small further increase in 
the ornithine yield compared to ORN2-Pgdh1, implying that the glutamate levels are not limiting the 
flux towards glutamate derived products in these strains. Although the gdh expression level of 
ORN2-Pgdh1 is sufficient to significantly increase the ornithine yield, further metabolic engineering 
downstream the GDH catalyzed step might require an increase in the level of activity needed. As 
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ORN2-Pgdh4 and ORN2-Pgdh1 had similar growth rates the higher specific activity of ORN2-Pgdh4 
does not appear to pose a metabolic burden to the cells and we used ORN2-Pgdh4 for further 
engineering. 
 
 
Table 2 - Effect of different promoters on GDH activity and ornithine yield. Specific activities were 
determined from cells grown in BHI and crude extracts from three independent experiments. Production of 
ornithine was performed in CgXII medium with 4% (w/v) glucose and 0.75 mM arginine until depletion of 
glucose. All values represent the mean and standard deviations of at least two independent experiments 
performed with biological triplicates.  	  	  
	  
	  
	  
	  
	  	  	  
5.4.3	  Alleviation	  of	  feedback	  inhibition	  of	  NAGK	  	  
Based on previous studies with PaNAGK (Fernandez-Murga and Rubio, 2008), 
TmNAGK (Ramon-Maiques et al., 2006), CgNAGK (Xu et al., 2012), and Corynebacterium 
crenatum NAGK (Xu et al., 2011) different mutations and combinations thereof were selected to 
construct feedback resistant NAGKs (Table 3). The gene argB from C. glutamicum was cloned into 
the replicative IPTG-inducible expression plasmid pEKEx3, and the selected mutations were 
introduced by site-directed mutagenesis. In addition, argB from E.coli was tested. The plasmids 
were transformed into ORN2B with the genetic background ∆argFRGB to avoid formation of 
NAGKs consisting of a mixture of endogenously and plasmid expressed subunits.  
Wild-type NAGK had the highest activity followed by NAGKs with the amino acid exchanges 
H268N or G287D (Table 3). The differences in the specific activities from the mutant NAGKs to 
wild-type NAGK are not in accordance with the studies performed with CgNAGKs and CcNAGKs 
purified from E. coli where all strains exhibited similar specific activities. The half-maximal 
inhibition of the wild-type enzyme was determined to be 2 mM which is in accordance with a 
previous report performed with crude extract (Sakanyan et al., 1996), but higher than the 0.4 mM  
obtained with purified His-tagged enzyme (Schendzielorz et al., 2013). Growth experiments with 
the various overexpressed argB genes resulted in similar yields for the strains ORN2B-
pEKEx3argBE19R, ORN2B-pEKEx3-argBG287D, ORN2B-pEKEx3-argBA49V,M54V and ORN2B-
pEKEx3-argBA49V,M54V,G287D. All these strains produced comparably high ornithine yields although 
their specific NAGK activities varied significantly (Table 3), a phenomenon previously observed 
(Schendzielorz et al., 2013).  
 
 
Strain -35 -10 Specific activity  
(U/mg) 
Yield  
(g orn / g glc) 
ORN2 TGGTCA CATAAT 1.4 ± 0.3 0.312 ± 0.016 
ORN2-Pgdh1 TGGTCA TATAAT 2.8 ± 0.8 0.374 ± 0.007 
ORN2-Pgdh2 TGGTCA TGCTATAATGG 3.7 ± 1 0.383 ± 0.014 
ORN2-Pgdh3 TTGACA TATAAT 5.5 ± 1.5 0.386 ± 0.016 
ORN2-Pgdh4 TTGCCA TATAAT 6.3 ± 1.4 0.395 ± 0.018 
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Table 3: Specific activities of NAGK of various strains. Crude extracts were prepared from cells grown in 
CgXII medium with 4% glucose, 1 mM IPTG, 0.25 mM arginine, and 100 µg/mL spectinomycin. For the 
production of ornithine strains were grown in CgXII with 4% glucose, 1 mM IPTG, 0.75 mM arginine, and 
100 µg/mL spectinomycin. ND = not determined. All values represent the mean and standard deviations of at 
least two independent experiments. 
	  	  
Neither NAGK activity nor ornithine accumulation could be detected for ORN2B-pEKEx3-argB∆1-
23 carrying the truncated NAGK. It was published that overexpression of pEKEx3-argBA26VM31V 
(here named pEKEx3-argB∆1-23) in the arginine producer C. glutamicum ∆argR resulted in a similar 
arginine concentration as the strain carrying pEKEx3-argBA49V,M54V (Schneider et al., 2011). 
Moreover, truncated versions of NAGK from C. glutamicum were reported to have significantly 
reduced activity compared to wild-type NAGK (Xu et al., 2012). It therefore appears that NAGK 
consisting of only truncated subunits results in an inactive protein or a protein with a very low 
activity, while heteromeric complexes of wild-type ArgB subunits and truncated ArgB subunits 
result in functionally active and feedback alleviated NAGK. 
Furthermore, activity could not be measured in crude extracts from ORN2B-pEKEx3-
argBE19R,H26E,A49V,M54V and ORN2B-pEKEx3-argBE19R,H26E,H268N. Most likely the activity of these 
enzymes were too low to be measured and too low to result in extracellular ornithine accumulation. 
Interestingly, a study showed that the expression of argBE19R,H26E,H268N in arginine producing C. 
crenatum resulted in an increase in arginine production and the purified enzyme expressed in E. coli 
had an activity at the same level as the wild type (Xu et al., 2011). The amino acid sequences of 
CgArgB and CcArgB are identical so an explanation for the contradictory observations could be the 
presence of wild-type and mutant NAGK subunits in C. crenatum. To support this theory we 
performed a growth experiment in CgXII medium with 4% glucose with ORN1-pEKEx3-argB and 
ORN1-pEKEx3-argBE19R,H26E,H268N and observed accumulation of 11.4 ± 0.2 g/L and 12.1 ± 0.5 g/L 
Strain 
Specific activity 
(U/mg) 
Yield 
(g ornithine / g glucose) 
IC50 
(mM) 
ORN2B-pEKEx3 0 0 ND 
ORN2B-pEKEx3-argB 1.58 ± 0.10 0.257 ± 0.044 2.0 ± 0.02  
ORN2B-pEKEx3-argB∆1-23 0 0 ND 
ORN2B-pEKEx3-argBE19R 0.77 ± 0.18 0.307 ± 0.041 3.6 ± 0.06 
ORN2B-pEKEx3-argBH26E 0.26 ± 0.07 0.242 ± 0.028 2.5 ± 0.01 
ORN2B-pEKEx3-argBH268N 1.09 ± 0.31 0.276 ± 0.024 13 ± 2.0 
ORN2B-pEKEx3-argBG287D 1.20 ± 0.33 0.292 ± 0.039 >50 
ORN2B-pEKEx3-argBA49V,M54V 0.51 ± 0.03 0.300 ± 0.047 5.1 ± 1.7 
ORN2B-pEKEx3-argBE19R,H26E,A49V,M54V 0 0 ND 
ORN2B-pEKEx3-argBA49V,M54V,H268N 0.39 ± 0.14 0.268 ± 0.047 >50 
ORN2B-pEKEx3-argBA49V,M54V,G287D 0.42 ± 0.09 0.278 ± 0.019 >50 
ORN2B-pEKEx3-argBE19R,H26E,H268N 0 0 ND 
ORN2B-pEKEx3-argBE19R,H26E,A49V,M54V,H268N 0 0.114 ± 0.013 ND 
ORN2B-pEKEx3-argBE19R,H26E,A49V,M54V,H268N,G287D 0.15 ± 0.05 0.200 ± 0.005 >50 
ORN2B-pEKEx3argBE.coli 0.64 ± 0.05 0.300  ± 0.021 >50 
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ornithine, respectively. The amino acid exchange H26E did not seem to be beneficial for ornithine 
production and strains harboring this exchange also had the lowest specific activities. 	  
5.4.4	  N-­‐acetylornithine	  aminotransferase	  encoded	  by	  argD	  is	  not	  essential	  for	  ornithine	  
biosynthesis	  
	  
N-acetylornithine aminotransferase, encoded by argD, catalyzes the transfer of an 
amino group from glutamate to N-acetylglutamate semialdehyde yielding 2-oxoglutarate and N-
acetylornithine. The overexpression of argD2 (cg2680) encoding a putative aminotransferase was 
previously shown to be beneficial for arginine production (Kim et al., 2011). The amino acid 
sequence presented in the patent differs from the sequence of C. glutamicum ATCC 13032 (RefSeq 
NC_006958.1) at the second amino acid position. Since the start codon of argD2 is TTG, four 
versions of the gene were cloned into pEKEx3 to test if the differences would have an effect on 
ornithine accumulation. The first two amino acids of the different plasmids with argD2 are LA, LT, 
MA, and MT.  
To begin with, the activity of the endogenous aminotransferases ArgD and ArgD2 were abolished 
to determine if argD2 could complement the deletions. The deletion of argD (ORN2D) did neither 
affect growth nor production of ornithine, wherefore argD does not appear to be essential for 
ornithine synthesis (Table 4). The disruption of argD2 in ORN2D did also not have an impact on 
growth or ornithine production. A BLAST analysis revealed that ArgD has two further homologs, 
namely 4-aminobutyrate aminotransferase (GabT) and adenosylmethionine-8-amino-7-
oxononanoate aminotransferase (BioA). Neither the deletion of gabT nor of bioA affected ornithine 
production and growth of the strains (Table 4). Hence, the presence of one or several non-specific 
transaminases appears sufficient to maintain the level of ornithine production in the deletion 
mutants to the level of the parent strain.  
In some microorganisms such as Thermus thermophilus the lysine and arginine biosynthesis 
pathways are interconnected (Ledwidge and Blanchard, 1999; Miyazaki et al., 2001). In E. coli, 
argD encodes an enzyme with activities of both N-acetylornithine aminotransferase of the arginine 
pathway and N-succinyldiaminopimelate aminotransferase of the lysine pathway (Ledwidge and 
Blanchard, 1999). C. glutamicum can synthesize lysine through the diaminopimelate and 
succinylase branches.  
Although two different genes encode N-acetylornithine aminotransferase and N-
succinyldiaminopimelate aminotransferase in C. glutamicum it is possible that the enzymes are 
promiscuous and therefore can catalyze the transfer of the amino group in both pathways. While it 
was already shown that a C. glutamicum strain deficient in dapC, ddh, and argD shows no growth 
deficiency (Hartmann et al., 2003), an additional deletion of dapC in the ∆argDD2 or 
∆argDD2∆gabT∆bioA background might reveal if N-succinyldiaminopimelate aminotransferase is 
capable of transferring the amino group to N-acetylglutamate-semialdehyde and thereby can 
substitute the N-acetylornithine aminotransferase activity of ArgD. 
The overexpression of argD and the argD2 variants in ORN2DD2 increased ornithine production 
(Table 4). There was no notable difference in the yields between strains with the overexpressed 
transaminase and putative transaminases. Moreover, in the particular genetic background it did not 
seem to make a difference if the start codon of argD2 was ATG or TTG, or if the second N-
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terminal amino acid was alanine or threonine. Thus, the increased expression of a gene for 
transaminase had a positive effect on ornithine accumulation. 
 
 
Table 4: Ornithine yields of strains derived from MB001. Strains were cultured in CgXII with 4% 
glucose and supplemented 0.75 mM arginine, 1 mM IPTG, and 100 µg/mL spectinomycin when appropriate. 
All values represent the mean and standard deviations of three independent experiments performed in 
triplicates. 
Strain g ornithine / g glucose 
ORN2 0.314 ± 0.002 
ORN2D 0.311 ± 0.007 
ORN2DD2 0.314 ± 0.015 
ORN2DD2∆gabT 0.320 ± 0.013 
ORN2DD2∆bioA 0.315 ± 0.002 
ORN2DD2∆gabT∆bioA 0.313 ± 0.007 
ORN2DD2-pEKEx3 0.277 ± 0.008 
ORN2DD2-pEKEx3-argD 0.306 ± 0.009 
ORN2DD2-pEKEx3-argD2LA 0.310 ± 0.003 
ORN2DD2-pEKEx3-argD2LT 0.302 ± 0.009 
ORN2DD2-pEKEx3-argD2MA 0.291 ± 0.010 
ORN2DD2-pEKEx3-argD2MT 0.298 ± 0.022 
	  	  
5.4.5	  Ornithine	  acetyltransferase	  another	  bottleneck	  in	  ornithine	  overproduction	  	  
OAT encoded by argJ in C. glutamicum is monofunctional and catalyzes the transfer 
of the acetyl group from N-acetylornithine to glutamate resulting in the formation of ornithine and 
N-acetylglutamate (Sakanyan et al., 1996). OAT was shown to be product inhibited by ornithine 
with an apparent Ki value of 5 mM (Sakanyan et al., 1996).  Recently, it was shown that OAT is 
also inhibited by citrulline, where a concentration of 30 mM inhibited OAT activity to 50% (Hao et 
al., 2015). Crude extract of C. crenatum was reported to have a higher OAT specific activity than 
crude extract of C. glutamicum (Dou et al., 2011). Although such differences were not observed 
with the purified enzymes produced in E. coli we here tested the expression of OAT from C. 
glutamicum and C. crenatum. 
The deletion of argJ in ORN2 resulted in no detectable extracellular accumulation of ornithine and 
overexpression of argJ from C. glutamicum and C. crenatum in ORN2∆argJ (ORN2J) could both 
complement the argJ deletion (Table 5). OAT from both organisms exhibited a similar activity, 
which reflects the production yields of both strains. The overexpression of the argJ variants in 
ORN2 resulted in a significant increase in the ornithine yield compared to the empty vector control 
(Table 5). This reflects that the reaction catalyzed by OAT poses another bottleneck of the ornithine 
pathway in strain ORN2, which is in agreement with previous published data (Dou et al., 2011; Hao 
et al., 2015). Hence overexpression and/or feedback alleviation of OAT is an important part of 
improving ornithine yield. 
	  	  72	  
	  	  
Table 5: Impact of argJ overexpression on ornithine yield and specific activities of OAT. For the 
production of ornithine strains were cultured in CgXII with 4% glucose and supplemented 0.75 mM 
arginine, 1 mM IPTG, and 100 µg/mL spectinomycin when appropriate. Specific activities were determined 
from cells grown in BHI with 1 mM IPTG and 100 µg/mL spectinomycin. All values represent the mean and 
standard deviations of three independent experiments performed in triplicates. 
 
Strain g ornithine / g glucose U/mg 
ORN2J-pEKEx3 0 n.d. 
ORN2J-pEKEx3-argJCg 0.219 ± 0.025 0.06 ± 0.01 
ORN2J-pEKEx3-argJCc 0.207 ± 0.019 0.07 ± 0.01 
ORN2-pEKEx3 0.307 ± 0.003 - 
ORN2-pEKEx3-argJCg 0.365 ± 0.015 - 
ORN2-pEKEx3-argJCc 0.361 ± 0.014 - 	  	  
5.4.6	  Introduction	  of	  multiple	  genomic	  changes	  resulted	  in	  a	  high	  ornithine	  producing	  strain	  	  
We have showed that a combination of tuning the gdh promoter and alleviating 
NAGK of feedback inhibition increased ornithine production remarkably. Therefore, the respective 
modifications were combined and introduced into the genome of ORN2. The amino acid changes 
A49V and M54V in ArgB were introduced into the genome of ORN2-Pgdh4 (ORN3). This increased 
the ornithine yield by 62% compared to the parent strain ORN2 (Figure 2). 
The production of ornithine is at the expense of three molecules of NADPH and the subsequent 
conversion of ornithine to arginine requires one additional NADPH molecule. Therefore recent 
efforts have been put into increasing the NADPH availability in the cell (Hwang and Cho, 2014; 
Jiang et al., 2013a; Jiang et al., 2013b; Kim et al., 2015). One of the strategies employed, which 
proved to be beneficial for lysine production (Lindner et al., 2013), is reduced translation of pgi 
achieved by exchanging the start codon ATG to the less preferred GTG (Park et al., 2014). The pgi-
encoded glucose-6-phosphate isomerase catalyzes the conversion of glucose-6-phosphate to 
fructose-6-phosphate. By reducing translation of pgi the flux into the pentose phosphate pathway is 
increased, which increases the NADPH level of the cell when glucose is used as substrate. 
Changing the translational start codon of pgi from ATG to GTG in strain ORN4 resulted in a 6.5% 
increased yield compared to ORN3 (Figure 2). 	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Figure 2: Yields of ornithine, proline, putrescine, citrulline, and arginine producing strains. The 
ornithine producing strains were cultured in CgXII medium with 4% glucose and supplemented 0.75 mM 
arginine. All other strains were cultured in CgXII medium with 2% glucose and supplemented 0.75 mM 
arginine (except for the arginine producing strain), 1 mM IPTG, and 25 µg/mL kanamycin. White bars, 
ornithine yield; dotted bars, proline yield; dark grey bars, putrescine yield; black bars, citrulline yield; light 
grey bars, arginine yield. All values represent the mean and standard deviations of at least two independent 
experiments performed in triplicates. 
	  
As overexpression of argB, argD, and argJ resulted in an increased ornithine yield (Tables 3, 4, and 
5), a second copy of the argCJBA49V,M54VD operon was introduced into the genome. To balance 
expression, the strength of the argC promoter was compared to the strengths of Ptuf and Psod, as 
these are two strong constitutive promoters commonly used for overexpression in C. glutamicum 
(Becker et al., 2011; Park et al., 2014). The promoter strengths were assayed using the promoter 
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probe vector pEPR1 with GFP as reporter, and then monitoring fluorescence and growth 
simultaneously in the biolector microfermentation system. Ptuf drove the strongest expression (35.3 
fluorescent units (FU)) followed by PargC  (19.1 FU) whereas Psod driven expression resulted in the 
lowest fluorescence intensity (3.63 FU) compared to the empty vector control (1.18 FU)(errors 
below 10%; data not shown). Therefore, Ptuf was chosen to drive the expression of the second copy 
of the operon. We constructed two different operons both transcribed from Ptuf with the gene orders 
argCJBA49V,M54VD and argBA49V,M54VJCD. It has previously been shown that the order of the genes 
in an operon can affect the product yield (Hiroe et al., 2012), hence the synthetic operon 
argBA49V,M54VJCD with a rearranged  gene order was constructed. 
These operons were introduced into the genome by homologous recombination at the former CGP1 
locus, which previously has been used successfully for the introduction of the carotenoid 
biosynthetic pathway (Heider et al., 2014). Initially the operons were integrated into the genome of 
ORN2∆argCJBD, resulting in strains ORN2∆argCJBD-argCJBA49V,M54VD and ORN2∆argCJBD-
argCJBA49V,M54VD. The strains were grown in CgXII medium with 4% glucose supplemented with 
0.75 mM arginine. No extracellular accumulation of ornithine by ORN2∆argCJBD could be 
detected, but the introduction of both operons argCJBA49V,M54VD and argBA49V,M54VJCD could 
complement the deletion of argCJBD. ORN2∆argCJBD-argCJBA49V,M54VD produced 0.334 ± 0.011 
g ornithine/g glucose (g/g) whereas ORN2∆argCJBD-argBA49V,M54VJCD produced 0.085 ± 0.008 
g/g. ORN2∆argCJBD-argCJBA49V,M54VD accumulated slightly more ornithine than ORN2, which 
can be explained by the assumed increased expression of the operon by Ptuf. Rearranging the order 
of the genes of the operon resulted in a low yield; this effect could be due to the introduction of 
ribosomal binding sites in front of the genes, the altered gene order, or a combination of both, 
although the decrease of the yield compared to ORN2 is rather drastic. 
Due to the lower yield obtained with the operon with the rearranged genes, argCJBA49V,M54VD was 
introduced into the genome of ORN3, resulting in the strain ORN5 with two copies of the operon 
on the genome along with Pgdh4 and feedback alleviated NAGK. The strains ORN4 and ORN5 had 
similar yields. By introducing the pgi start codon mutation to the genome of ORN5, the resulting 
strain ORN6, was capable of producing 71% more ornithine than ORN2. Experiments performed 
with ORN6 resulted in difficulties with retaining genetic stability, as recombination leaving only 
the promoter and the terminator at the CGP1 locus was a reoccurring event, and therefore a 
decrease in production was observed.  
Compared to most published ornithine producing strains our strain does not carry a deletion of proB 
encoding the first enzyme of the proline pathway that also uses glutamate as precursor (Hwang and 
Cho, 2014; Jiang et al., 2013a; Jiang et al., 2013b; Kim et al., 2015). We chose not to introduce this 
deletion, as it would entail proline auxotrophy. Exchanging the translational start codon of proB to 
less preferred start codons was shown to increase putrescine production by C. glutamicum and 
circumvented proline supplementation, however, the best putrescine producing strain carried wild-
type proB (Nguyen et al., 2015a). As exemplified by others, plasmid-based overexpression of 
argCJBD increases ornithine production, but to avoid the use of plasmids we integrated the operon 
into the chromosome (Hwang et al., 2008; Kim et al., 2015). Tuning the gdh promoter combined 
with the use of a gene variant of argB encoding feedback resistant NAGK was pivotal to achieve 
high ornithine production by C. glutamicum. The yield of C. glutamicum ORN6 of 0.524 ± 0.026 
g/g described here is to the best of our knowledge the highest reported ornithine yield so far. 
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5.4.7	  Production	  of	  Proline,	  Putrescine,	  Citrulline,	  and	  Arginine	  from	  Ornithine	  	  
An ornithine producing strain has the potential to be converted into a proline, 
putrescine, citrulline, or arginine producing strain by plasmid-based expression of appropriate 
pathway modules with one to three genes. Here we wanted to establish if the ornithine producing 
strains could be used as a platform for the production of the aforementioned compounds. First, 
plasmids for the appropriate pathway modules were constructed. The plasmids pVWEx1-
argFBA49V,M54V, pVWEx1-ocdPp, pVWEx1-speCEc, and pVWEx1-argGFBA49V,M54V were 
transformed into ORN2, resulting in the citrulline producer CIT1, the proline producer PRO1, the 
putrescine producer PUT2, and the arginine producer ARG5, respectively. The same plasmids were 
also transformed into ORN2-Pgdh4 and ORN4, resulting in the next two generations of producers. 
These strains were all cultured in CgXII medium with 2% glucose, 1 mM IPTG, 25 µg/mL 
kanamycin, and 0.75 mM arginine (except for the arginine producing strains, that did not require 
arginine as supplement). Indeed, ornithine producing base strains transformed with the appropriate 
citrulline, proline, putrescine or arginine pathway modules accumulated the respective compounds 
in the supernatants as major products (Figure 2). Production of citrulline and arginine by CIT2, 
CIT3, ARG6, and ARG7, respectively did not improve compared to the yield by the CIT1 and 
ARG5 strains (Figure 2). This and the observation that strains CIT3 and ARG7 accumulated 
slightly more ornithine than CIT1 and ARG5, suggested that the reaction catalyzed by ornithine 
transcarbamylase and potentially other reactions are limiting citrulline and arginine production 
(Table 6).  
 
 
Table 6: Accumulation of glutamate and ornithine by the arginine and citrulline producing strains. All 
values represent the mean and standard deviations of two independent experiments performed in triplicates. 
 
 
 
 
 
 
 
 
 
 
 
Moreover it cannot be excluded that the potential inhibition of OAT by ornithine and citrulline has 
an effect on the obtained yields. Both ORN2-Pgdh4 and ORN4 could be used as platform strains for 
the production of proline (Figure 2). While ORN2-Pgdh4 could be used for increased putrescine 
production (PUT3), introduction of pVWEx1-speCEc into ORN4 resulted in a lower accumulation 
of putrescine (PUT4) (Figure 2). The putrescine producing strains all accumulated acetylputrescine 
in the range 7.11-10.44 mM. To construct a platform strain optimized for the production of all five 
compounds, further genetic modifications have to be performed. To avoid the formation of 
acetylputrescine it is necessary to delete snaA that recently was shown to be responsible for the 
Strain 
Glutamate 
(mM) 
Ornithine 
(mM) 
CIT1 1.55 ± 0.15 0.69 ± 0.28 
CIT2 1.67 ± 0.15 0.92 ± 0.42 
CIT3 1.87 ± 0.49 3.30 ± 1.45 
ARG5 0.13 ± 0.01 0.23 ± 0.01 
ARG6 0.15 ± 0.01 0.41 ± 0.05 
ARG7 0.67 ± 0.06 2.31 ± 1.13 
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acetylation of putrescine (Nguyen et al., 2015b). Accumulation of citrulline as a byproduct by the 
arginine producing strain could be avoided by overexpression of argGH as previously shown (Park 
et al., 2014). Moreover strategies for increased citrulline production should be explored, this could 
include construction of feedback resistant OAT and specifically for citrulline production 
overexpression or deletion of transport proteins, and optimization of the carbamoylphosphate 
supply. 
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5.4	  Conclusions	  	  
An ornithine producing strain was rationally engineered by feedback alleviation of N-
acetylglutamate kinase, tuning of the gdh promoter, lowering expression of pgi, along with the 
introduction of a second copy of the ornithine operon argCJBA49V,M54VD into the genome. These 
modifications resulted in an ornithine producing strain with a more than 70% higher yield than the 
parental strain.  
Strains constructed for increased ornithine production could be used for improved proline and 
putrescine production. Conversion of the ornithine to citrulline or arginine producing strains was 
possible, however, the resulting strains were not superior to previously engineered citrulline and 
arginine producing strains. This may indicate bottlenecks in conversion of ornithine to citrulline and 
arginine. Thus, converting a platform strain capable of producing high yields of ornithine to strains 
overproducing proline, putrescine, citrulline, or arginine has to take into account optimization of the 
specific ornithine-converting reactions. Further metabolic engineering of C. glutamicum for 
production of citrulline and arginine could benefit from insight into glutamate, ornithine, and 
citrulline transport, along with exploring optimization of required precursors such as 
carbamoylphosphate and aspartate, and importantly elucidating the regulation of the arginine 
pathway. C. glutamicum has the potential to serve as an excellent platform strain for production of 
amino acids and putrescine. We have taken the first steps to construct superior platform strains with 
high ornithine yields and demonstrated how these strains easily can be converted into proline, 
putrescine, citrulline, and arginine overproducing strains. Notably, our approach was rational with 
employing classical mutagenesis or in vivo evolution. Thus, the ornithine platform strain and the 
citrulline, proline, putrescine or arginine producing strains derived from it by modular pathway 
engineering have the full potential for further improvements by classical mutagenesis or in vivo 
evolution.
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6.1	  Abstract	  	  
	  
Present-day approaches to the engineering of amino acid metabolic pathways in C. 
glutamicum can be tedious and cumbersome. In this work we developed the CRISPR/dCas9 
technology for the quick and efficient screening of the effect that gene repression can have on the 
yields of amino acids. 
By designing RNA-guided deactivated nucleases, we successfully repressed the expression of pgi, 
pck and pyk, resulting in increased yields of lysine and glutamate, comparable to those obtained by 
the deletion of these genes. We show that the sgRNA/dCas9 tool can be efficiently used for 
pathway modeling, without the need for gene deletions or mutations and selection thereof, in as 
little as four days.  	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6.2	  Introduction	  
	  
For the past 50 years, the industrialized world has relied on an extraordinary ability of 
the soil organism Corynebacterium glutamicum to synthesize and secrete incomparable amounts of 
amino acids [1]–[3]. These molecules are obtained by fermentation and are amongst the most 
relevant industrial bioproducts of the present time, to reach a market size of US $20.4 billion by 
2020 [4]. They are mainly used as a component of animal feed and as flavor enhancers, while being 
also used in nutritional supplements and cosmetics as well [5]–[7]. 
 
Efforts aimed at increasing the amino acid production by C. glutamicum cell factories have 
historically been placed at creating random mutant strains [1]. These uncharacterized strains were 
obtained via chemical or UV-induced mutations. Despite their stronger producer phenotype they 
were often genetically unstable and had growth defects [1], [8]. With the advancement of molecular 
genetics and whole genome sequencing, many were finally characterized. Rather than working on 
largely uncharacterized mutant strains [1], specific genes could then be knocked out or introduced 
into the genetic makeup of an organism [9]. In 1991 the term metabolic engineering was coined to 
describe strain improvement mediated by genetic alterations [10].  
 
Despite the need, the panoply of genetic engineering tools available for the manipulation of the 
chromosome of C. glutamicum remains scarce and tedious. In the last two decades many 
transposable elements were described for this organism, while enabling only random mutagenesis 
[8]. On the other hand, precise gene modifications rely on the integration of suicide vectors, with 
the low possibility of a double crossover event removing the plasmid backbone, based on the sacB 
counter selection.  Cre/loxP has further enabled the deletion of chromosomal regions [8], [11].  
 
Systems biology has made considerable contributions to understanding the intricacies of metabolic 
pathways [2], [12], [13]. By shedding light onto how pathways are interrelated, predictive strain 
design is within reach [14]–[18]. 
 
For the purpose of increasing production yields through pathway engineering, the ideal approach 
would be to quickly and efficiently test the phenotype resulting from single or multiple gene 
function loss. Nonetheless, no tool currently available is capable of quickly enabling such 
screening. Metabolic engineers still rely on deleting or mutating genes in order to observe or 
confirm a phenotype. This approach is often a time and resource sink due to technical difficulties in 
generating such mutants, and results often diverge from the intended.  
 
There is the need for a quick, reliable and easy approach to knock out gene expression in C. 
glutamicum. The availability of such a tool would certainly equip metabolic engineers with the 
prospect of testing several and multi targets in a matter of days, instead of months. With such a 
straightforward method, one could potentially fine-tune the ability of strains to produce amino acids 
[19], [20].  
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With this goal in mind we adapted the deactivated version of the celebrated Clustered Regularly 
Interspaced Short Palindromic Repeats/Cas9 (CRISPR/Cas9) [21], [22], also known as 
CRISPR/dCas9 system for gene repression in C. glutamicum [23], [24]. 
 
Originally, the CRISPR/Cas9 system was described as being a bacterial immune-like system, 
enabling recognition and cleavage of foreign DNA at varying efficiency rates [21], [22], [25]. 
Traditionally, specialized Cas endonucleases (type I and III) or double stranded RNA ribonucleases 
triggered by trans-activating CRISPR targeting RNAs (tracrRNA) (type II systems) convert the pre-
crRNA into mature CRISPR targeting RNA (crRNA). This product then assembles into a single 
(type II) or multi-Cas complex (type I and III), with the capacity to recognize and cleave crRNA-
complementary DNA sequences [26]–[29]. The need for the additional processing step was 
supplanted by the realization that, in type II systems, a single RNA synthetic sequence (sgRNA) 
could suffice for Cas9-mediated cleavage. For efficient recognition of the target site, it was found 
that the base-pairing regions and a protospacer adjacent motif (PAM) containing a GG dinucleotide, 
adjacent to the crRNA-binding region in the target DNA sequence, sufficed. This simplified greatly 
the process of building customized sgRNAs [27]. 
 
As opposed to the cleaving CRISPR/Cas9 system, the deactivated Cas9 enzyme (dCas9) in the 
CRISPR/dCas9 system lacks the nuclease activity characteristic of its active counterpart. It 
nonetheless retains the capacity to complex with the sgRNA and bind to the homologous locus. Yet, 
instead of cleaving the DNA, this complex sterically blocks the progression of the RNA 
polymerase. As a result, the gene is not transcribed but also not mutated. The wild type phenotype 
of the organism is restored once induction ceases [23], [30]. 
 
As the intricacies of the metabolic pathways are disclosed, novel potential targets surface. 
Understandably so, the number of these possible targets and combinations thereof make their 
disruption a monumental and unappealing task. Such an easily multi-target scalable system could 
very well fasten strain improvement as well as pathway elucidation. 	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6.3	  Results	  	  
6.3.1	  sgRNA/dCas9-­‐based	  regulation	  of	  amino	  acid	  production	  by	  C.	  glutamicum	  	  
To test whether the sgRNA/dCas9 system can be used for pathway regulation in C. 
glutamicum, we built several sgRNAs to sterically block gene transcription. We specifically 
selected genes known to indirectly impact the production of the two amino acids with the largest 
market size. We opted for pgi, whose repression results in high lysine titers [31], and pyk [32] and 
pck [33], which once repressed lead to higher titers of glutamate. 
 
The lysine producing C. glutamicum strain DM1729 was transformed with the empty vector 
pAL374 or pAL-pgi targeting either the template or non-template strand of pgi. When cultured in 
CGXII minimal medium these strains all produced lysine to the same level (Figure 1). 
Simultaneously the DM1729 strains additionally harboring plasmid pZ8-T_dcas9 were cultured in 
CGXII. By targeting the non-template strand of pgi in the presence of dCas9, the lysine titer was 
increased by a factor of 2.1 (Figure 1). This indicates a transcriptional repression by the 
sgRNA/dCas9 system. The same effect was not observed when the sgRNA targeted the template 
strand of the gene.  	  	  
	  
	  
 
Then the sgRNA/dCas9 system was tested against genes whose repression is known to have a 
positive impact on the production of glutamate, another economically relevant amino acid. Here the 
template or non-template strands of genes pck or pyk were targeted. 
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Figure 1. Lysine production by Corynebacterium glutamicum DM1729. Titers are 
the mean of three independent experiments performed in triplicates. 	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C. glutamicum 13032 (Cg) was transformed with pAL374, pAL-pck, or pAL-pyk and with both 
pAL374, pAL-pck, or pAL-pyk and pZ8-T_dcas9.  
Again no notable difference in glutamate accumulation was observed when strains only harboring 
plasmids with sgRNAs compared to the empty vector control were cultured (Figure 2). However it 
appears that both Cg-pAL-pyk (NT) and Cg-pZ8-T_dcas9 pAL374 accumulated more glutamate 
than the other control strains. Since Cg-pAL-pyk (NT) and Cg-pZ8-T_dcas9 pAL374 have similar 
glutamate titers and the standard deviations partially overlap with those of the other control strains 
these differences are likely due to the ethambutol-induced glutamate production. Compared to 
lysine production the standard deviations for glutamate production are much higher, which is not 
uncommon for ethambutol-induced glutamate production [34].  
Contrary to the results obtained for lysine production by targeting pgi, targeting the template strands 
of pck and pyk resulted in an increase in the glutamate production (Figure 2). 	  	  
	  
	  	  
In fact, targeting either of the strands of pck or pyk resulted in elevated glutamate concentrations 
compared to Cg-pZ8-T_dcas9 pAL374. There was a fold increase of 2.0, 1.9, 2.2, and 2.0 when 
targeting the template or non-template strands of pck or pyk, respectively.  	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Figure 2. Glutamate production by Corynebacterium glutamicum. Titers are the 
mean of biological triplicates. 	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6.3.2	  Quantification	  of	  sgRNA/dCas9-­‐based	  repression	  	  
We next evaluated the levels of transcription of each target gene. In order to obtain a 
picture of the levels of transcriptional repression, we sampled the C. glutamicum cultures in mid-
exponential phase for relevant mRNA estimation.  
 
No sgRNA/dCas9-mediated repression was observed when targeting the template strand of pgi in 
DM1729 during the exponential phase, targeting the non-template strand led to strong repression. 
The relative levels of mRNA were reduced by nearly 98%, resulting in a 33% increase in lysine 
production (Figure 3). 
	  	  
	  	  
When targeting the template strand of pck in C. glutamicum, a 70% reduction in its mRNA levels 
led to 28% more secreted glutamate. The transcriptional repression levels were however lower 
when dCas9 was led to the non-template strand of pck, resulting in 46% more glutamate with a 98% 
reduction in transcription (Figure 4). 	  
Figure	  3.	  mRNA	  levels	  of	  sgRNA/dCas9	  targeted	  pgi	  in	  DM1729.	  mRNA	  levels	  decrease,	  with	  an	  increase	  in	  the	  lysine	  levels.	  Results are the mean of 
three independent experiments performed in triplicates. *p≤ 0.05, **p≤ 0.01 and 
***p≤ 0.001, respectively.	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When targeting the template strand of pyk in C. glutamicum, an 82% reduction in its mRNA levels 
led to 97% more secreted glutamate. The transcriptional repression levels were even lower when 
dCas9 was led to the non-template strand of pyk, resulting in 204% more glutamate with a 96% 
reduction in transcription (Figure 5).  
 	  
	  
	  
	  	   	  
Figure 4. mRNA levels of sgRNA/dCas9 targeted pck in C. glutamicum. 
mRNA levels decrease, with an increase in the glutamate levels. Results are the 
mean of three independent experiments performed in triplicates. 	  
Figure 5. mRNA levels of sgRNA/dCas9 targeted pyk in C. glutamicum. 
mRNA levels decrease, with an increase in the glutamate levels. Results are the 
mean of three independent experiments performed in triplicates. 	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6.3.3	  Impact	  of	  dCas9	  on	  cell	  growth	  	  	  
We were concerned that the overexpression of dCas9 might result in cell toxicity, as 
previous attempts to express dCas9 driven by unrepressed Ptac in C. glutamicum resulted in cell 
death. Previous work in other bacterial hosts exhibited similar issues [35], [36]. 
To address this concern, we compared the growth rates of C. glutamicum carrying plasmid pZ8-
T_dcas9 and its dCas9-less version (pZ8-Ptac), with different concentrations of the inducer IPTG. 
No difference in the growth rates independent of the plasmid harbored and the concentration of 
IPTG used could be observed (Table 1). Therefore dCas9 appears not to affect the viability of C. 
glutamicum when expressed from pZ8-Ptac.	  	  	  
Table 1. Growth rates of C. glutamicum pZ8-Ptac and pZ8-T_dcas9 cultured in CgXII medium with 
2% (w/w) glucose, and 25µg/mL kanamycin. Results are the mean of three independent experiments 
performed in triplicates. 	  	  	  	  	  	  	  
	  	   	  
IPTG 
(mM) 
WT pZ8-Ptac 
(h-1) 
WT pZ8-T_dcas9 
(h-1) 
0 0.35 ± 0.01 0.38 ± 0.02 
0.5 0.36 ± 0.01 0.36 ± 0.02 
1 0.36 ±0.02 0.37 ± 0.02 
10 0.37 ± 0.2 0.36 ± 0.02 
	  	  89	  
6.4	  Discussion	  	  
The CRISPR/(d)Cas9 system has enabled researchers to edit DNA or regulate gene 
transcriptional levels from a range of organisms [37]–[39]. 
C. glutamicum plays a multi-billion dollar role on the worldly stage of production of lysine for 
animal feed and the savory additive glutamate. While the level of amino acids this organism has 
been engineered to produce is considerably high, we understand the need to increase it further. Yet, 
the panoply of tools available for engineering C. glutamicum remains scarce [11], [40]. It thus 
seemed germane to engineer the CRISPR/dCas9 system for use in this organism, given its 
simplicity of design and employment. In our system, the dCas9 and sgRNAs were expressed from 
independent replicative plasmids. It has previously been established that co-expression of both parts 
from a single plasmid can result in reduced host growth [35], having toxicity also been observed 
when overexpressing either of the parts [36]. Specifically, we expressed the sgRNA constitutively 
while controlling the expression of dcas9 via the well-established LaqIq system.  
We tested the usefulness of such tool for what is traditionally considered a cumbersome task: 
engineering metabolic pathways, towards increased titers of a given bio-product. In the case of C. 
glutamicum, it was clear that the product should be amino acids. Yet, our goal was not to further 
engineer pathways, but to test the performance and suitability of this tool for pathway engineering. 
To establish this, we decided to target genes pgi, pck and pyk using the sgRNA [27] and the 
nuclease-inactivated dCas9 enzyme [41]. Following this approach we were able to obtain the C. 
glutamicum strains for testing in 4 days from the initial cloning in E. coli to the final C. glutamicum 
colonies carrying dCas9 and the sgRNA. 
 
It is well characterized how the repression of these genes indirectly results in an increased 
production of lysine when targeting pgi [31], and glutamate when targeting pck [33] or pyk [16]. 
We found the repression level caused by the steric blockage of pck and pyc to the progression of the 
RNA polymerase efficient whether dCas9 annealed onto the template or non-template strands of the 
coding region. Nonetheless, such observation seemed to be gene or target-sequence specific, as we 
were not able to extend such observation to all three genes.  
 
Despite observing a significant increase of amino acid production mediated by any of the sgRNAs 
in the presence of dCas9, the binding of the complex to the non-template strand of the gene 
exhibited a stronger phenotype for pgi, pck, and pyk in the eksponential growth phase. Earlier 
publications accounted for an ineffective template-strand targeting [23], [27], which has been 
repeatedly demystified as reports of efficient template-based repression arise [24], [36]. 
Our results compare with the described ratio of increase in lysine production when deleting pgi  (2.1 
vs. 1.7) [31]. This ratio for pck sgRNA/dCas9 targeting both target and non-target strands was half 
of the published ratio when deleting pck (2.0 and 1.9 vs. 4.5) [16]. Lastly, the ratio for pyk 
sgRNA/dCas9 targeting went slightly beyond the published results for gene deletion (2.2 and 2.0 vs. 
1.25) [33]. The final amounts of amino acids produced were however not as high as the previously 
published titers [16], [31], [33]. 
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As expected, in the absence of dCas9 neither of the sgRNAs interfered with the production of the 
two amino acids, the indirect result of tempering with the levels of Pck, Pyk or Pgi available in the 
cell. As the presence of the sgRNA alone, both in lysine and glutamate production experiments, was 
not sufficient to perturb gene expression, the presence of dCas9 is essential for gene repression. 
The presence of dCas9 and the sgRNAs significantly drove up the production of glutamate, when 
compared with the strains carrying the sgRNAs alone.  
 
Following the amino acid production experiments, the mRNA quenching capabilities of the 
sgRNA/dCas9 system of pgi, pck, and pyk were quantified.  
In the specific case of pgi, the levels of amino acid production in mid-exponential phase and pgi 
mRNA levels were inversely proportional when the sgRNA targeted the non-template strand. This 
is in line with the stationary phase observations made.  On the other hand, the sgRNA towards the 
template strand had a much smaller impact on production. In fact, the results were found not to be 
statistically significant.  
The sgRNA toward the template strands of pck and pyc and especially toward the non-template 
strands were efficient at repressing transcription, also reflected in the levels of the glutamate 
produced.  
Overall the experiments show that the CRISPR/dCas9 system could efficiently be used in C. 
glutamicum for increasing amino acid production by lowering the transcription of the targeted 
genes. 
 
It is important to mention that the steric transcriptional control is indeed merely steric. The 
likelihood of a complete shutdown is low, given that with each cell division the bacterium needs to 
again express dCas9, which subsequently needs to be guided by the sgRNA towards the specific 
target locus. When using this tool to study the impact of such gene repressions, it is important to 
take into account that despite the versatility of this tool, even a lowered expression level of certain 
metabolic genes could contribute with enough enzyme activity to maintain flux at the wild-type 
level. Owing to this, some residual wild type phenotype is would not be surprising, though it will 
likely not impede the observation of the repression-based phenotype, as shown in this manuscript. 
 
In contrast to the traditional gene knockout approach, which if unlucky can take months, it takes as 
few as four days to obtain the strain of interest for testing when taking advantage of the 
transcriptional repression power of sgRNA/dCas9. The use of dCas9 instead of Cas9 further 
shortens the time-to-screen, as it omits the tedious need to select for the rarer sgRNA/Cas9-derived 
mutants [25]. The system has great potential for applications in metabolic engineering of C. 
glutamicum, as it can significantly speed up the process of identifying targets and combinations of 
targets for increased production of industrially relevant bioproducts. 
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6.5	  Materials	  and	  Methods	  	  	  
6.5.1	  Microorganisms,	  plasmids	  and	  growth	  conditions	  	  
All plasmids were transformed into and maintained in E. coli DH5α, grown in 
Lysogeny broth (for liquid cultures, Miller, LabExpress, USA) or agar (for plates, with 15 % agar, 
Apex), with the appropriate antibiotics (Table 2), and incubated at 37°C. C. glutamicum strains 
were also maintained on LB agar plates, supplemented with the appropriate antibiotic when 
necessary (Table 2), but incubated at 30°C. Liquid cultures were prepared using Brain-Heart 
Infusion (BHI, Sigma-Aldrich, Germany) medium. 	  
Table 2. List of strains and plasmids used in this study. 
 
Strain 
 
Properties Source 
C. glutamicum 
ATCC 13032 Wild type, biotin auxotroph ATCC 
C. glutamicum  
DM1729  
DM1729 is an aminoethylcysteine-resistant mutant of ATCC 13032; pyc(P458S) 
hom(V59A) lysC(T311I) - L - Lysine overproducer 
Evonik 
Industries 
AG 
E. coli DH5α Cloning strain [42] 
 
Plasmids 
 
Properties Source 
pDSW204 E. coli IPTG inducible expression vector, AmpR [43] 
pZ8-1 E. coli – C. glutamicum Ptac constitutive expression shuttle vector, KanR [44] 
pAL374 E. coli – Corynebacterineae expression shuttle vector, SpecR [45] 
pZ8-T_dcas9 pZ8-1 plasmid carrying dcas9, driven by the IPTG-inducible tac promoter, KanR This study 
pZ8-Ptac IPTG inducible version of pZ8-1 plasmid, by cloning of lacIq, KanR This study 
pPP208 Donor of dcas9 [41] 
pAL-pgi (T) pAL374 plasmid carrying the pgi (T) sgRNA, targeting the template strand of pgi, SpecR This study 
pAL-pgi (NT) pAL374 plasmid carrying the pgi (NT) sgRNA, targeting the nontemplate strand of pgi, SpecR This study 
pAL-pck (T) pAL374 plasmid carrying the pck (T) sgRNA targeting, the template strand of pck, SpecR This study 
pAL-pck (NT) pAL374 plasmid carrying the pck (NT) sgRNA, targeting the nontemplate strand of pck, SpecR This study 
pAL-pyk (T) pAL374 plasmid carrying the pyk (T) sgRNA targeting the template strand of pyk, SpecR This study 
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pAL-pyk (NT) pAL374 plasmid carrying the pyk (NT) sgRNA targeting the nontemplate strand of pyk, SpecR This study 
pK19mobsacB Integrative plasmid carrying the counter-selection gene sacB, KanR [46] 	  	  
The plasmid pZ8-Ptac, which is an inducible version of plasmid pZ8-1, was obtained by cloning 
lacIq from pDSW405 upstream the tac promoter. The Isothermal Assembly Method[47] was used 
for building the vector. The primers used are listed in Table 3. 	  
Table 3. Primers used for the construction and verification of plasmids. 
Template Strand Primer sequence (5’ – 3’) 
lacIq for 
pZ8-Ptac 
F GCGTCAGGCAGCCATCGGAAGCTGTGGTATGGCCGCTATCGCTACGTGACTGG 
R CGAATTATGCAGTGATTTACGACCTGCACAGTCACTGCCCGCTTTCCAGTCG 
pZ8-1 
backbone 
for pZ8-
Ptac 
F CGACAGGTTTCCCGACTGGAAAGCGGGCAGTGACTGTGCAGGTCGTAAATCACTGC 
R GCAGCCATGACCCAGTCACGTAGCGATAGCGGCCATACCACAGCTTCCGATGG 
dcas9 for 
pZ8-Ptac 
F CACACAGGAAACAGAATTCATGGACTACAAAGACCATGACG 
R GCAGGTCGACGGATCCCCGGTCAGCCCACCTTCCTCTTCTTC 
pZ8-1 
backbone 
for pZ8-
Ptac 
F GCTAGGAGGTGACCCCAAGAAGAAGAGGAAGGTGGGCTGACCGGGGATCCGTCGACCTGC 
R CATGATCTTTATAATCACCGTCATGGTCTTTGTAGTCCATGAATTCTGTTTCCTGTGTGA 
pAL374 
backbone 
F CTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTATGGAATTGGATCCGTGGAAG 
R CATTATACGAGCCGATGATTAATTGTCAACAGCTCATTTCAGAATATTTGCC 
pgi - 
qPCR 
F TCATTGGTTTCGCTCGTCCA 
R AGCGTTCTTACCGAAAGCCA 
pck - 
qPCR 
F ATTGGCTACAACGCTGGTGA 
R CCACTTCAGAACGCGAGAGT 
pyk - 
qPCR 
F GATACCGCAAAGCGTGTGG 
R GACAGGTGGACACAGGAAGG 
16S rRNA 
- qPCR 
F TTACCTGGGCTTGACATGGAC 
R GCTGGCAACATAAGACAAGGG 	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The gene coding for a nuclease-inactivated version of Cas9 - dCas9 - from Streptococcus pyogenes 
was cloned into the C. glutamicum replicative plasmid pZ8-Ptac, under the control of an IPTG 
inducible promoter.  
 
The short, synthetic version of the sgRNA was designed to contain a 24 bp region of homology to 
the transcriptional template or non-template strands of the target DNA including the seed sequence, 
followed by the dCas9 handle and the S. pyogenes terminator. The expression of this set was driven 
by an unrepressed tac promoter, ordered as a gBlock from IDT and cloned into the replicative 
plasmid pAL374. The base-pairing regions, handle, and terminators used were the same as those 
previously described for the sgRNA [23]. The target sequences are listed in Table 4. All sgRNAs 
were cloned into pAL374 by the Isothermal Assembly Method, having the plasmid backbone been 
amplified using the primers listed in Table 3, which also removed the trc promoter. 	  
Table 4. Genes and sequences targeted by dCas9/sgRNA. 
Gene 
targeted 
(ID) 
Strand 
targeted 
Target sequence 
(5’ – 3’) 
PAM 
(5’ – 3’) 
pgi 
(AGT04848.1) 
T TGACCGATCATTACTCAAACTTCC AGG 
NT TTGCCTGGAAGTTTGAGTAATGAT CGG 
pck 
(AGT06569.1) 
T AGGGCGAGGCGCCGACCAAGAATA AGG 
NT TCCAGTTCAGCAGTTCCTTATTCT TGG 
pyk 
(AGT05824.1) 
T AGATTGTATGTACCCTAGGCCCAG CGG 
NT ATTCCATCTGCACTAGCCACCGCT GGG 	  
	  
6.5.2	  sgRNA/dCas9-­‐based	  regulation	  of	  amino	  acid	  production	  by	  C.	  glutamicum	  	  
Genes pgi (AGT04848.1), pck (AGT06569.1) and pyk (AGT05824.1), coding for 
enzymes known to affect the production of L-lysine (pgi) and L-glutamate (pck and pyk) were 
selected as individual targets for repression by the sgRNA/dCas9 complex. The sgRNAs were 
designed to anneal onto the first 150 bp of the template and non-template strands of genes pgi, pck 
or pyk. 
 
Prior to every amino acid production experiment, C. glutamicum cells from glycerol stocks were 
streaked onto LB agar plates with the appropriate antibiotics and incubated at 30°C overnight. 
These cells were subsequently used to inoculate BHI broth. Upon overnight growth, the uninduced 
precultures were harvested by centrifugation (4000 rpm, 5 min, 4°C) and washed with 0.9% NaCl. 
Ten mL CgXII minimal medium[48] with 2% (w/v) glucose, supplemented with 30 µg/L 
protocatechuic acid and 1 mM of the dcas9 inducer IPTG were inoculated to an optical density 
(OD) of 1 at 610 nm. When appropriate, kanamycin and/or spectinomycin were added to a final 
concentration of 25 µg/mL and 100 µg/mL, respectively.  
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The cultures were grown in 125mL flasks at 30°C, with a shaking frequency of 200 rpm, until 
glucose depletion, measured using Quantofix® Glucose strips (Machery-Nagel, Germany).  
 
The strain C. glutamicum ATCC 13032 was used for L-glutamate production. It required 
supplementing CgXII with 20 mg/L ethambutol, a trigger for L-glutamate secretion [49]. For the 
experiment where samples where taken after glucose depletion, the preculture was also induced by 
adding 1 mM IPTG. 
 
Lysine production did not require any additional supplements, having been performed by C. 
glutamicum DM1729. This strain is an S-aminoethyl-L-cysteine-resistant mutant of ATCC 13032, 
previously developed for the specific purpose of L-lysine overproduction.  
 
Growth of all cultures was monitored over time by measuring their OD throughout the experiment, 
using an Infinite 200 Pro microplate reader (Tecan, Switzerland). Three independent experiments 
were performed in triplicate. 
 
The OD610nm conversion to cell dry weight (CDW) followed the ratio previously described of 
OD610nm1 = 0.25 g CDW [50]. 
 
6.5.3	  Quantification	  of	  sgRNA/dCas9-­‐based	  repression 	  
In order to determine the level of dCas9/sgRNA-based transcriptional repression, 
quantitative reverse transcription PCR (qRT-PCR) was performed on total RNA samples. One mL 
aliquots of each culture were taken at mid-exponential phase for total RNA extraction. 
  
All aliquots were centrifuged at 17.000 rpm for 15 seconds, the pellets were immediately flash 
frozen and stored at -80°C until further processing. The cells were lysed by resuspension of pellets 
in RA1 buffer and bead beating 2 x 15 sec. (Mini-Beadbeater-16, Biospec Products, USA) with 
intermittent cooling on ice. The steel beads used were RNase-free and 0.2 mm in diameter (KSE 
Scientific, USA).  
 
The total RNA was extracted using the Illustra RNAspin Mini Kit according to the 
recommendations of the manufacturer (GE Life Sciences, UK). To remove residual co-extracted 
DNA, the purified RNA was treated with DNase (Turbo DNA-free kit, Life Technologies, USA). 
 
qRT-PCR was performed using the KapaTM SYBR®Fast One-Step qRT-PCR kit (Kapa 
Biosystems, USA), the LightCycler® 96 System (Roche, USA), 50 ng of total RNA extracted, 16S 
rRNA as reference and the primers indicated in Table 2. The results were analyzed following the 
Livak method [51]. 	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6.5.4	  Amino	  acid	  quantification	  	  
Samples for amino acid quantification were taken in mid-exponential phase and 
directly after glucose depletion. The samples were centrifuged at 17.000 rpm for 15 seconds and 
automatically derivatized using the Fluoraldehyde™ o-Phthaldialdehyde Reagent Solution (Thermo 
Scientific, USA), prior to entering the chromatographic separation column.  Compound separation 
was performed by high-pressure liquid chromatography (HPLC, 1200 series, Agilent) with a RP18 
column (Eclipse XDB-C18, 4.6 x 150 mm, Agilent) and a fluorescence detector (FLD G1321A, 
1200 series, Agilent).  
 
The mobile phases were 0.1 M sodium acetate at pH 7.2 (A) and 100% methanol (B). The gradient 
used was as follows: 0 min 20% B, 0.5 min 38% B, 2.5 min 46% B, 3.7 min 65% B, 5.5 min 70% 
B, 6 min 75% B, 6.2 min 85% B, 9.7 min 20% B and 11.9 min 20%, at a flow rate of 1.2 mL/min. 
 
Ornithine was used as internal standard, and standard curves for the determination of the amino acid 
concentrations in the supernatants was determined using solutions of glutamate and lysine with 
known concentrations. 
 
6.5.5	  Statistical	  treatment	  of	  data	  	  
Results were tested for significance using the parametric unpaired T-Student test. The 
level of significance of the differences observed between the control and test samples was 
expressed as one, two or three stars, for *p≤ 0.05, **p≤ 0.01 and ***p≤ 0.001, respectively. 	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Chapter	  7.	  Discussion	  	  	  
The members of the glutamate family; ornithine, proline, citrulline, putrescine, and 
arginine are highly relevant industrial products with wide applications in the food and feed, 
cosmetic, chemical, pharmaceutical, and plastics industries [1]–[5]. Production of proline, ornithine, 
and arginine by microorganisms has been explored for more than five decades [6]. Most of the 
strains used in these processes were constructed by means of random mutagenesis and selection 
[6]–[10]. Although these strains can accumulate high concentrations of amino acids, they often 
accumulate undesired mutations resulting for instance in auxotrophy, low productivity, low stress 
tolerance, or sensitivity to external perturbations [11]. Over the years DNA technologies have 
developed and cloning tools for Corynebacterium glutamicum have been established [12]. This has 
entailed a number of recent publications on ornithine-, putrescine-, and arginine-producing strains 
constructed using metabolic engineering [13]–[19].  
In this work the first rationally engineered citrulline producing C. glutamicum strain was 
constructed, the first rationally engineered proline producing strain along with optimization of 
proline production was published, and different strategies to increase ornithine production by the 
platform strain were explored. Following this work we tried to translate the increased ornithine 
production into increased production of proline, citrulline, putrescine, and arginine. Lastly we 
showed how the CRISPR/dCas9 system could be employed for metabolic engineering in C. 
glutamicum 
Some of the discoveries of this thesis will be discussed more thoroughly here in context to previous 
findings. However, first the thermodynamics of the biochemical reactions of the arginine pathway 
will be examined.  	  
7.1	  Considering	  the	  thermodynamics	  	  
The laws of thermodynamics apply to biochemical reactions and therefore the 
feasibility of a reaction pathway can be evaluated with thermodynamics [20]. This makes it possible 
to pinpoint potential difficulties of the pathway. The overall change in entropy determines the 
spontaneity of a process. Only reactions with a negative change in Gibbs free energy (∆rG) proceed 
spontaneously. Increasing substrate concentration and/or decreasing product concentration can 
force the direction in which a reaction occurs [20].  
In the cell, reactant and product concentrations do not necessarily remain steady; moreover their 
concentrations are not likely to be those of the standard conditions (pH of 7, ionic strength of 0.1 
mM, a temperature of 25°C, and concentrations of reactants and products of 1 M). Erroneous 
conclusions can therefore be made when evaluating the thermodynamic feasibility based on those 
values [20]. Concentrations resembling reality should always be used when a thermodynamic 
analysis is performed because reactant and product concentrations can have a large effect on ∆rG’ 
(the change in Gibbs free energy of a reaction taking pH and ionic strength into account). Moreover 
the laws of thermodynamics only apply to ∆rG’ and not ∆rG’° (∆rG’ in standard conditions) [21]. 
The concentration ranges of metabolites should be measured	  experimentally to calculate ∆rG’. The 
reactions catalyzed by the enzymes of the arginine pathway, along with enzymes catalyzing the 
	  	  101	  
formation of proline and putrescine can be found in Table 1. Since the intracellular	  concentrations 
of the metabolites of the arginine pathway are not readily available for C. glutamicum the values 
listed in Table 2 are the ∆rG’m (∆rG’° but with concentrations of reactants and products of 1 mM) 
and ∆rG’ of reactions calculated with different concentrations of reactants and products. The 
software eQuilibrator [21] was used to calculate the net feasibility of the reactions. 
 	  
Table 1. Genes, reactions, and enzymes of glutamate derived molecules. 
	  
 
Although we cannot make a thermodynamic analysis based on the values in Table 2 they still 
provide an understanding of the reactions. The ∆rG’m of the reactions catalyzed by NAGK, ArgD, 
OAT, and ASS are positive, which means that in theory they should proceed in the opposite 
direction of the reactions shown in Table 2.  
If all concentrations of the reactants are set to 10 mM and concentrations of the product to 0.1 mM 
only the ∆rG’ of the NAGK catalyzed reaction remains positive. The reaction will be at equilibrium 
with high reactant concentrations of 41 mM and concentrations of 0.1 mM of the products. If 
however the concentrations of the products are lowered to 1 µM only 1 mM of the reactants are 
needed for the forward reaction to proceed (∆rG’ = -4.4 ± 6.0 kJ/mol). This indicates that low 
concentrations of N-acetylglutamatephosphate or very high concentration of N-acetylglutamate are 
important for the NAGK catalyzed reaction to take place. From a thermodynamic point of view the 
NAGK catalyzed reaction could be limiting in production of glutamate derivatives. 
 
Gene Enzyme  Step Reaction 
gdh Glutamate dehydrogenase 
(GDH) 
1 2-oxoglutarate + NADPH + NH3 -> glutamate + NADP+ 
+ H2O  
cg3035 N-acetylglutamate synthase 
(NAGS) 
2 Acetyl-CoA + glutamate <-> CoA + N-acetylglutamate 
argB N-acetylglutamate kinase 
(NAGK) 
3 ATP + N-acetylglutamate <-> ADP + N-
acetylglutamatephosphate 
argC N-acetylglutamylphosphate 
reductase (ArgC) 
4 NADPH + N-acetylglutamatephosphate <-> NADP+ + 
orthophosphate + glutamate semialdehyde 
argD N-acetylornithine 
aminotransferase (ArgD) 
5 Glutamate + glutamate semialdehyde <-> 2-
oxoglutarate + N-acetylornithine 
argJ Ornithine acetyltransferase 
(OAT) 
6 Glutamate + N-acetylornithine <-> ornithine +  N-
acetylglutamate    
argF Ornithine transcarbamylase (OT) 7 Ornithine + carbamoylphosphate <-> orthophosphate + 
citrulline 
argG Argininosuccinat synthetase 
(ASS) 
8 ATP + aspartate + citrulline <-> diphosphate + AMP + 
argininosuccinate 
argH Argininosuccinate lyase (AL) 9 Argininosuccinate <-> arginine + fumarate 
carAB Carbamoylphosphate synthase 
(CPS) 
- 2 ATP + glutamine + CO2 + H2O <-> 2 ADP + 
orthophosphate + glutamate + carbamoylphosphate 
ocd Ornithine cyclodeaminase (Ocd) - Ornithine <-> NH3 + proline 
speC Ornithine decarboxylase (ODC) - Ornithine <-> CO2 + putrescine 
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Table 2. Feasibility of the reactions of the glutamate derived molecules. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               mReactants set to 1 mM and products set to 1 mM 
               aReactants set to 10 mM and products set to 0.1 mM 
                                                           bReactants set to 0.1 mM and products set to 10 mM 
 
Reactions with large negative energy such as those catalyzed by NAGS and OT are often 
considered key control points in a pathway, as they are essentially irreversible based on their ∆rG’°. 
This means that in the case of the NAGS catalyzed reaction, even when low levels of glutamate or 
high levels of N-acetylglutamate are present the reaction will still take place. 
The reaction catalyzed by ASS is for instance rather close to equilibrium, this makes it relatively 
sensitive to substrate and product concentrations as can be seen from Table 2.  Hence, it can rapidly 
communicate changes in flux.  
Notably the reactions catalyzed by Ocd and ODC have a large negative ∆rG’m. Interestingly it was 
found that ornithine production could be enhanced by Ocd in proline supplemented cultures [22]. 
Or rather, it was assumed that the reaction was taking place based on the experiments performed, 
although the conversion of proline and ammonia to ornithine was not directly demonstrated. From 
the thermodynamic calculations performed with eQuilibrator and our findings on Ocd enzyme 
activity, this assumption can be challenged. In order for the reaction catalyzed by Ocd to proceed in 
the reverse direction more than 290 mM proline and 290 mM ammonia are required if the 
concentration of ornithine is 0.01 mM. As the intracellular glutamate concentration in a lysine 
producing strain was determined to be 190 mM, which was by far the highest concentration of all 
the proteinogenic amino acids measured, it seems unlikely that the reaction in the opposite direction 
can take place [23]. The maximum concentration of proline that was added to the medium in the 
study to promote the conversion of proline and ammonia to ornithine was 30 mM; this is unlikely to 
be a high enough concentration for the reaction to proceed. Moreover when we performed an Ocd 
activity assay no activity was observed, which indicated that the enzyme did not have this putative 
function (Chapter 3). Taken together, these findings indicate that ornithine production was not and 
cannot be enhanced by Ocd in proline supplemented cultures of C. glutamicum.  
 
Reaction catalyzed by 
∆rG’m 
(kJ/mol) 
∆rG’a 
(kJ/mol) 
∆rG’b 
(kJ/mol) 
GDH -21.8 ± 0.7 -50.3 ± 0.7 6.7 ± 0.7 
NAGS -27.4 ± 6.5 -50.2 ± 6.5 -4.6 ± 6.5 
NAGK 29.8 ± 6.0 7.0 ± 6.0 52.6 ± 6 
ArgC -25 ± 3.2 -53.5 ± 3.2 3.5 ± 3.2 
ArgD 11 ± 6.5 -11.8 ± 6.5 33.8 ± 6.5 
OAT 3.1 ± 5.8 -19.7 ± 5.8 25.9 ± 5.8 
OT -28.9 ± 5.8 -51.7 ± 5.8 -6.1 ± 5.8 
ASS 1.7 ± 2.9 -32.5 ± 2.9 35.9 ± 2.9 
AL -4.7 ± 5.8 -21.8 ± 5.8 12.5 ± 5.8 
CPS -23.7 ±5.2 -75.0 ± 5.2 27.7 ± 5.2 
Ocd -39.5 ± 8.2 -56 ± 8.2 -22.4 ± 8.2 
ODC -60.4 ± 10.6 -77.5 ± 10.6 -43.2 ± 10.6 
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This section on thermodynamics was written to illustrate that metabolic engineering is not only 
about introducing mutations, insertions, or knockouts, and repressing or overexpressing genes; it is 
also about understanding the chemistry and physics of the cell. In the iterative cycle of metabolic 
engineering an important part of evaluating what steps are to be taken next is the characterization of 
the strain. Here thermodynamic analysis combined with methods such as metabolic control analysis 
and flux analysis can be valuable to determine flux distributions. This would be valuable for the 
planning of further metabolic engineering strategies, and would shed light on the where the actual 
bottlenecks are located.  
Making such an analysis of the arginine pathway could give insight into where the bottlenecks are 
located especially before and after feedback alleviation of NAGK and OAT. In the literature there is 
still some uncertainty as to where the bottlenecks of the arginine pathway are and in which order 
they should be addressed when performing metabolic engineering. Currently the bottlenecks are 
considered to be the reactions catalyzed by NAGK and OAT, the supply of glutamate, 
carbamoylphosphate, and NADPH, and the expression level of argGH. 
 	  
7.2	  Production	  of	  glutamate	  derivatives	  by	  Corynebacterium	  glutamicum	  	  	  	   Hwang et al. (2008) first published a rationally constructed ornithine producing C. 
glutamicum strain. This strain carried a deletion of argF whose gene product is responsible for the 
conversion of ornithine to citrulline, and hence important for ornithine accumulation. Moreover 
argR encoding the repressor ArgR that regulates the transcription of the genes of the arginine 
pathway was deleted to further boost the ornithine titer. These deletions are common for most of the 
efficient ornithine producers published in literature and were also used in this work to construct the 
initial strain used for all further modifications (Chapters 3, 4, and 5).  	  
7.2.1	  Feedback	  inhibition	  	  
In the process of metabolic engineering for the production of amino acids abolishing 
feedback inhibition is commonly one of the first targets to be addressed as it controls the flux 
through the pathway [24]–[26]. The finding that acetylglutamate, the substrate of NAGK, 
accumulates intracellularly in C. glutamicum wild-type and C. glutamicum ∆argFR [27] indicates 
that the step of the pathway catalyzed by NAGK is a bottleneck of the arginine and ornithine 
biosynthetic pathways. Studies performed on C. glutamicum [28], Corynebacterium crenatum [29], 
Pseudomonas aeruginosa [30], and Escherichia coli [31] have revealed mutations that release the 
enzymes NAGK, or in the case of E. coli, NAGS from inhibition by arginine, the end product of the 
arginine pathway. Based on published data we could show that the expression of a variety of 
feedback resistant NAGKs was beneficial for ornithine overproduction (Chapter 5). The NAGK 
variants had lower specific enzyme activities than wild-type NAGK, in one case even a 4 times 
lower activity. But once these argB variants were overexpressed they resulted in higher ornithine 
yields than when wild-type argB was overexpressed. This indicates that in order to increase the 
ornithine titer in the ∆argFRGB background it is more important to reduce the level of feedback 
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inhibition of NAGK than to maintain the specific enzyme activity to the level of wild-type NAGK. 
Overexpression of argBA49VM54V, encoding feedback alleviated NAGK in proline producing C. 
glutamicum increased the proline titer but also decreased the growth rate and the total biomass 
formed (Chapter 3). Introduction of such mutations in NAGK have previously been connected to a 
lowered carbon consumption rate in arginine overproducing C. glutamicum and hence the feasibility 
of the mutations should be evaluated [14]. 
 
7.2.2	  Increasing	  the	  precursor	  supply	  	  
The glutamate supply has also been assumed to be limiting for overproduction of 
ornithine, hence a push-strategy was employed to assess if this was the case [13]. The gene pck 
encoding phosphoenolpyruvate kinase catalyzing the first step of gluconeogenesis was deleted and 
pyc encoding pyruvate carboxylase catalyzing the carboxylation of pyruvate to form oxaloacetate 
was overexpressed. This resulted in accumulation of glutamate in the ∆argFR∆proB background 
but did not translate into increased ornithine production [13]. This finding, in combination with the 
observation that glutamate accumulated extracellularly as byproduct in proline production (Chapter 
3) meant we initially assumed that glutamate availability was not limiting in the ornithine pathway. 
However, a study on medium optimization for the production of ornithine indicated that the 
addition of the surfactant Tween 80, known to elicit glutamate overproduction, had a positive effect 
on ornithine accumulation [32]. In an attempt to determine if a more direct approach to increase the 
intracellular glutamate concentration was beneficial for ornithine production we tuned the promoter 
of gdh (Chapter 5). We showed that this resulted in increased enzyme activity and that this could 
not only be translated into increased production of ornithine but also to increased production of 
putrescine and proline. To this end it is not clear why the push-strategy did not result in a higher 
ornithine titer while tuning the gdh promoter did. Unknown regulatory mechanisms could possibly 
be involved.  	  
7.2.3	  Aminotransferases	  involved	  in	  ornithine/arginine	  biosynthesis	  	  
Aminotransferases are enzymes involved in, but not limited to, amino acid 
biosynthesis [33]. These enzymes are known to have overlapping substrate specificity, which has 
already been demonstrated for instance in E. coli. Here enzymes encoded by tyrB, ilvE, and aspC 
and involved in tyrosine, phenylalanine, and aspartic acid biosynthesis respectively can overlap 
each others function [34]. Another example is the overlapping functions of the enzymes encoded by 
avtA and ilvE in valine biosynthesis in C. glutamicum [33]. 20 putative aminotransferases were 
identified in C. glutamicum with a bioinformatic approach [35]. One of them, acetylornithine 
aminotransferase encoded by argD was not essential for ornithine production by C. glutamicum 
MB001∆argFRG (Chapter 5). Hence we expected another enzyme to be able to overtake its 
function, however additional deletions of the aminotransferases encoded by argD2, gapT, and bioA 
did also not result in ornithine auxotrophy. This finding was surprising as the deletion of argD in C. 
glutamicum RES167 resulted in arginine auxotrophy [35]. Moreover it was later shown that C. 
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glutamicum ∆argDR accumulates acetylglutamate semialdehyde, the substrate of ArgD, which 
neither the wild-type nor C. glutamicum ∆argFR did [27].  
C. glutamicum has no annotated genes involved in arginine catabolism and no published findings on 
an arginine degradation system, hence it should not be possible for arginine to be converted into a 
compound that can be converted into ornithine. Although it is not surprising that ArgD is not 
essential for ornithine production, as aminotransferases are known to have overlapping substrate 
specificity, it is interesting that this finding is contradiction to results published in literature. A 
recent study showed that the overexpression of gabT resulted in an improved ornithine titer, more 
interestingly the overexpression of the gene almost tripled specific aminotransferase activity [36]. 
Additionally we showed that overexpression of argD2 improved the ornithine yield.  Although 
speculative an upregulation of expression of a gene encoding an aminotransferase may be 
responsible for the lack of ornithine auxotrophy observed in the MB001∆argFRGD strain. Further 
experiments have to be performed to determine if genetic differences between the strains can 
explain the results.	  	  
7.2.4	  Medium	  optimization	  	  
The medium used for industrial fermentations should allow maximum concentration 
of product or biomass per unit mass of substrate, minimum production of byproducts, and a 
consistent product quality to ensure a cost-efficient process [37]. Defined media are often used for 
experiments where chemical, physical, and physiological parameters have to be standardized or 
growth has to be assessed, as all components of the medium are chemically defined [37]. 
Fermentation media for industrial processes often contain cheap complex compounds like 
hydrolysates and extracts of waste products with an undefined chemical composition. The cheap 
substrates such as cane molasses, corn steep liquor, yeast hydrolysate etc. are used to keep 
production costs low [38]. 
Often medium optimization is required for optimal conversion of substrate to product; here design 
of experiments (DOE) can be used to reduce the resources and time spent compared to using a 
single factor at a time method. Such a systematic approach allows one to determine the optimum 
medium composition and other variables that might influence the fermentation process, such as 
inoculum size [37]. 
For cultivation of C. glutamicum in defined medium, CGXII is commonly used. The medium is rich 
in N-source, with 20 g/L ammonium sulfate and 5 g/L urea. When C. glutamicum ∆argFR with 
plasmid-based overexpression of ocd to facilitate proline production was cultured in CGXII both 
glutamate and ornithine accumulated (Chapter 3). The reaction catalyzed by Ocd releases both 
proline and ammonia, hence the ammonia required for the GDH catalyzed reaction converting 2-
oxoglutarate to glutamate is recycled once released with the formation of proline. Thereby the 
overall ammonium requirement of the cell should be reduced and hence reduce the amount of N-
source needed in the growth medium. We therefore performed a DOE to determine if medium 
optimization could reduce accumulation of intermediates in the culture medium and thereby 
increase the proline yield. Once the medium was modified to contain 5 g/L urea as sole nitrogen 
source and 35 g/L glucose instead of 40 g/L, proline production was increased by 25% and 
byproduct formation was reduced (Chapter 3).  
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To achieve the best possible production of each of the five compounds dealt with in this thesis it 
may be necessary to optimize the medium for each of these compounds seperately. It is only in 
proline production that the ammonia consumed by the GDH catalyzed reaction can be recycled, 
therefore the optimal production of ornithine, citrulline, and arginine are likely to have a higher 
demand for a nitrogen source. This is supported by previous reports on medium optimization for the 
production of ornithine and arginine where the final media contained 35 and 60 g/L ammonium 
sulfate, respectively [32], [39].  
Along with strain construction and optimizing the fermentation process, the medium composition 
plays a role in establishing an overall optimized production process of a compound and therefore 
contributes to establishing a cost efficient production process. 	  
7.2.5	  Citrulline	  and	  arginine	  production	  	  
For the first time, we demonstrated how C. glutamicum could be engineered to 
accumulate citrulline extracellularly. Surprisingly we found that deleting both argG coding for 
argininosuccinate synthase responsible for the conversion of citrulline into argininosuccinate, and 
plasmid-based overexpression of argF, neither resulted in citrulline production nor accumulation of 
ornithine. Overexpression of an argB variant encoding feedback resistant NAGK (argBfbr) was 
necessary for citrulline accumulation in C. glutamicum MB001∆argFRG (Chapter 4).  
Around the time we published these results another paper dealing with citrulline production by C. 
glutamicum was published. The authors observed accumulation of 0.15 g/L citrulline extracellularly 
and a deletion of argR and argG further increased the titer to 5.43 g/L [40]. This was unexpected as 
we had not been able to detect extracellular accumulation of citrulline in wild-type C. glutamicum, 
when using a fluorescence detector to detect amino acid derivatives; a more sensitive instrument 
than the UV-detector used in their study. 
Theoretically the genetic background of our strain only differed from their strain in the deletion of 
the three prophages and argF. Although unlikely, it cannot be excluded that the differences 
observed were due to the fact that we had deleted argF and overexpressed it on a plasmid. Other 
differences could be determined by whole-genome sequencing along with transcriptomics and could 
potentially reveal regulation that causes our strain not to accumulate citrulline extracellularly. 
One theory that could explain why neither ornithine nor citrulline accumulated extracellularly in 
cultures of C. glutamicum MB001∆argFRG overexpressing argF, is that citrulline inhibits NAGK. 
If the intracellular citrulline concentration is not sufficient to activate a putative citrulline exporter 
but conversely high enough to inhibit NAGK, then neither ornithine nor citrulline can accumulate in 
the medium. Although this is rather speculative it would be in line with an earlier study that showed 
that the deletion of argR in C. glutamicum was not enough to produce arginine extracellularly, the 
overexpression of argBfbr was also required [19].  
We were not able to increase arginine or citrulline production by increasing the glutamate level of 
the cell even though it increased ornithine production notably (Chapter 5). This indicates that in 
those strains the reactions following ornithine formation are limiting. Park et al. solved this by 
removing at least one of the bottlenecks downstream the ornithine pathway. This was achieved by 
exchanging the argG promoter with the strong tuf promoter, and the carA promoter with the strong 
sod promoter. After the introduction of these modifications citrulline no longer accumulated as 
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byproduct in arginine production [14]. If the modifications performed above to construct an 
arginine producing strain were combined with the tuned gdh promoter that increases the supply of 
glutamate, this increased supply could possibly be translated into increased citrulline or arginine 
production.  
 
7.2.6	  Summary	  
 
 Bottlenecks of the ornithine/arginine pathway include, but are not necessarily limited 
to; the glutamate supply and the reactions catalyzed by NAGK and OAT, the carbamoylphosphate 
supply, and the expression level of argGH. For the GDH and NAGK catalyzed reactions it appears 
that at a certain threshold level an increase of the enzymatic activity does not equal an increase in 
the production of ornithine. This indicates that these reactions are no longer limiting for ornithine 
production when the expression of gdh is increased and NAGK is alleviated of feedback inhibition 
by arginine. The bottlenecks located in the arginine specific part of the pathway prevent an 
increased level of ornithine production to be translated into an increased production of citrulline or 
arginine. Citrulline production required the presence of feedback alleviated NAGK, possibly 
suggesting that the enzyme is not only regulated by arginine, but also by citrulline. ArgD was not 
essential for ornithine production indicating that another transaminase can substitute its function. 
Lastly it was shown that medium optimization could be an important part of improving the 
conversion of substrate into product. By the example of proline production its was shown that the 
reduction of the nitrogen content in the medium had a positive effect. It was also argued that 
optimal medium composition for ornithine, putrescine, citrulline, and arginine likely differs from 
proline production medium as these compounds have a different demand for nitrogen.  
In the next subsection it will be discussed which next steps can be taken to further increase the 
production of the glutamate derivatives, and the potential of the platform strain.  
 
7.2.7	  Improving	  the	  platform	  strain 	  
Ornithine aminotransferase (OAT) is feedback inhibited by ornithine and citrulline. OAT may be 
the major bottleneck of the ornithine pathway once NAGK is feedback alleviated and sufficient 
concentrations of glutamate are supplied. When argJ encoding OAT was overexpressed in ornithine 
producing strains, the specific enzyme activity remained largely unchanged in one report and more 
than doubled in another [13][36].  Based on our studies plasmid-based overexpression of argJ had a 
major impact on the ornithine yield and could reflect an increased enzyme activity (Chapter 5). We 
were able to construct an ornithine producing strain with a high yield of 0.52 g ornithine / g glucose 
without the use of a feedback resistant OAT. Based on the findings described above further 
experiments are required to determine whether overexpression of argJ is sufficient for increased 
production of the glutamate derivatives or if alleviation of feedback inhibition of OAT can boost the 
production even further. Thus far no protein engineering efforts have been made to remove the 
potential bottleneck feedback inhibition might be. Though the amino acid change G330D of OAT 
has been reported, the effect of the exchange on feedback inhibition has not been investigated [36].  
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To determine if overexpression of argJ encoding feedback alleviated OAT is more beneficial for 
overproduction of the glutamate derivatives than overexpression of wild-type argJ, the following 
experiments could be performed; Feedback resistant mutants could be obtained by the classical 
approach where C. glutamicum is treated with a mutagen or UV-irradiation and mutants are selected 
based on their resistance to toxic ornithine analogues such as α-methylornithine or 
difluoromethylornithine. The mutants can then be tested for growth and ornithine production using 
for instance the biolector microfermentation system as it allows simultaneous cultivation and online 
monitoring of growth for up to 48 strains. Although more challenging and resource intensive 
rational protein engineering by construction of a homology model based on published crystal 
structures can be performed. By rationally selecting amino acid(s) to exchange, a number of 
different mutations can be tested to construct a feedback resistant enzyme. Although this is a 
targeted approach, still a large number of clones would have to be screened since every target 
amino acid can be exchanged with up to 19 other amino acids. 
 
Increased levels of ornithine should entail increased production of the other glutamate derivatives; 
this was not the case for the production of putrescine, citrulline, and arginine. Therefore further 
changes have to be made to facilitate this. For increased putrescine production the deletion of snaA 
to avoid the conversion of putrescine to acetylputrescine along with replacing the promoter of the 
gene coding for the putrescine exporter with a stronger one should be performed. It should be 
determined if citrulline inhibits NAGK and NAGK resistant to feedback inhibition by arginine. To 
remove the bottlenecks downstream the ornithine pathway the carbamoylphosphate supply could be 
increased by overexpression of carAB and the flow from the ornithine pathway into the arginine 
pathway could be improved by overexpressing the argF(GH) genes. 
It could also be beneficial to engineer the transport systems for increasing the production of the 
glutamate derivatives. LysE is a carrier protein shown to export both lysine and arginine at similar 
rates across the membrane of C. glutamicum, but it does not export ornithine [41]. When the N-
terminal of the protein was extended with the amino acids methionine, valine, and isoleucine, the 
export of lysine and arginine was improved. In the ∆argFRGH background it also led to increased 
ornithine production [42]. The experiments performed in the study indicated that the modified 
protein could facilitate the export of ornithine. It was claimed that this was the result of a change in 
the secondary structure. Hence it could be beneficial to introduce the modified lysE gene in the 
platform strain and test its effect on the production of ornithine, citrulline, and arginine. However if 
ornithine can be exported this modification could be detrimental to citrulline and arginine 
production. 
Lastly the product range of the platform strain has the potential to be extended even further by 
establishing the overproduction of spermidine, a polyamine synthesized from putrescine. 
	  
7.3	  Metabolic	  engineering	  	  	  
A major challenge in metabolic engineering is selecting the right targets at the right 
step in the process. Although several targets for metabolic engineering can usually easily be 
identified by looking at the pathway along with information in the literature, the modification of the 
chosen target will not necessarily have the desired effect. For one there might be a bottleneck 
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upstream the target that has to be solved first, in that case improving the target could show a small 
effect or non at all. On the other hand improving one target and then moving on in the iterative 
metabolic engineering cycle does not mean that the solved bottleneck might not become a 
bottleneck later on. When a target is optimized, it will necessarily be optimized for the particular 
genetic background of that strain. Once the strain has undergone several more rounds of alterations, 
the previously engineered targets may no longer be optimal for the new genetic background of the 
strain. Metabolic engineering can be seen as an endless tinkering of metabolism to obtain the best 
producing strains. Performing genetic alterations on the genome such as deletions can at times be 
quite cumbersome if the same or multiple targets have to be tested in different genetic backgrounds. 
Computational simulations may be able to facilitate a better engineering of the strain if it is based 
information such as kinetic data and 13C flux analysis [43]. 
Technology-wise much has happened since Bailey coined the term ‘metabolic engineering’ in 1991. 
New exciting technologies and fields such as synthetic biology have come along the way. This has 
the potential to take metabolic engineering to the next level where cell factories can be constructed 
in a more predictive, fast, and efficient way.  
An example of a new genetic engineering tool is the Clusters of Regularly Interspaced Short 
Palindromic Repeats (CRISPR)/dCas9 system. This technology opens new avenues for metabolic 
engineering. 
	  
7.3.1	  Increasing	  the	  pace	  of	  pathway	  engineering	  with	  the	  CRISPR/(d)Cas9	  system	  	  
The CRISPR/dCas9 system allows for a quick determination of whether modifications 
are beneficial alone or in combination with other targets and can speed up the strain construction 
process. We for the first time showed that the CRISPR/dCas9 system is functional in C. glutamicum 
(Chapter 6). We were able to repress selected genes beneficial for glutamate and lysine production 
by targeting non-template and in some cases template strands. In the case of lysine production we 
repressed the expression of pgi, redirecting the flux into the pentose phosphate pathway, thereby 
generating more NADPH know to be beneficial for lysine production [44]. We showed that the 
perturbation of pgi resulted in nearly complete repression, where we observed a fold increase in 
lysine production comparable to that of a pgi deletion mutant. When we targeted genes pyk and pck 
whose repression is beneficial for glutamate production we also observed a nearly complete 
repression when targeting non-template strands. When template strands of pyk and pck were 
targeted an efficient but not complete repression was obtained and glutamate production was 
significantly increased. This study exemplifies how the CRISPR/dCas9 system can be used in C. 
glutamicum to evaluate the feasibility of different targets for metabolic engineering. 
The CRISPR/(d)Cas9 system has great potential to take genetic engineering to a new level, 
allowing metabolic engineers to significantly reduce the time needed for strain construction. 
Especially the potential the system has for multiplex targeting, which allows one to evaluate the 
combination of different targets simultaneously is valuable. The multiplex targeting can easily be 
achieved by cloning several small guide RNAs (sgRNA) into one plasmid [45]. 
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There is still much room for optimization of the system for C. glutamicum. For one the system we 
constructed was based on the IPTG inducible tac promoter, this system is known to be leaky [46]. 
We also used a propionate inducible promoter in an attempt to reduce basal expression of dcas9, but 
this system was also too leaky (unpublished results). For some applications it might be necessary to 
have a completely tight system; to achieve this other inducible systems such as the tetracycline 
inducible system could be used. Another option is to put the sgRNA under the control of an 
inducible promoter to reduce sgRNA/dCas9 repression under uninduced conditions.  
 
The system can also be developed to activate transcription of genes and could thereby be used to 
increase transcription of weakly expressed genes. This was achieved by fusing dCas9 with the 
omega subunit of RNA polymerase in E. coli, that had a deletion of rpoZ encoding the omega 
subunit [47]. With the help of the sgRNA the dCas9-ω fusion protein is guided to the promoter 
region, where the ω subunit recruits the RNA polymerase by interacting with the β’ subunit [47]. It 
would be even more useful to develop the CRISPR/Cas9 system for genome editing in C. 
glutamicum. This was already accomplished in E. coli and Streptococcus pneumonia where the 
introduction of marker-free mutations was demonstrated [48]. This was achieved by introducing a 
system targeting a locus in the genome along with a template to recombine into the targeted locus. 
We already constructed a plasmid capable of replicating in C. glutamicum with cas9 under the 
control of Ptac. Other than Cas9 and sgRNA, an editing template is required. Two challenges of the 
system are the potential low efficiency of editing the target of choice, as it is dependent on a rare 
homologous recombination event to take place and to select against non-edited cells. A more 
general limitation of the system is the need of a protospacer-adjacent motive (PAM) an NGG 
sequence required for the sgRNA to recognize the target sequence [45]. The sgRNA is designed 
based on where a PAM can be found, if there is no PAM in the promoter sequence or in the 5’ 
region of the gene, then the maximum achievable repression might not be as high as desired. 
Nonetheless research within the use of the CRISPR/(d)Cas9 system is progressing rapidly, 
advancing the technique and so its current limitations may soon belong to the past. 
 
The CRISPR/dCas9 system would be a powerful tool for further engineering of the ornithine 
producing platform strain. For instance the simultaneous perturbation of expression of the genes 
encoding the enzymes catalyzing the first step of proline and glutamine biosynthesis that both 
compete with the arginine pathway for glutamate could be tested for increased titers of ornithine, 
proline, and putrescine. This could be even further extended to construct a plasmid with sgRNAs 
targeting the genes proB, aceA, pck, odhA and pgi. Where the perturbation of aceA, pck, and odhA 
should direct the flux into the arginine pathway. 
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7.4	  Final	  remarks	  	  
 These times are truly exciting for metabolic engineers. Not only can we use well 
established tools such as metabolic control analysis, flux balance analysis, 13C metabolic flux 
analysis, RNA sequencing (transcriptomics), metabolomics, proteomics, but newer exciting tools 
have also been developed. The CRISPR/Cas9 system has made precise genetic modifications 
possible in a range of organisms, including mammalian cells. This system has now been established 
for the use in C. glutamicum and has the potential to significantly reduce the strain construction 
process. The concept of constructing a platform strain for the production of a range of bioproducts 
is not new, but like the CRISPR/dCas9 system, it can shorten the strain construction process as the 
different products have a common precursor. 
A challenge in the development of a platform strain for the production of the glutamate derivatives 
is the very different co-factor, substrate, and energy requirements for synthesis of ornithine, proline, 
and putrescine versus synthesis of arginine and citrulline. This makes the engineering of these 
compounds more challenging and requires even further tinkering of the metabolism to achieve high 
yields of the individual compounds. 	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Table S1. Plasmids used and constructed in this study. 
Plasmids	   Reference	  pK19mobsacB	   [1]	  pK19mobsacB∆argFR	   [2]	  pK19mobsacB∆argG	   This	  study	  pK19mobsacB∆argCJBD	   This	  study	  pK18mobsacB∆argB	   [3]	  pK18mobsacB∆argJ	   [3]	  pK19mobsacB∆argD	   This	  study	  pK19mobsacB∆argD2	   This	  study	  pK19mobsacB∆gabT	   This	  study	  pK19mobsacB∆bioA	   This	  study	  pK19mobsacB-­‐Pgdh	   This	  study	  pK19mobsacB-­‐Pgdh1	   This	  study	  pK19mobsacB-­‐Pgdh2	   This	  study	  pK19mobsacB-­‐Pgdh3	   This	  study	  pK19mobsacB-­‐Pgdh4	   This	  study	  pK19mobsacB-­‐pgiGTG	   Provided	  by	  Prof.	  Dr.	  Bernhard	  Eikmanns	  pK19mobsacB-­‐argBA49V,M54V	   This	  study	  pK19mobsacB-­‐CGP1.1-­‐Ptuf-­‐argCJBA49V,M54VD-­‐rrnBT1T2-­‐CGP1.2	   This	  study	  pK19mobsacB-­‐CGP1.1-­‐Ptuf-­‐argBA49V,M54VJCD-­‐rrnBT1T2-­‐CGP1.2	   This	  study	  pEPR1	   [4]	  pEPR1-­‐Ptuf	   This	  study	  pEPR1-­‐Psod	   This	  study	  pEPR1-­‐PargC	   This	  study	  pEKEx3	   [5]	  pEKEx3-­‐argB	   This	  study	  pEKEx3-­‐argB∆1-­‐23	   [2]	  pEKEX3-­‐argBE19R	   This	  study	  pEKEX3-­‐argBH26E	   This	  study	  pEKEX3-­‐argBH268N	   This	  study	  pEKEX3-­‐argBG287D	   This	  study	  pEKEX3-­‐argBA49V,M54V	   [2]	  pEKEX3-­‐argBE19R,H26E,A49V,M54V	   This	  study	  pEKEX3-­‐argBA49V,M54V,H268N	   This	  study	  pEKEX3-­‐argBA49V,M54V,G287D	   This	  study	  pEKEX3-­‐argBE19R,H26E,H268N	   This	  study	  pEKEX3-­‐argBE19R,H26E,A49V,M54V,H268N	   This	  study	  pEKEX3-­‐argBE19R,H26E,A49V,M54V,H268N,G287D	   This	  study	  pEKEX3argBE.coli	   [2]	  pEKEx3-­‐argD	   This	  study	  pEKEx3-­‐argD2LA	   This	  study	  pEKEx3-­‐argD2LT	   This	  study	  pEKEx3-­‐argD2MA	   This	  study	  pEKEx3-­‐argD2MT	   This	  study	  pEKEx3-­‐argJCg	   This	  study	  pEKEx3-­‐argJCc	   This	  study	  pVWEx1	   [6]	  pVWEx1-­‐argFBA49V,M54V	   This	  study	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pVWEx1-­‐argGFBA49V,M54V	   This	  study	  pVWEx1-­‐ocdPp	   [7]	  pVWEx1-­‐speCEc	   [8]	  	  	  
Table S2. Primers used for the construction of plasmids. Bases in italics denote restriction 
recognition sites, bases in lower case denote overlapping regions, bases in bold denote mutations. 
#	   Primer	  	   Primer	  sequence	  5’-­‐>3’	   Purpose	  1	   argG-­‐up-­‐fw	  	   CTTgaattcAGAAGCTGCGCCGCATG	   Deletion	  of	  argG	  	  2	   argG-­‐up-­‐rv	  	   agagacgacctaagccagtctAACGATGCGGTTAGTCATGAGG	   Deletion	  of	  argG	  3	   argG-­‐dw-­‐fw	   agactggcttaggtcgtctctGCTAACAAGCGCGATCGC	   Deletion	  of	  argG	  4	   argG-­‐dw-­‐rv	   CCTctgcagAACGACCAGCGCGCAGA	   Deletion	  of	  argG	  5	   argCJBD-­‐up-­‐fw	   CTTgaattcACTTCCAGCTCCTCCAGCAG	   Deletion	  of	  argCJBD	  6	   argCJBD	  -­‐up-­‐rv	   agagacgacctaagccagtctGCAAATTATTCATGCATAAATTTTTG	   Deletion	  of	  argCJBD	  7	   argD-­‐up-­‐fw	   CTTgaattcCATTAACGCCGATACCGCA	   Deletion	  of	  argD	  8	   argD-­‐up-­‐rv	   agactggcttaggtcgtctctAGTTTCCAGCGTGCTCATTTAC	   Deletion	  of	  argD	  9	   argD-­‐dw-­‐fw	   agactggcttaggtcgtctctGACGCAGTCAAGGCTATTGCC	   Deletion	  of	  argCJBD	  and	  argD	  10	   argD-­‐dw-­‐rv	   CCTggatccAGTCTGGATGCTTGAAAAGGTGG	   Deletion	  of	  argCJBD	  and	  argD	  11	   argD2-­‐up-­‐fw	   CTTgaattcTGGATGCACAACCCAGATGT	   Deletion	  of	  argD2	  12	   argD2-­‐up-­‐rv	   agagacgacctaagccagtctGTAACCCTTCAATGCCAAACCA	   Deletion	  of	  argD2	  13	   argD2-­‐dw-­‐fw	   agactggcttaggtcgtctctGCTGTCGAGCTGACCTTC	   Deletion	  of	  argD2	  14	   argD2-­‐dw-­‐rv	   CCTctgcagCATGCTGGCCAAATGGTTGT	   Deletion	  of	  argD2	  15	   gabT-­‐up-­‐fw	   CTTgaattcCGATCGCGATGACCCCTG	   Deletion	  of	  gabT	  16	   gabT-­‐up-­‐rv	   agagacgacctaagccagtctGTATGAGAGATCTTCCACGGTTCC	   Deletion	  of	  gabT	  17	   gabT-­‐dw-­‐fw	   agactggcttaggtcgtctctCTAGAGCGCGAAACCGC	   Deletion	  of	  gabT	  18	   gabT-­‐dw-­‐rv	   CCTggatccCCATGGGGTGATCGCCAG	   Deletion	  of	  gabT	  19	   bioA-­‐up-­‐fw	   CTTgaattcTGGTTACTGAGATCGCACCG	   Deletion	  of	  bioA	  20	   bioA-­‐up-­‐rv	   agagacgacctaagccagtctCAAGCTGGGGTTTTCCATTTTC	   Deletion	  of	  bioA	  21	   bioA-­‐dw-­‐fw	   agactggcttaggtcgtctctTGCACTGCGCTTCATGCTG	   Deletion	  of	  bioA	  22	   bioA-­‐dw-­‐rv	   CCTggatccGCATTCAAAGCGGAGGCAAC	   Deletion	  of	  bioA	  23	   Pgdh-­‐fw	   CTTgaattcGTCGGTGGGGGAGTTGGA	   Amplification	  of	  gdh	  promoter	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region	  
24	   Pgdh-­‐rv	   CCTggatccCAAGGCACACGGAAGATGAG	   Amplification	  of	  gdh	  promoter	  region	  25	   Pgdh1-­‐fw	  	   ACACTGCTATAATTGAACGTGAGCATTTACCA	   SDM	  of	  gdh	  promoter	  region	  26	   Pgdh1-­‐rv	   CAATTATAGCAGTGTCGCACAGATATGACCA	   SDM	  of	  gdh	  promoter	  region	  27	   Pgdh2-­‐fw	   CGACTGTGCTATAATGGAACGTGAGCATTTACCA	   SDM	  of	  gdh	  promoter	  region	  28	   Pgdh2-­‐rv	   CCATTATAGCACAGTCGCACAGATATGACCACAA	   SDM	  of	  gdh	  promoter	  region	  29	   Pgdh3-­‐rv	   CAATTATAGCAGTGTCGCACAGATATGTCAAC	   SDM	  of	  gdh	  promoter	  region	  30	   Pgdh4-­‐rv	  	   CAATTATAGCAGTGTCGCACAGATATGGCAAC	   SDM	  of	  gdh	  promoter	  region	  31	   argB*-­‐fw	   ATGAATGACTTGATCAAAGATTTAGGC	   Amplification	  of	  argBA49V,M54V	  32	   argB*-­‐rv	   TTACAGTTCCCCATCCTTGT	   Amplification	  of	  argBA49V,M54V	  
33	   argCJBD-­‐fw	   CTTcatatgGAAAGGAGGCCCTTCAGATGACAATCAAGGTTGCAATCG	   Construction	  of	  argCJBA49V,M54VD	  operon	  
34	   argCJBD-­‐rv	   CCTcatatgTTATGCGATTGTCTCGGCAATAG	  	   Construction	  of	  argCJBA49V,M54VD	  operon	  
35	   CGP1.1-­‐fw	   ACGCCAAGCTTGCATGCCCAGTGAAGGATCGGTGCG	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
36	   CGP1.1-­‐rv	   GTAACGGCCACCTATCTGCTGGCCGGTG	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
37	   Ptuf-­‐fw	   AGCAGATAGGTGGCCGTTACCCTGCGAATG	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
38	   Ptuf-­‐rv	   cacgcgtagagacgacctaagccagtctcatatgcTGTATGTCCTCCTGGACTTC	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
39	   argB-­‐fw	  	   CCAGGAGGACATACAGCAGAAAGGAGGCCCTTCAGATGAATGACTTGATCAAAGATTTAGGC	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  40	   argB-­‐rv	   GCCTTTTTCTGCCATCTGAAGGGCCTCCTTTCTTACAGTTCCCCATCCTTGT	   Construction	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argBA49V,M54VJ
CD	  operon	  
41	   argJ-­‐fw	   GATGGGGAACTGTAAGAAAGGAGGCCCTTCAGATGGCAGAAAAAGGCATTACC	  	  	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
42	   argJ-­‐rv	   AACCTTGATTGTCATCTGAAGGGCCTCCTTTCTTAAGAGCTGTACGCGGA	  	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
43	   argC-­‐fw	   GCGTACAGCTCTTAAGAAAGGAGGCCCTTCAGATGACAATCAAGGTTGCAATCG	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
44	   argC-­‐rv	   TTCCAGCGTGCTCATCTGAAGGGCCTCCTTTCTTAAGGTGCGACGCCGAC	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
45	   argD-­‐fw	   GGCGTCGCACCTTAAGAAAGGAGGCCCTTCAGATGAGCACGCTGGAAACTTGG	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
46	   argD-­‐rv	   TCTCATCCGCCAAAAcACGCGTTATGCGATTGTCTCGGCAATAG	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
47	   rrnBT1T2-­‐fw	   gcatatgagactggcttaggtcgtctctacgcgtgTTTTGGCGGATGAGAGAAG	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
48	   rrnBT1T2-­‐rv	   CTAGGTACAGCAAAAGAGTTTGTAGAAACGCA	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
49	   CGP1.2-­‐fw	   AACTCTTTTGCTGTACCTAGCGCAAGTAGTAAGA	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  
50	   CGP1.2-­‐rv	   AACGACGGCCAGTGAATTCTGCTCATCCTTCAACAAC	   Construction	  of	  argBA49V,M54VJ
CD	  operon	  51	   argB-­‐fw	   GAAAGGAGGCCCTTCAGATGAATGACTTGATCAAAGATTTAGGC	   Amplification	  of	  argB	  52	   E19R-­‐rv	   GCTCGGGCGTTGCCATGGTTGCAGCACTTCCGCG	   SDM	  of	  argB	  53	   H26E-­‐fw	   TGGCAACGCCTCAGCGAGGACATTTGCGCG	   SDM	  of	  argB	  54	   H26E-­‐rv	   GCTGAGGCGTTGCCATGGTTGCAGGAATTCCGCG	   SDM	  of	  argB	  55	   H268N-­‐RV	   CAATGACATTAGCAGCGCTTACTCCCCCACG	   SDM	  of	  argB	  56	   H268N-­‐FW	   GCTGCTAATGTCATTGACGGCCGCATCGC	   SDM	  of	  argB	  57	   G287D-­‐fw	   CATGGGTGATATTGGCACGATGGTGCTG	   SDM	  of	  argB	  58	   G287D-­‐rv	   CAATATCACCCATGGTCAAAAGCTCCAGC	   SDM	  of	  argB	  59	   E19R-­‐H26E-­‐fw	   GCTCGGGCGTTGCCATGGTTGCAGGAATTCCGCG	   SDM	  of	  argB	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60	   E19R-­‐H26E-­‐rv	   TGGCAACGCCCGAGCGAGGACATTTGCGCG	   SDM	  of	  argB	  61	   argD-­‐fw	  	   CTTgtcgacAAGGAGATATAGATATGAGCACGCTGGAAACTTGG	   Amplification	  of	  argD	  62	   argD-­‐rv	   CCTgaattcTTATGCGATTGTCTCGGCAATAG	   Amplification	  of	  argD	  63	   argD2LA-­‐fw	   CTTgtcgacAAGGAGATATAGATTTGGCATTGAAGGGTTACACCA	   Amplification	  of	  argD2	  64	   argD2LT-­‐fw	  	   CTTgtcgacAAGGAGATATAGATTTGACCTTGAAGGGTTACACCA	   Amplification	  of	  argD2	  65	   argD2MA-­‐fw	  	   CTTgtcgacAAGGAGATATAGATATGGCATTGAAGGGTTACACCA	   Amplification	  of	  argD2	  66	   argD2MT-­‐fw	  	   CTTgtcgacAAGGAGATATAGATATGACCTTGAAGGGTTACACCA	   Amplification	  of	  argD2	  67	   argD2-­‐rv	   CCTcccgggTTAGAACAACGCCCCAGCG	   Amplification	  of	  argD2	  68	   argJCg-­‐fw	   CGggatccGAAAGGAGGCCCTTCAGATGGCAGAAAAAGGCATTACCG	   Amplification	  of	  argJ	  69	   argJCg-­‐rv	   GGgaattcTTAAGTGCTGTACGCGGAGTTG	   Amplification	  of	  argJ	  70	   argJCc-­‐rv	   GGgaattcTTAAGAGCTGTACGCGGAGTTG	   Amplification	  of	  argJ	  71a	   argJCc-­‐mut-­‐rev	   TCAAGGCATACTGCTTTATCATTGAAGAAC	   Introduction	  of	  internal	  mutation	  71b	   argJCc-­‐mut-­‐for	   GTTCTTCAATGATAAAGCAGTATGCCTTGA	   Introduction	  of	  internal	  mutation	  72	   argF-­‐fw	  	   CTTgtcgacAAGGAGATATAGATATGACTTCACAACCACAGGTTCG	   Amplification	  of	  argF	  73	   argF-­‐rv	  	   CCTggatccTTACCTCGGCTGGTTGGC	   Amplification	  of	  argF	  74	   argG-­‐fw	  	   GGGgtcgacGAAAGGAGGCCCTTCAGATGACTAACCGCATCGTTCTTG	   Amplification	  of	  argG	  75	   argG-­‐rv	  	   GGGgtcgacTTAGTTGTTGCCAGCTTCGCGA	   Amplification	  of	  argG	  76	   Ptuf-­‐fw	   TGGCCGTTACCCTGCGAATG	   Amplification	  of	  Ptuf	  77	   Ptuf-­‐rv	   TGTATGTCCTCCTGGACTTC	   Amplification	  of	  Ptuf	  78	   Psod-­‐fw	   TAGCTGCCAATTATTCCGGG	   Amplification	  of	  Psod	  79	   Psod-­‐rv	   GGGTAAAAAATCCTTTCGTAGGTT	   Amplification	  of	  Psod	  80	   PargC-­‐fw	   AAATTCATGCTTTTACCCACTTG	   Amplification	  of	  PargC	  81	   PargC-­‐rv	   AGTTACACCATACACGTTATGCATG	   Amplification	  of	  PargC	  
	  
	  
Construction	  of	  plasmids	  used	  in	  the	  study	  	  
pK19mobsacB∆argG was constructed by amplifying up- and downstream regions of argG with 
primers 1 and 2, and 3 and 4, respectively. The two resulting fragments were combined by 
crossover PCR using primers 1 and 4. The final fragment was treated with PstI and EcoRI and 
ligated with similarly treated pK19mobsacB. 
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pK19mobsacB∆argCJBD was constructed by amplifying up- and downstream regions of argCJBD 
with primers 5 and 6, and 9 and 10, respectively. The two resulting fragments were combined by 
crossover PCR using primers 5 and 10. The final fragment was treated with BamHI and EcoRI and 
ligated with similarly treated pK19mobsacB. 
 
pK19mobsacB∆argD was constructed by amplifying up- and downstream regions of argCJBD 
with primers 7 and 8, and 9 and 10, respectively. The two resulting fragments were combined by 
crossover PCR using primers 7 and 10. The final fragment was treated with BamHI and EcoRI and 
ligated with similarly treated pK19mobsacB. 
 
pK19mobsacB∆argD2 was constructed by amplifying up- and downstream regions of argD2 with 
primers 11 and 12, and 13 and 14, respectively. The two resulting fragments were combined by 
crossover PCR using primers 11 and 14. The final fragment was treated with PstI and EcoRI and 
ligated with similarly treated pK19mobsacB. 
 
pK19mobsacB∆gabT was constructed by amplifying up- and downstream regions of gabT with 
primers 15 and 16, and 17 and 18, respectively. The two resulting fragments were combined by 
crossover PCR using primers 15 and 18. The final fragment was treated with BamHI and EcoRI and 
ligated with similarly treated pK19mobsacB. 
 
pK19mobsacB∆bioA was constructed by amplifying up- and downstream regions of bioA with 
primers 19 and 20, and 21 and 22, respectively. The two resulting fragments were combined by 
crossover PCR using primers 19 and 22. The final fragment was treated with BamHI and EcoRI and 
ligated with similarly treated pK19mobsacB. 
 
pK19mobsacB-Pgdh was constructed by amplifying the upstream region of gdh with primers 23 and 
24. The final fragment was treated with BamHI and EcoRI and ligated with similarly treated 
pK19mobsacB. 
 
pK19mobsacB-Pgdh1 was constructed by site-directed mutagenesis (SDM) using primers 25 and 26 
with pK19mobsacB-Pgdh.  
 
pK19mobsacB-Pgdh2 was constructed by site-directed mutagenesis (SDM) using primers 27 and 28 
with pK19mobsacB-Pgdh.  
 
pK19mobsacB-Pgdh3 was constructed by site-directed mutagenesis (SDM) using primers 25 and 29 
with pK19mobsacB-Pgdh.  
 
pK19mobsacB-Pgdh4 was constructed by site-directed mutagenesis (SDM) using primers 25 and 30 
with pK19mobsacB-Pgdh.  
 
pK19mobsacB-argBA49V,M54V  was constructed by amplifying argBA49V,M54V  from pEKEx3-
argBA49V,M54V  using primers 31 and 32. The final fragment was phosphorylated and ligated with 
SmaI digested pK19mobsacB. 
 
pK19mobsacB-CGP1.1-Ptuf-argCJBA49V,M54VD-rrnBT1T2-CGP1.2: the CGP1.1 upstream region 
was amplified from genomic C. glutamicum MB001 DNA with primers 35 and 36 , Ptuf was 
amplified from genomic C. glutamicum ATCC 13032 DNA with primers 37 and 38,   rrnBT1T2 
was amplified from pEKEx3 with primers  47 and 48, and the CGP1.2 upstream region was 
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amplified from genomic C. glutamicum MB001 DNA with primers 49 and 50. pK19mobsacB was 
treated with PstI and EcoRI and pK19mobsacB-CGP1.1-Ptuf-rrnBT1T2-CGP1.2 was assembled by 
the Gibson assembly method. argCJBA49V,M54VD was amplified from genomic ORN3 DNA with 
primers 33 and 34. The resulting fragment was digested with NdeI and ligated with similarly treated 
pK19mobsacB-CGP1.1-Ptuf-rrnBT1T2-CGP1.2. 
 
pK19mobsacB-CGP1.1-Ptuf-argBA49V,M54VJCD-rrnBT1T2-CGP1.2: argBA49V,M54V  was amplified 
from pEKEx3-argBA49V,M54V with primers 39 and 40,  argJ was amplified from genomic C. 
glutamicum ATCC 13032 DNA with primers 41 and 42, argC was amplified from genomic C. 
glutamicum ATCC 13032 DNA with primers 43 and 44, and argD was amplified from genomic C. 
glutamicum ATCC 13032 DNA with primers 45 and 46.  pK19mobsacB-CGP1.1-Ptuf-rrnBT1T2-
CGP1.2 was treated with MluI and NdeI and pK19mobsacB-CGP1.1-Ptuf-argBA49V,M54VJCD-
rrnBT1T2-CGP1.2 was constructed by the Gibson assembly method.  
 
pEPR1-Ptuf was constructed by amplifying Ptuf with primers 76 and 77, phosphorylating the 
resulting PCR product and ligating it with SmaI digested pEPR1. 
 
pEPR1-Psod was constructed by amplifying Psod with primers 78 and 79, phosphorylating the 
resulting PCR product and ligating it with SmaI digested pEPR1. 
 
pEPR1-PargC was constructed by amplifying PargC with primers 80 and 81, phosphorylating the 
resulting PCR product and ligating it with SmaI digested pEPR1. 
 
pEKEx3-argB was constructed by amplifying argB with primers 51 and 32, phosphorylating the 
resulting PCR product and ligating it with SmaI digested pEKEx3.  
 
pEKEX3-argBE19R was constructed by site-directed mutagenesis (SDM) using primers 52 and 60 
with pEKEx3-argB. 
 
pEKEX3-argBH26E was constructed by site-directed mutagenesis (SDM) using primers 53 and 54 
with pEKEx3-argB. 
 
pEKEX3-argBH268N was constructed by site-directed mutagenesis (SDM) using primers 55 and 56 
with pEKEx3-argB. 
 
pEKEX3-argBG287D was constructed by site-directed mutagenesis (SDM) using primers 57 and 58 
with pEKEx3-argB. 
 
pEKEX3-argBE19R,H26E,A49V,M54V was constructed by site-directed mutagenesis (SDM) using 
primers 59 and 60 with pEKEx3-argBA49V,M54V. 
 
pEKEX3-argBA49V,M54V,H268N was constructed by site-directed mutagenesis (SDM) using primers 
55 and 56 with pEKEx3-argBA49V,M54V. 
 
pEKEX3-argBA49V,M54V,G287D was constructed by site-directed mutagenesis (SDM) using primers 
57 and 58 with pEKEx3-argBA49V,M54V. 
 
pEKEX3-argBE19R,H26E,H268N was constructed by site-directed mutagenesis (SDM) using primers 
55, 56, 59, and 60 with pEKEx3-argB. 
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pEKEX3-argBE19R,H26E,A49V,M54V,H268N was constructed by site-directed mutagenesis (SDM) using 
primers 55, 56, 59, and 60 with pEKEx3-argBA49V,M54V. 
 
pEKEX3-argBE19R,H26E,A49V,M54V,H268N,G287D was constructed by site-directed mutagenesis (SDM) 
using primers 57 and 58 with pEKEX3-argBE19R,H26E,A49V,M54V,H268N. 
 
pEKEx3-argD was constructed by amplifying argD with primers 61 and 62. The PCR product was 
treated with SalI and EcoRI and ligated with similarly treated pEKEx3. 
 
pEKEx3-argD2LA was constructed by amplifying argD2 with primers 63 and 67. The PCR product 
was treated with SalI and XmaI and ligated with similarly treated pEKEx3. 
 
pEKEx3-argD2LT was constructed by amplifying argD2 with primers 64 and 67. The PCR product 
was treated with SalI and XmaI and ligated with similarly treated pEKEx3. 
 
pEKEx3-argD2MA was constructed by amplifying argD2 with primers 65 and 67. The PCR 
product was treated with SalI and XmaI and ligated with similarly treated pEKEx3. 
 
pEKEx3-argD2MT was constructed by amplifying argD2 with primers 66 and 67. The PCR product 
was treated with SalI and XmaI and ligated with similarly treated pEKEx3. 
 
pVWEx1-argF was constructed by amplifying argF with primers 72 and 73. The PCR product was 
treated with SalI and BamHI and ligated with similarly treated pVWEx1. 
 
pVWEx1-argFBA49V,M54V was constructed by purification of BamHI and KpnI digested 
argBA49V,M54V from pEKEx3-argBA49V,M54V  and ligated with similarly treated pVWEx1-argF. 
 
pVWEx1-argFGBA49V,M54V was constructed by amplifying argG  with primers 74 and 75. The 
PCR product was treated with SalI and ligated with similarly treated pVWEx1-argFBA49V,M54V. 
 
pEKEx3-argJcg was constructed by amplifying argJ with primers 68 and 69. The PCR product was 
treated with BamHI and EcoRI and ligated with similarly treated pEKEx3. 
 
pEKEx3-argJcc was constructed by introducing N-terminal and internal mutations into argJ from 
C. glutamicum by using primers 68 and 71a as well as 71b and 70. The Fragments were linked by 
crossover PCR by using primers 68 and 70, treated with BamHI and EcoRI and ligated with 
similarly treated pEKEx3.	  
	  
	  
References	  
	  
1. Schäfer, A., et al., Small mobilizable multi-purpose cloning vectors derived from the 
Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome 
of Corynebacterium glutamicum. Gene, 1994. 145(1): p. 69-73. 
2. Schneider, J., K. Niermann, and V.F. Wendisch, Production of the amino acids L-glutamate, 
L-lysine, L-ornithine and L-arginine from arabinose by recombinant Corynebacterium 
glutamicum. J Biotechnol, 2011. 154(2-3): p. 191-8. 
3. Petri, K., et al., A novel type of N-acetylglutamate synthase is involved in the first step of 
arginine biosynthesis in Corynebacterium glutamicum. BMC Genomics, 2013. 14(1): p. 
713. 
	  	  124	  
4. Knoppova, M., et al., Plasmid vectors for testing in vivo promoter activities in 
Corynebacterium glutamicum and Rhodococcus erythropolis. Curr Microbiol, 2007. 55(3): 
p. 234-9. 
5. Stansen, C., et al., Characterization of a Corynebacterium glutamicum lactate utilization 
operon induced during temperature-triggered glutamate production. Appl Environ 
Microbiol, 2005. 71(10): p. 5920-8. 
6. Peters-Wendisch, P.G., et al., Pyruvate carboxylase is a major bottleneck for glutamate and 
lysine production by Corynebacterium glutamicum. J Mol Microbiol Biotechnol, 2001. 3(2): 
p. 295-300. 
7. Jensen, J.V. and V.F. Wendisch, Ornithine cyclodeaminase-based proline production by 
Corynebacterium glutamicum. Microb Cell Fact, 2013. 12: p. 63. 
8. Schneider, J. and V.F. Wendisch, Putrescine production by engineered Corynebacterium 
glutamicum. Applied Microbiology and Biotechnology, 2010. 88(4): p. 859-868. 
 	  
 
